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 I feel honoured to be invited to introduce the publication ‚Refinement and standardization 
of storage procedures for clonal crops – Collective Action for the Rehabilitation of Global 
Public Goods Phase 2‛. I am grateful to the authors of this publication, in particular to 
Nicolas Roux, coordinator of centres’ in vitro conservation specialist community. 
The impact of the International Agricultural Research centres’ work towards sustainable 
development largely depends on the centres’ genebanks, which hold the world’s most 
complete collections of plant diversity for food and agriculture. Four centres (Biodiversity, 
CIAT, CIP, and IITA) maintain over 28,000 ex situ accessions of bananas, plantains, cassava, 
potatoes, sweet potatoes, Andean roots and tubers and yams. From this total, 85% are also 
held as in vitro collections under slow growth conditions, and 10% of these have been placed 
under cryopreservation. The conservation of clonal material poses additional and unique 
challenges, especially when in vitro conservation methods are implemented.  
Although the feasibility of using in vitro culture methods for plant genetic resources 
conservation was advocated in the mid to late 1970’s (e.g. by the late G Henshaw and his 
group), it was only in the 1980’s that the International Board for Plant Genetic Resources 
(IBPGR) established a working group of specialists, with the coordination of T Williams and 
L Withers, to look at critical aspects of in vitro plant conservation. As a follow-up, the 
IBPGR/CIAT project was implemented in 1987-89 to assess the technical and logistical 
aspects of establishing and running an in vitro active genebank using cassava as a model. In 
order to realize the potential of in vitro conservation at the CGIAR system and global levels, 
one lesson learned indicated that generic conservation quality standards should be 
developed. Early contributions towards these objectives included the IBPGR status report on 
in vitro conservation techniques by S Ashmore in 1997, and the technical guidelines for the 
management of field and in vitro collections by B Reed et al. in 2004. 
A milestone of the centres’ long history of working together on genetic resources issues 
was the creation of the System-wide Genetic Resources Programme (SGRP) in 1994. Based on 
two external reviews, commissioned by the SGRP in 1995 and 1998, an investment plan was 
developed with World Bank funding; the plan comprised a two-phase programme. The 
programme’s first project ‚Global Public Goods Rehabilitation Project‛, Phase 1 (GPG1), in 
2003-06, raised the standards, and upgraded the operations of CGIAR genebanks. Centres 
holding clonal collections in vitro, made substantial impact on accessions backlog processing, 
advanced the preparation of safety backups, and improved the health status of collections.  
The second project, ‚Collective Action for the Rehabilitation of Global Public Goods 
Phase 2 (GPG2) aimed at enhancing the security and stewardship of the genetic resources held 
in trust in CGIAR genebanks. This project is the central topic of this publication which presents 
the outcomes, lessons learned, and points out key challenges involved in furthering the GPG2 
activity ‚Refinement and standardization of storage procedures for clonal crops‛, sub-activity 
‚Review of in vitro protocols applied to clonal crops‛.  
The GPG2 project (2007-09) successfully promoted collective actions for the conservation 
of clonal genetic resources, specifically to increase their security, to use best practices across 
genebank processes needing validation, third party accreditation and risk management. In 
this context, the evolving role for germplasm curators was envisioned to satisfy 
stakeholders’ demands in meeting high standards in storage procedures (including in vitro 
  
slow growth and cryopreservation), to provide access to taxonomic and trait-related 
information, to develop modern genebank inventory systems for storage and delivery of 
accession data,  and to develop high throughput screening techniques for new traits (such as 
abiotic stress, micronutrient and health-related phytochemical content).  
In pursuing the collective actions for implementing system-wide priorities, attention 
should be placed on the use of best practices for raising the quality standards in the 
management for clonal collections, and on seeking qualification by International Standard 
Organization accreditation, e.g. the recent certification of CIPs’ genebank with ISO 17025. 
Maintenance of third party certifications will require continuous, rigorous controls, processes 
and validations within and between centres. 
To successfully move ahead in implementing the GPG2 objectives, key challenges 
requiring collective attention still need to be tackled. These include: a) establishing practical 
risk-amelioration strategies for in vitro genebanks, especially in disaster-prone areas; 
b) developing simple, low cost, conservation protocols to expand the in vitro genebanks in 
developing countries; c) linking fundamental and applied research in in vitro conservation, 
for expanding the range of cryo-response in the germplasm, for increasing the subculture 
interval of slow growth, and improving the efficiency of disease-indexing techniques at in 
vitro level, and d) developing high throughput screening techniques for relevant new traits, 
such as abiotic stress, micronutrient and health-related phytochemical content.  
 
 
William Roca 
Consultant 
Genetic Resources and Biotechnology 
Lima, Peru 
(w.roca@cgiar.org) 
 
 The mission of the Consultative Group on International Agricultural Research (CGIAR) is: ‚to 
achieve sustainable food security and reduce poverty in developing countries through 
scientific research and activities in agriculture, fisheries, policy, and the environment.‛ To 
facilitate this process, the System-wide Genetic Resources Programme (SGRP) of the CGIAR 
(http://sgrp.cgiar.org/) unites the collective efforts of its individual institutes. The System-wide 
Information Network for Genetic Resources (SINGER) is an information product of SGRP; this 
is an infrastructure that provides CGIAR partners with easy access to information about 
diversity, germplasm conservation as well as crop-related knowledge. In support of CGIAR’s 
mission, SGRP created the Global Public Goods (GPG) project to upgrade the management of 
its in-trust collections. The collective action for the rehabilitation of Global public goods 
system: Phase 2 (GPG2) specifically aims to enhance the security and stewardship of crop 
genetic resources held in-trust by the CGIAR’s genebanks, these collections comprise >650,000 
samples of plant genetic resources. The GPG2 Project and its associated knowledge base 
(http://cropgenebank.sgrp.cgiar.org/) were implemented under the aegis of SGRP in order to 
provide a comprehensive, system-wide work programme for upgrading the crop genebanks 
and the practices used to manage their collections. This will ensure that the CGIAR centres 
meet their in-trust commitments, manage their collections efficiently and sustainably and 
facilitate access by users. The GPG2 Project positions CGIAR’s genebanks to play a leading role 
in building a comprehensive global system for conserving, managing and exchanging plant 
genetic resources for food and agriculture.  
1.1 High standard stewardship for clonal crop in vitro conservation  
The GPG2 project involves upgrading genebank operations and facilities and guiding 
CGIAR’s contribution in developing a global, secure plant genetic resources system. 
Implicitly, high standards of stewardship require collective activities consolidated by 
common, cross-cutting best practices and quality systems and to achieve this, GPG2 
conforms to Logframe Based Management embodied in six outputs and outcomes. It has the 
development goal ‚crop genetic resources and associated biodiversity are put to use in 
developing countries to fight poverty, enhance food security and health, and protect the 
environment.‛ The six issues that define the overarching activities of the project membership 
are shown in Figure 1, noting that in the wider context trust collections are international 
public goods and their use is not restricted to developing countries.  
1.2 Aims 
An overarching objective of GPG2 is to build upon the existing competencies of CGIAR’s 
centres, to develop new modes of collaboration and maximize integration and sharing of 
standards and methods. This document specifically concerns Activity GPG2 1.2: ‚Refinement 
and standardization of storage procedures for clonal crops. In addition, Sub Activity 1.2.1 
provides a ‚Review of in vitro protocols applied to clonal crops‛ in the context of GPG2’s cross-
cutting themes of best practice development, risk management and performance 
measurement. The milestones associated with Activity 1.2 require an appraisal of clonal crop in 
vitro conservation status and the formulation of multi-crop guidelines. The work plans 
associated with these milestones include a CGIAR Clonal Crop Task Force survey, a workshop 
and literature review.  
  
 
Figure 1. Distillation of the six cross-cutting activities of the Collective action for the rehabilitation of 
global public goods in the CGIAR genetic resources system: Phase 2 project. Culminating in the 
development goal (centre box) and implemented under the aegis of the CGIAR System-wide Genetic 
Resources Programme (SGRP). 
 
The overarching rationale of these activities is to apply the information to develop 
collectively, multicrop guidelines for the conservation of clonal crops. This involves 
technology transfer and knowledge exchange to validate best practices for preserving the in 
vitro germplasm of Andean root and tuber crops, cassava, Musa, potato, sweetpotato, and 
yam. Three outputs have been compiled to aid this process and ensure compliance with the 
delivery of GPG2 Activity 1.2 milestones, they comprise:  
 Part I - Global Public Goods Phase 2 (GPG2) - Project landscape and general status of 
clonal crop in vitro conservation technologies. 
 Part II - In vitro conservation status of potato, cassava, Musa, yam, sweetpotato, Andean 
root and tuber crops.  
 Part III - Multi-crop guidelines for developing in vitro conservation best practices for 
clonal crops. 
These outputs are also intended to facilitate in vitro preservation by the wider plant 
conservation community of practice, therefore, Part I introduces the GPG2 project within the 
CGIAR landscape and overviews the status of in vitro plant conservation subsequent to the 
IPGRI-commissioned report of Ashmore (1997).  
 The CGIAR’s global membership comprises developing and industrialized countries, private 
foundations, regional and international organizations each cooperating to provide strategic 
direction, technical assistance and funds in support of CGIAR’s mission. Co-sponsorship is 
provided by the Food and Agriculture Organization (FAO) of the United Nations (UN), The 
United Nations Development Programme (UNDP), and the International Fund for 
Agricultural Development (IFAD) and the World Bank. 
2.1 Overview: CGIAR’s plant genetic resources conservation landscape  
Of the 15 CGIAR research centres, the following four are involved with conserving clonal 
crops in vitro: Centro Internacional de Agricultural Tropical (CIAT), Centro Internacional de 
la Papa (CIP), International Institute of Tropical Agriculture (IITA) and Bioversity 
International. Most activities of the group are common to all CGIAR centres and they are 
mandated to respond to GPG2 by: 
 Collective programmatic action to increase the overall impact of Centre activities on 
poverty alleviation. 
 Collective institutional action to increase Centre impact efficiency.  
In vitro conservation presents challenges not encountered in other modes of germplasm 
management, consequently, CIAT, CIP, IITA and Bioversity comprise a specialist community 
maintaining the international genebanks, which preserve and distribute the in vitro genetic 
resources of clonal crops. These centres cooperate as the ‘Clonal Crop Task Force’ (CCTF) 
and they have a common mission to conserve germplasm from Andean root and tuber crops, 
cassava, Musa, potato, sweetpotato and yam. Their operations are shaped by:  
 The Global Plan of Action, for the Conservation and Sustainable Utilization of Plant 
Genetic Resources for Food and Agriculture (FAO 1996). 
 The International Treaty of Plant Genetic Resources for Food and Agriculture (FAO 2002).  
 The System Priorities for CGIAR Research (CGIAR Science Council 2005).  
2.2 The Global Plan of Action 
Critical issues pertinent to in vitro conservation in the Global Plan of Action are: 
 Sustaining existing ex situ collections. 
 Regenerating threatened species accessions. 
 Supporting the collecting of plant genetic resources for food and agriculture. 
 Expanding ex situ conservation activities.  
These are targeted because genebanks and their ex situ holdings increased substantially 
during the 1970-1980s in response to increased threats to global genetic resources security. The 
need to upgrade and rehabilitate infrastructures was identified as most countries had limited 
long-term storage facilities and focused support was required to enable ex situ conservation by 
rationalizing activities across genebanks. The Global Plan of Action also recognized the need to 
conserve under-utilized species and recommends low-cost technology development suited to 
local conditions, but it cautions that some technologies transferred from temperate climates 
may not be appropriate for tropical countries and vice versa. 
  
2.3 International Treaty of Plant Genetic Resources for Food and 
Agriculture  
The objectives of the International Treaty are aligned with the Convention on Biological 
Diversity (CBD) and the FAO of the United Nations. They concern the conservation and 
sustainable use of plant genetic resources for food and agriculture and the fair and equitable 
sharing of the benefits arising from their use. Supporting components are the Global Plan of 
Action Articles 14 and 15 for ex situ collections of plant genetic resources for food and 
agriculture held by the International Agricultural Research Centres (IARCs). They concur 
with other international institutions and agendas related to plant conservation (Ashmore et 
al. 2007b) and sub-sections specify that the facilities supporting the ex situ collections remain 
under the authority of the IARCs. These undertake their management and administration in 
accordance with internationally accepted standards endorsed by the FAO Commission on 
Genetic Resources for Food and Agriculture (Genebank Standards 1994).  
2.4 The system priorities for CGIAR research 
A process of system-level priority setting was undertaken in 2005 by the Science Council and 
the SGRP, culminating in the identification of a research projection to 2015 (CGIAR Science 
Council 2005). The aim being to develop a more cohesive, focused and high quality research 
programme for alleviating poverty, hunger and malnutrition. CGIAR’s Science Council 
prioritized: 
 Achieving a greater impact through a more consolidated research focus.  
 Avoidance of research dispersion.  
 Rationalization of project funding to maximize the core strength of the CGIAR as a 
supplier of research pertaining to global public goods.  
 More effective mobilization of research capacity across the CGIAR system. 
 Strategic engagement in multi-pronged research involving different commodities, themes 
and disciplines. 
 Enhancement of coordination and cooperation across CGIAR’s centres. 
 Research focused on well-defined system priorities to develop more effective 
partnerships with National Agricultural Research Systems (NARS) and advanced 
institutes in the north and south. 
 Well defined and consolidated research approaches identifying clear routes to poverty 
alleviation to enhance the participation of stakeholders in priority setting and assist 
donor resource allocation, thereby leading to greater impacts. 
 Setting System priorities to enhance accountability.  
Five CGIAR System priority areas, each defined by four priorities, were targeted by 
CGIAR’s Science Council for action in the period 2005-2015; Priority Area 1 is central to the 
remit of this review:  
 Priority Area 1: Sustaining biodiversity for current and future generations.  
 Priority Area 1A: Promoting conservation and characterization of staple crops. 
 Priority Area 1B: Promoting conservation and characterization of underutilized plant 
genetic resources.  
 
 2.5 Implementing system-wide priorities in a cooperative landscape  
Undertaking a ‘system priorities’ approach to CGIAR’s 2005-2015 activities under the 
auspices of SGRP presents new elements that will focus on capacity building, conservation, 
and genetic enhancement activities. These are linked to germplasm and crop usage and 
research is undertaken for development by matching appropriate technologies to projects. 
With respect to research management, priorities maintain a system-wide focus for which the 
cross-cutting theme of poverty alleviation underpins all endeavours. Future interdisciplinary 
connectivity is intimated, for example, by the successful establishment of in-trust collections 
of plant germplasm being followed by conserving animal and fish genetic resources. 
Emphasis is placed on collective research management, review and analysis. This involves 
creating a framework to optimize collaboration across CGIARs’ clonal genebanks, and 
centres are expected to make evolutionary not revolutionary changes to their scientific 
programmes. The Science Council and SGRP highlighted CGIAR’s need to translate new 
priorities into coherent research programmes that bridge and synchronize the efforts of the 
centres and those of their partners.  
  
The SGRP’s GPG2 Project was devised to facilitate CGIAR centres in meeting their in-trust 
commitments for managing collections efficiently and sustainably, now and in the future. 
The Project’s overarching remit is to facilitate building a comprehensive global system, for 
conserving, managing and exchanging plant genetic resources for food and agriculture, it 
comprises two phases.  
3.1 Phase 1 - Springboard for sustainability 
The first phase (2003-2006) addressed the most urgent needs identified by each CGIAR 
centre and SINGER. These included, upgrades in capital items, technical activities and 
dealing with backlogs in essential conservation operations; for genebanks conserving clonal 
crops, Phase 1 involved the Clonal Crops Task Force in the CGIAR’s upgrading exercise. 
Consequently reported achievements were: improved storage facilities, alleviating 
processing accession backlogs, safety-duplication; improved plant health facilities, 
processing of plant health backlogs, new molecular identification facilities and enhanced 
accession characterization. Hardware and software upgrades were important outcomes, 
including barcoding instalment, enhanced SINGER operations and functions and data 
quality improvement. Phase 1 showed the proven impact of investment quantified as 
improved infrastructures and capacity building, thereby enhancing the safety and security of 
global public goods.  
3.2 Phase 2 - Consolidation, research and leadership  
The second phase of GPG2, and the one to which these documents (Parts I, II and III) pertain, 
builds upon the efforts of Phase 1. Implemented in January 2007 for a period of three years it 
focuses on optimizing the CGIARs’ contribution to global conservation and the use of its 
genetic resources held in trust. The centres benefit by enhancing their own facilities, 
operations and capacities, making them better equipped to serve stakeholders and 
beneficiaries. The core practical and operational benefits of their collective actions make for a 
more accessible, cost effective, efficient and secure stewardship of their in-trust collections. 
Benefits are captured through collective activities (Figures 1-2) targeted at improving the 
security of crops held in common, through knowledge sharing, cohesive risk management 
and best practices development. The definitive beneficiaries of the GPG2 project will be the 
poor farmers of the developing world, as well as national agricultural research stations, 
public and private plant breeding organizations and seed producers. As a result, there will 
be a greater confidence in the security of genetic resources in a world increasingly impacted 
by the challenges of climate change, environmental erosion and conflict. Collective action for 
the rehabilitation of genebanks in Phase 2 also supports a greater access to crop diversity 
held in-trust by the CGIAR. 
3.3 Optimizing genebank operations for clonal crop germplasm 
CGIAR’s Science Council 2005 review conveyed the intent to link priority setting to 
monitoring, evaluation and performance measurement. This intercalation was deemed vital 
for research efficiency and meeting the CGIAR’s commitment to the UN Millennium 
 Development Goals (MDG). Linking these priorities (see Figure 2) aids high standard 
stewardship through collective genebank experience. Concomitantly, this will improve the 
quality of and access to information related to CGIAR’s germplasm collections and improve 
streamlined ordering. On completion of the GPG2 project, the Knowledge Base will provide 
a communications hub (http://cropgenebank.sgrp.cgiar.org/) and a one-point access to 
information on best practices, policies, risk management, inventory systems, performance 
indicators, crop information, guidelines and training materials.  
 
Figure 2. Targets in GPG2 for optimization of genebanking standards and attainment of high standard 
stewardship within the CGIAR centres.  
3.4 In vitro genebank standards 
The long-term objective of GPG2 is to raise plant genebanking standards worldwide. This 
requires compliance with regulations concerning germplasm acquisitions, material transfer 
agreements, ownership and phytosanitary legislation, all of which are drivers for quality 
management and best practice development. With respect to technical issues, priority areas 
are: protocol optimization, validating best practices and undertaking risk assessments between 
cooperative partners. However, attaining high standard stewardship across the 
CGIAR’s genebanks will progress differently as some standards are generic (quality, 
sustainability, security and accessibility) and cross-cutting (Figure 2) whereas, others are 
technically specific, albeit overarching standards are common (see Genebank Standards 1994). 
3.4.1 The significance of standards in quality storage systems 
A standard is a level of quality accepted as the norm, or a means by which attainments are 
judged, they are important targets for individuals, groups and organizations to aim for, and 
they are central to developing quality systems across federated genebanks. Commonly held 
standards also provide cohesion across their communities of practice and they help to build 
  
consensus in meeting collective compliance with regulations, good practices and codes of 
conduct (von Versen et al. 2000). However, Genebank Standards (1994) offer two cautionary 
points: (1) limitations of fixing of standards in a point in time and (2) inability of some 
institutions to attain standards. Problems can arise when existing standards limit 
advancements that are in step with future technological developments. It is therefore 
important that the CGIAR’s global genebank networks do not become fixed at any one level, 
this concern is addressed in force by the GPG2 project and its motivation for best practice 
development. Intrinsically more problematic, are constraints in institutions, for which 
standard attainment will remain aspirational whilst their capacity building progresses 
(OECD 2007). Genebank Standards (1994) specify two standards: 
 Acceptable standard: in many cases minimal, but adequate in the short term. 
 Preferred standard: a higher and consequentially safer standard. 
The CGIAR has progressively developed standards and technical guidelines for in vitro 
germplasm collections (Withers 1985; IBPGR 1986; IPGRI-CIAT 1994; Panis and Thinh 2001; 
Engels and Visser 2003; Reed et al. 2004a; Rao et al. 2006; Panis 2009). These contemporary 
standards have added value when working towards and sustaining accreditation, such as 
ISO certification via an external body at CIP. However, once awarded there is a need for a 
long-term financial and service commitment to maintain accreditation status. Where 
resources and infrastructures are limited, curators need to be pragmatic, as although 
prevailing conditions may be less than ideal, collections should not be placed in jeopardy 
(Genebank standards 1994). It is critical to perform risk assessments when setting standards, 
for germplasm held in vitro, these may need to be more risk averse to compensate for the 
potential loss of essential infrastructures such as liquid nitrogen (LN) supply. The 
management and stewardship of clonal genetic resources maintained in culture and 
cryogenic storage has some commonality with orthodox seed banking (Genebank Standards 
1994; Engels and Visser 2003; Rao et al. 2006) but there are some critical differences between 
these two modes of conservation. For in vitro conservation, long-term, sustainable efforts are 
best supported by preferred standards due to the (very) long-term security and safety 
requirements of specialist infrastructures.  
 Seed storage is the preferred conservation method, but it is not feasible for germplasm from 
crops that are either clonally propagated and/or that do not produce seeds. For some 
genotypes, elite genetic combinations are only preserved through clonal means as their 
conservation is dictated by breeding strategy, this is because heterozygosity does not permit 
the maintenance of desired characteristics. Clonally propagated plants thus require special 
conservation approaches. Options include maintenance in field genebanks and the 
conservation, in cold stores of dormant vegetative propagules (Reed 2001), however, these 
methods have limitations regarding efficiency, costs, security and long-term maintenance. In 
vitro conservation is preferentially applied to clonal crop germplasm as it also supports safe 
germplasm transfers under regulated phytosanitary control (IBPGR 1988).  
4.1 Principles of the in vitro genebank (IVGB) 
Conservation in IVGBs combines tissue culture and cryopreservation for medium-term 
(MTS) and long-term (LTS) storage respectively (Figure 3). For MTS, subculture intervals are 
extended, reducing processing costs by arresting growth using reduced temperature 
treatments and/or growth retardants. For LTS, germplasm (usually shoot tip meristems) 
from in vitro-propagated plants is cryobanked for long-term storage in liquid nitrogen (LN) 
to a minimal temperature of -196°C in the liquid phase.  
4.1.1 The in vitro base genebank (IVBG) 
As defined by Genebank standards (1994) for seed germplasm, base collections are a set of 
genetically distinct different accessions as close, as is possible to the samples originally 
procured that are used to establish the collection (Figure 3). Key attributes of germplasm in 
the base collection are: (a) it is preserved for the long-term and (b) it is not normally 
distributed directly to users. A base collection ideally represents a comprehensive genepool 
of the crop or species; for security purposes this is dispersed and managed across different 
institutions. Since the germplasm they hold is stored for extended periods, IVBGs are usually 
designated as cryobanks (IBPGR 1986; IPGRI-CIAT 1994). Different cultures, explants and 
germplasm types are used for conserving plant genetic resources. Examples include: pollen, 
seeds, embryonic axes, excised zygotic embryos, somatic embryos, dormant and/or 
acclimated bud material, shoot meristems, nodal cuttings, callus and cell suspensions (Day 
and Stacey 2007; Reed 2008). Cryopreservation has been applied to a wide range of crops and 
other socio-economic plant groups, including, clonal forestry and agroforestry species, 
horticultural plants, biotechnologically significant, secondary metabolite producing cell lines 
and transformed plant germplasm and cultures (Benson 2008a). This report is mandated to 
place emphasis on CGIAR’s genebanks; as such focus is given to the in vitro cryopreservation 
of shoot meristems derived from clonally propagated crops.  
4.1.2 The in vitro active genebank (IVAG) 
As defined by Genebank standards (1994) an active collection comprises accessions 
immediately available for multiplication, distribution and use and based on the principles 
similar to those developed for seed banks, the IVAG was created (Withers 1989). The cyclic 
flow of material is the key feature of IVAGs, which maintain by successive subculturing, the 
  
renewal and distribution of their cultures (Figure 3). Within IVAGs, cultures are maintained 
under conditions that slow or retard growth (IPGRI-CIAT 1994); this increases the efficient 
use of resources and staff time and offsets selection risks and contamination.  
4.2 In vitro technologies and the safe movement of germplasm 
The IVGB supports the safe movement of germplasm across international borders providing 
assurance that pathogens (including viruses, viroids, phytoplasmas, microorganisms, pests) 
are not transmitted, this is facilitated by: 
Phase 1: Germplasm import, in vitro pathogen testing, eradication, and indexation. 
Phase 2: In vitro storage of certified pathogen/disease-free germplasm.  
Phase 3: Germplasm export, shipment from the in vitro conservation laboratory. 
 
Figure 3. Principles of the in vitro genebanks and their relationships with other operations (based on 
IBPGR 1986).  
IVAG = In vitro active genebank, utilizing slow growth for medium-term storage (MTS)  
IVBG = In vitro base genebank, utilizing cryostorage for long-term storage (LTS).  
Critical points of security are indicated. 
 
Regulated quarantines and inspections take place in Phases 1 and 3, on collection and 
distribution. The timing of pathogen indexing is critical and may require in vitro quarantine, 
dependent on whether initial indexing and virus elimination have been performed before, or 
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 after germplasm is placed in culture (Reed et al. 2004a), as would be the case for germplasm 
collected using in vitro techniques (Pence et al. 2002). Virus and pathogen testing and 
elimination may be undertaken at any stage, no plants should be distributed until testing is 
complete and delineation of in vitro collections into tested, certified disease-free and untested 
components is advisable.  
4.2.1 Containment, quarantine and testing 
In vitro containment, in combination with disease indexing and transfer of cultures maintains 
a high level of phytosanitary control (IBPGR 1988; Reed et al. 2004a), although this is only 
upheld if critical conditions and requirements are met:  
1. Documentation: robust record keeping and the use of tracking systems throughout, so 
that the phytosanitary status of a sample is known at any time, optimally by using bar-
coded electronic inventories and data loggers. 
2. Quarantine: in vitro containment is not a substitute for quarantine and at appropriate 
points (e.g. entry of materials into the collection) stringent isolation procedures should be 
adhered to in compliance with quarantine regulations.  
3. Timing of pathogen testing: separation and safe containment of different collections into 
the safe storage of material, prior to therapy and by the segregation of indexing into 
‘pathogen tested’ and ‘pathogen untested’ and the control of flow through collections as 
materials progress through the various stages of phytosanitary treatment. This includes 
materials infected with more than one pathogen and those that have not completed a 
therapeutic cycle or been certified free from pathogens.  
4. Testing containment: comprising totally contained pathogen-testing systems.  
5. Phytosanitary treatments: visual inspection, pest/pathogen testing and treatment, virus 
indexing and elimination (meristem culture, thermotherapy, chemotherapy, cryotherapy) 
leading to disease-free status certification. 
6. Technology updates: keeping pace with new technologies for pathogen testing. 
7. Testing in vitro: where virus testing/indexing is undertaken in vitro, detection and 
elimination procedures must be developed for cultured materials as the amount of virus 
can vary in plants. It is cautioned that in vitro plants may not provide adequate inoculum, 
so maintenance of positive in vitro controls in special collections helps to circumvent the 
risks of false negatives. The potential for tissue culture components (e.g. plant growth 
regulators) interfering with test outcomes requires clarification and steps should be 
applied to prevent false negatives. 
8. Safe destruction and disposal: safe removal and disposal of infected materials ensures 
that a pathogen or pest is not released into the environment. 
9. Purposeful retention of infected cultures: it may be desirable to maintain some infected 
in vitro materials under strict containment so they may be used, as reference materials or 
as positive controls in testing procedures. 
10. Distribution control: stringent procedures for the distribution of materials that are 
acceptable to recipients and plant health authorities; in vitro processes offer advantages 
as small volumes of disease-free certified materials can be dispatched more effectively. 
Stringent virus therapy, and disease indexing are crucial for offsetting the risks of 
pathogen transmission; unless treatments are robust in vitro material cannot be 
guaranteed virus free (IBPGR 1998).  
  
4.3 Security of in vitro germplasm storage   
Security measures should be compliant with safety, and ethical authorities, regulations and 
guidelines; including observance of: (a) the Convention on Biological Diversity, (b) the 
Standard Material Transfer Agreement (SMTA) for plant genetic resources exchange and 
(c) the International Plant Protection Convention. Security is required to ensure the core 
responsibilities of all biorepositories (Stacey and Day 2007) which are: 
Purity: freedom from contaminating organisms, 
Authenticity: correct identity, 
Stability: fit-for-purpose and trueness-to-type. 
4.3.1 Purity: freedom from contamination 
Tissue culture is central to clonal plant health care, conservation, and safe germplasm 
movement and risks of containment breach (Figure 4) must be addressed. Following 
phytosanitary processing there remain three main modes of entry of a potential contaminant 
that can compromise the in vitro conservation cycle by pathogenic or adventitious means: 
(1) a covert or unknown organism goes undetected; (2) contamination enters from the 
external environment or as a consequence of operations and (3) cross contamination from 
another culture, culture vessel or cryovial. 
Figure 4. Critical containment zones (1-7) for clonal plant germplasm in an in vitro genebank:  
(1) processing before entry into the genebank; (2) entry after confirmation of negative test result; 
(3) serial subculture for regeneration, bulking up of germplasm for the IVBG, IVGB and dispatch; 
(4) IVAG, associated black box; cryogenic containment in: (5) the cryovial; (6) the cryotank and 
associated black box and (7) the transit Dewar. Breach of containment at any one stage can lead to 
contamination.   
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 All these factors should be considered a real risk and operators are cautioned to assume 
their practices ensure, at all times, that germplasm is not and does not become contaminated; 
yet take precautionary measures because they may be infected (Pegg 1999). Protection of 
germplasm conserved in vitro is reliant on good laboratory practices and asepsis; stringent 
attention to containment is essential and implicit to IVGB operations is testing for aseptic 
technique competency.  
It is likely a contaminant still residing in germplasm after disease eradication and 
sterilization procedures is of unknown source and identity. This type of infection can be 
more problematic to control than a pathogen eradicated by disease indexing before entry to 
the IVGB. Pernicious contaminants are usually covert, resilient and systemic endophytes and 
once in the IVGB they can become opportunistic pathogens and pandemic agents, 
particularly if they are spread by vectors such as mites. Latent infections are challenging as 
they can go unnoticed for several months. Standard tissue culture media may not support 
the active proliferation of many bacteria, fungi and yeasts, as certain components attenuate 
the growth of nuisance microflora leading to undetected false negatives. These are revealed 
later as positives when cultures become stressed by extended subculture cycles, slow 
growth, and cryopreservation. Some organisms are opportunistic pathogens, whilst others 
have beneficial associations with plant materials (Hamill et al. 2005). Any microorganism or 
its propagule able to grow in culture is a contaminant and even if benign, it may become 
pathogenic or a nuisance under different conditions. Bunn and Tan (2004) report that any 
bacterium in a tissue culture can form epiphytic, endophytic, or pathogenic associations. 
Over 40 different bacteriological genera have been isolated as plant tissue culture 
contaminants, including both gram negative and positive bacteria. These have been found in 
similar proportions and commonly include Bacillus spp. and Pseudomonas spp. (Leifert and 
Waites 1990); the axenic state is therefore only a presumed and temporary condition. To 
circumvent risks of contamination from covert, adventitious organisms it is recommended 
that potential routes and points of entry are identified and measures are taken to block them 
(Cassels 1991; Bun and Tan 2002; Thomas and Prakash 2004; Thomas 2007). It is prudent to 
ensure that cultures are indexed and eradicated of nuisance and covert microflora before any 
germplasm enters the genebank (Tanprasert and Reed 1997a, b).  
4.3.2 Authenticity: correct identity 
Authenticity is confirmation a genetic resource is what it is assumed to be, it is a process that 
uses stable phenotypic and genotypic characters as evidence to verify that the identity of 
germplasm is correct (Müller et al. 2005, 2007; Stacey and Day 2007). Obviating the risks of 
misidentification and incorrect labelling are key quality control measures in clonal crop 
genebanks, particularly for those using a multiplicity of procedures and conservation 
processes. Failure to retain an authentic status has severe consequences and in some sectors, 
cultures not matching their purported origin and identity have resulted in published 
research papers being withdrawn and the invalidation of research projects (Stacey 2004). 
Within CGIAR’s genebank operations authentication commences with the verification of 
documentation associated with germplasm acquisition. This involves confirming evidence 
with donors concerning the reliability of passport information, followed by the classification 
of incoming accessions by testing standard markers and descriptors. Informatics tools may 
be used and incoming accessions are categorized as ‘tentative’ until they have been 
characterized. A wide range of molecular techniques can be applied to authenticate 
germplasm (de Vicente 2004) and their use is evidence that plant genebanks are evolving to 
  
meet the needs, and harness the benefits of molecular technologies; this has advantages in 
enabling the analysis of holdings and connecting omics technologies (see Section 6.2) and 
research to genetic resources conservation and use. This includes the possible authentication 
of plant genebank holdings by embracing the ‘bar-code-of-life,’ a concept which is currently 
evolving in other bioresources sectors (see Gachon et al. 2007; Williamson and Day 2007). 
DNA barcoding is a robust technology with multiple uses,  in addition to  research benefits it 
helps avoids unnecessary duplication, allows routine checks for genetic authenticity, and 
helps to ensure a mistaken identity is not perpetuated. However, the technology will require 
further research before its application in crop genebanks is possible and practical.  
Stringent recording and documentation of stored materials within and across MTS and 
LTS inventories is essential as germplasm is maintained for extended timelines in cryobanks 
and slow growth. Furthermore, records and documentation processing is effected when staff 
and modes of record-keeping change. Electronic inventory systems are robust traceability 
processes as they support retention of authenticated status and help to prevent errors arising 
from transcribing hand written records. They also help to optimize management practices 
and as such become cost effective and efficient tools. Electronic barcoding is also a powerful 
quality assurance tool as it allows instant traceability and provides current information on 
status at any point in the genebank and its process chain. 
4.3.3 Stability: optimal storage  
In vitro genebank practices need to ensure their biological resources maintain their special 
characteristics and are not changed because of storage and associated tissue culture practices. 
Genetic instability includes the risks of in vitro-generated instability termed somaclonal 
variation (SCV), defined by Scowcroft (1984) as heritable genetic variability in plants 
generated through tissue culture. Genetic changes can also arise because of epigenetic 
processes, stress and selection pressure. The consequences of SCV are significant for genetic 
resources conservation as it is manifest in the regenerated plant; therefore, reducing the 
potential risk of SCV is necessary. Scowcroft (1984) suggested that in vitro storage protocols 
should avoid practices that increase the risks of genetic variation occurring. These are: 
(1) avoiding germplasm propagation via dedifferentiated (callus) and adventitious routes; 
(2) limiting the use of plant growth regulators that increase the possibility of 
dedifferentiation and adventitious development, and (3) selecting germplasm from young 
cultures as SCV increases and totipotency decreases during prolonged culture. 
Genetic instability arising from tissue culture is particularly significant for clonally 
propagated crops as compared to sexually propagated species in which chromosomal 
abnormalities are eliminated by gametogenesis and fertilization (Cassels and Curry 2001). 
Ideally, germplasm with a higher risk of manifesting genetic instability should be monitored at 
the genetic level, as recessive genetic changes occurring during the tissue culture of asexually 
propagated species will have no phenotypic expression. In this context (see Scowcroft 1984), 
clonal crops may thus be expected to display a potentially higher frequency of SCV than those 
propagated by seed; however, as off-types can arise in field-grown, clonally propagated plants, 
some variation may be unrelated to culture conditions. In vitro conservation can help 
safeguard against the genetic changes that occur in field-propagated materials that have a 
predilection to producing off-types.  
The issue of in vitro-generated genetic instability and its consequences for clonal crop 
conservation thus requires very careful consideration and in all probability, on a crop-by-
 crop basis. This is the case for banana, which has a tendency to produce off-types and for 
some genotypes this inclination can be exacerbated by tissue culture (Sandoval et al. 1996; 
Sahirjam et al. 2003; Ramage et al. 2004; Strosse et al. 2004). A prudent measure may be to 
conduct a risk management exercise for those crops, species, or genotypes that are known to 
have a higher propensity for off-type production and instability. This approach would help 
to allocate the safest conservation strategy by taking practical measures to reduce the risks of 
any instability occurring. For example, by considered selection of explant type and plant 
growth regulators, applying regeneration cycles and using quality controls to define the 
limits of acceptance of variants (de Oliveira et al. 2000; Lakshmanan et al. 2007). Sharma et al. 
(2007) assessed the stability of potato plants regenerated by various routes and concluded 
that low-level molecular variation may become apparent on a genome-wide level and, that in 
the case of somatic embryogenesis this could be attributed to epigenetic changes. In their 
study, differences in yield and height at the time of harvesting were not significantly 
different among potato plants propagated through four different routes (axillary bud 
proliferation, somatic embryogenesis, microtubers and true potato seed). Tyagi et al. (2007) 
observed no significant variation in shoot cultures of turmeric conserved in vitro for one year. 
In this study, stability was confirmed by comparing 25 primer-RAPD profiles of mother 
plants with those of in vitro conserved plantlets. Ryynänen and Aronen (2005) similarly used 
RAPD analysis to demonstrate stability in short and long-term tissue cultures of silver birch 
and for meristems recovered from cryostorage. In contrast, using 44 primer-RAPD profiles, 
Santos et al. (2008) found variability in micropropagated, ornamental pineapple.  
Scowcroft (1984) recommended field performance trials of clonal crops should be 
extended to two propagation cycles, this is based on the potential for both pre-existing and 
induced genetic variation becoming manifest in culture-derived plants (Scowcroft 1985). 
Rani and Raina (2000) caution that variation and instability is not only confined to callus 
cultures and they present evidence for SCV arising from organized meristems, as revealed by 
molecular technologies. The finding that SCV occurs in plants derived from organized, 
meristematic shoot cultures has ramifications for the in vitro conservation of clonal crops, 
although its prevalence is most likely to be crop-specific. Strosse et al. (2004) reported SCV to 
be widespread in banana plants regenerated from shoot cultures, they found the incidence of 
this occurring to be cultivar dependent, and that the frequency of instability was amplified 
by culture-induced factors. Thus, the number of in vitro generation cycles affected the rate of 
variation, whereas standard growth regulators did not. 
Growth retardants might impose selection pressures and genetic change with time, and 
environmental stress could induce mechanisms, which cause genomic modification, 
particularly at the epigenetic level (Cassels and Curry 2001; Harding 2004). The biological 
stasis of storage in LN may be expected to offset the risks of genetic instability occurring; 
although culture practices associated with pre- and post-cryopreservation manipulations 
may still cause stability problems (Harding 1996). Stability testing of plants recovered from 
MTS and LTS has been undertaken at cellular, biosynthetic, phenotypic and genotypic levels 
(Harding 2004; Cha-um and Kirdmanne 2007). A result may not be indicative of genetic 
instability or stability and trueness-to-type evaluations (Perazzo et al. 2000) thus, crop 
performance indicators (Martínez-Montero et al. 2002; Medina et al. 2007) may be applied to 
support molecular testing. Methods include the molecular, genotypic and phenotypic 
assessment of stability and evaluations of developmental competence and field performance 
of clonal crops regenerated from in vitro storage. Examples are: nuclear and chloroplast DNA 
  
(Harding and Benson 2000); microsatellite analysis (Harding and Benson 2001); long-term 
field performance trials (Konan et al. 2007); biometric analysis of phenotypes and 
developmental competency (Benson et al 1996a; Harding and Staines 2001, Harding and 
Benson 1994); AFLPs (Hao et al. 2001, 2002a, b); RAPDs (Schäfer-Menuhr et al. 1997; Hirai 
and Sakai 2000; Dixit et al. 2003); SSRs (Perazzo et al. 2000); combined analyses of genotype, 
phenotype and biosynthetic stability (Ahuja et al. 2002); secondary metabolite production 
(Dixit et al. 2003); RFLP ribosomal RNA genes (Harding 1991, 1997), RAFs (Randomly 
Amplified Polymorphic DNA Fingerprinting) (Kaity et al. 2008); DNA methylation (Harding 
1994; Harding et al. 2000, Kaity et al. 2008), flow cytometry (Ward et al. 1993) and ploidy 
status (Benson et al. 1996a) and assessment of transgene stability (Ryynänen et al. 2005). 
Harding (1996) comments on these methods in assessing the risks of genetic change in plants 
recovered from in vitro-stored germplasm. In this document, these issues are discussed with 
respect to contemporary conservation developments (see Sections 6.2, 6.3.4 and 6.4.3).  
 In the GPG2 project, risk management is core to all activities and has a wider significance in 
anticipating and avoiding any threat to the security and sustainability of in-trust collections. 
In the GPG2 project risk management has two main contexts: 
1. Internal risk management concerning technical, physical and biological risks to which the 
collections and their related information are exposed. 
2. External risk management concerning factors threatening project objectives. 
The risk of a potential hazard occurring, or a threat to safety and security to achieving a 
desirable outcome requires evaluation across different operational activities these are 
described as follows.   
5.1 Links between risk management, best practices and safety 
Effective management of risk is essential for creating and maintaining a safe in vitro storage 
environment, including the safety of personnel regarding their exposure to potentially 
hazardous procedures, substances and equipment. Understanding relationships between 
best practices, risk management and safety is thus imperative for achieving a successful 
outcome. A best practice is thus inherently dependent upon managing risks that might lead 
to its failure or cause harm and, it is an activity or process that is:  
1. More effective at delivering an outcome than any other method. 
2. The most efficient and effective way of accomplishing a task. 
3. Produces an outcome with fewer problems. 
Risk assessment provides a useful framework in which to develop best practices, 
although it is important to be aware that managing risk can become prescriptive where 
regulatory and statuary obligations come into force. Non-compliance with regulations 
pertaining to the acquisition, transfer, safe movement and conservation of germplasm in an 
IVGB is a serious risk. Compliance also includes risks to personnel health and safety in the 
workplace and conforming to regulations, these must take precedence as they dictate the 
route by which a technical procedure is safely undertaken. Implicitly a best practice must not 
put at risk any person, component, process or procedure and it is essential to be aware that 
levels of risk and tolerance can change during research and development. For example, as a 
methodology proceeds from research to validation and becomes implemented as a routine 
procedure. Changes in statutory, regulatory policies are often invoked in response to an 
unforeseen event or accident and can have ramifications for existing best practices (Pegg 
1999; Fuller and Dijk 2008). This is complicated by personnel health and safety risk 
assessments having various levels of compliancy in different countries, regions, institutions 
and sectors (Tomlinson and Sakkas 2000; Tomlinson and Pacey 2003; Tomlinson 2005, 2008). 
These regulations take priority where extreme hazards are concerned, as would be the case 
for the handling of LN, pressurized gases and hazardous chemical substances. Risk 
assessment is not static, as new knowledge about a process, substance or pathogen can 
change, the level at which a risk is assessed may also necessitate changes to a best practice. 
For example, experience gained from a failure to identify a LN containment problem 
precipitated an immediate change in risk management, new regulation, and improved best 
practices in the medical cryopreservation community (HFEA 1998, 2007; Pegg 1999).  
  
Risk assessment has therefore an inextricable role in developing best practices, and can 
be used to advantage by: (1) providing a robust framework in which best practices are 
developed; (2) signposting where best practices need to comply with regulatory obligations 
and (3) creating opportunities to refine existing best practices. Practically, this is the case 
when new information emerges from risk mitigation research, training and development. 
5.2 Developing risk assessments for in vitro genebanks  
Identifying type of hazard and its associated risks are the first steps of any assessment for 
which, there are two main categories of risk. Unavoidable risks are outside the control of the 
operator, as no matter what safety measures are in place they cannot offset the risk. These are 
usually a force majeure and include climatic disasters, armed conflict and terrorism. 
Avoidable risks are potential hazards resulting from routine operations conducted without 
due care and vigilance; these are identified and measured in the first stage of a risk 
assessment. The second stage describes actions required to prevent incidents from 
happening and the third informs how to deal with their consequences as effectively as 
possible. These measures are formalized by a risk assessment which is a systematic, recorded 
operation that rationally foresees and puts into place measures to protect against an adverse 
or damaging incident occurring. An integral part of a risk management process involves the 
reporting of accidents and incidents, usually formalized in a no blame culture. Incident 
outcomes involve the fourth risk management stage, which is learning from accidents in 
order to refine risk management procedures. 
Various information sources are used to compile a technical risk assessment: 
international and national regulations, guidelines and agreements (e.g. for phytosanitary 
control) providers of chemicals and their Material Safety Data Sheets (MSDS), specialist 
cryogenic instrument and gas suppliers and international and national government health 
and safety bodies. The UK’s Health and Safety Executive (HSE 2006) suggest five steps to 
start a risk assessment:  
Step 1 Identify the hazards. 
Step 2 Decide who or what may be harmed.  
Step 3 Evaluate the level of risk and decide on precautions. 
Step 4 Record the finding and implement them. 
Step 5 Review the assessment and update regularly. 
A hazard is defined as anything or a process that can potentially cause harm, a risk is the 
chance high, or low of harm being caused. Identified hazards can be cumulative and risk 
assessment involves the whole process or procedure, in its totality as well as its component 
steps. This includes an indication of how serious, the harm could be and its long-term effect, 
as well as the impact of hazards, an analysis of which can be formally structured using 
quality assurance systems such as the Hazard Analysis Critical Control Point (HACCP). This 
may be applied to plant tissue culture and IVGB operations, for example, as adapted from 
Leifert and Cassells (2001) a critical point assessment for microbiological contamination 
might include: 
1. In depth analysis of all contamination sources using the identification of indicator 
organisms for specific contamination sources. 
2. Establishing monitoring systems for all contamination sources at critical control points 
(CCPs) and developing improved detection methods for contaminants and their sources. 
 3. Improving methods for prevention of contamination at critical control points. 
4. Developing deterrence methods in case preventative strategies fail.  
The HACCP method is useful for developing risk assessment in IVGBs that have 
problems with persistent, latent (i.e. endophytic) bacterial contamination (Leifert and Waites 
1990; Cassels 1991; Leifert and Cassels 2001) and assessing containment risks during complex 
manipulations, such as meristem excision and cryoprotection. 
5.2.1 Collective action for risk assessment in CGIAR’S in vitro genebanks 
Risk assessments undertaken within GPG2 are formalized using a generic template and 
assessment metrics. Training in risk management and working towards a common 
consensus across a community of practice is advisable.  
Technical risk auditing for biorepositories involves several levels of complex evaluations 
which can be simplified using a logical risk matrix (Table 1). Possible strategies for generic 
risk identification can be based on personnel, sample, process, facilities, and infrastructure. 
Mapping out risk zones, areas and processes within genebank activities and operations aids 
risk identification and reduces the possibility of overlooking a potential hazard. Work flow-
charts used in quality assurance exercises can also be used to plot risks in a logical order. In 
developing a risk map for an IVGB, the following exemplars may be included:  
1. Institutional infrastructures: essential infrastructures and services (e.g. electricity, 
generators water, gas, maintenance; IT support and computers; security systems, alarms, 
alert devices, fire).  
2. Specialist facilities: LN supply; special containment zones, laminar airflow cabinets, 
ventilation/air conditioning, culture/growth rooms, task lighting (for culture rooms); 
autoclave, laboratory equipment and instrumentation (calibration, validation, auditing, 
safety and routine maintenance); cryotanks, freezer, refrigerator; cryotank surveillance 
and monitoring, LN-low-level security systems alarms, low level-O2 personnel safety 
monitors, alarms and alert devices.  
3. Generic methodologies and processes: compliance with regulations; germplasm 
acquisition, collection, germplasm and tissue culture selection, processing, treatment; 
culture media quality assurance and preparation; phytosanitary treatments, quarantine, 
containment, monitoring and surveillance; records management, documentation, 
tracking and traceability; post-storage recovery procedures, regeneration, stability and 
field performance assessments; germplasm exchange and transfers. 
4. Specific storage methods: germplasm selection, for slow growth (culture medium, 
temperature, osmotic and special treatments); germplasm selection, treatment for 
cryopreservation, meristem excision, risks of different cryopreservation protocols 
(pregrowth, cryoprotection, cryogenic protocol; cryovial, cryotank, choice of LN phase, 
cryotank inventories and input output procedures; rewarming, recovery, shipment in dry 
shippers) black box security, containment, security; regulatory safety audits of cryogenic 
equipment.  
Once a consensus for risk assessment has been collectively agreed upon, a logical framework is 
created to sequence, group and assess the risk; each step is identified with a specific level of 
  
risk, with respect to its impact, probability, and acceptance. It is usual to prioritize risks into 
levels from very high to very low, with the greatest loss and greatest probability of a risk 
occurring being considered first. This can be difficult to rationalize, particularly for complex 
and multiple procedures and to assist this process Tomlinson (2005, 2008) has adopted the 
Australian/New Zealand model for managing risks associated with cryopreservation. The 
score is the product of the consequences and the chance of it occurring, i.e. risk x likelihood, it 
indicates the adequacy of controls and informs as to whether to accept the risk or not. 
 
Table 1. Generic risk assessment metrics for GPG2 Activity 1.1 used to develop and implement 
risk management procedures in CGIAR’s crop genebanks.  
Description Assessment and score metrics 
Genebank objective IVAG (MTS)  IVBG (LTS)  
Genebank activity 
Operations component 
e.g. culture initiation, culture media preparation, slow growth, 
cryoprotection, cryopreservation, phytosanitary treatments, storage, 
recovery and regeneration procedures, cryogenic transit shipments, black 
boxes  
Risk identification Sequential identification of risk pertaining to each procedure and activity  
Risk potential impact Very Low (VL), Low (L), Medium (M), High (H), Very High (VH)  
Risk probability Very Low (VL), Low (L), Medium (M), High (H), Very High (VH) 
Accepted risk  No (N), Yes (Y)  
Actions and strategies to eliminate 
or manage risks 
Sequential corrective actions  
 
A well-audited, accurately scored technical risk assessment is desirable as it guides 
where resources, personnel, and funding are required to ensure successful risk mitigation. 
Validation of risk assessment and safety procedures is also desirable and has been 
undertaken in cryobanks to minimize the risks of contamination (Maertens et al. 2004). 
Technical risk assessments of complex IVGB processes should yield concise, accurate, and 
easy to understand information. This is necessary as all technical operators must understand 
the process and the process informs how risk management decisions are prioritized and 
acted upon efficiently and cost effectively (Tomlinson 2008). 
5.3 Actions and strategies to eliminate or manage risks 
Once a risk assessment exercise has been performed for all the components of an activity, 
actions and resources can be put in place to eliminate and manage the risks, for example: 
1. Compliance: with standards and regulations specifically designed to offset and eliminate 
risk and adherence to manufacturers’ and chemical suppliers’ instructions.  
2. Risk avoidance: not performing an activity that carries a risk. 
3. Risk elimination: putting in place measures, controls, countermeasures to eliminate risk. 
 4. Risk reduction: putting in place measures controls and countermeasures that reduce the 
severity of a risk. 
5. Risk contingency and emergency: putting in place measures controls and 
countermeasures that deal with the outcomes of an incident or accident should all risk 
countermeasures fail. 
5.3.1 Examples of risk amelioration strategies for IVGBs 
1. Staff safety equipment, personal protective clothing, alarms for LN or O2 depletion, 
putting medical, health and safety protocols in place in case of an accident. 
2. Screening for pathogenic, adventitious, endophytic, systemic and covert microbial flora 
and pests before allowing entry to the IVGB. 
3. Physical security and containment of growth rooms, clean rooms and cryotanks.  
4. A reliable LN supply and a back up or alternative supply for contingencies. 
5. Back up duplication of accessions in black box collections. 
6. Containment of culture and cryostorage vessels. 
7. Correct choice and containment of cryovials, to reduce transmission of cross and 
adventitious contamination by direct exposure to LN and to prevent explosion hazards. 
8. Appropriate choice of LN phase storage to avert cross contamination of samples and the 
destabilization of vitrified germplasm around the critical Tg zone. 
9. Locating cryotanks in clean rooms to minimize cumulative adventitious contamination.  
10. Alarmed cryotanks and auto-fill systems. 
11. Avoiding use of equipment unsuitable for cryogenic manipulations. 
12. Adherence to manufacturers’ safety advice for use of cryogenic equipment. 
13. Witnessing, security labelling and barcode tracking. 
14. Spot-check monitoring and use of sentinels for pathogenic, adventitious and covert 
microbial flora, pests and mites throughout the genebank process chain. 
15. Stability surveillance and assessments. 
5.4 Risk management reviews and training  
Continual reviewing and updating of risk management procedures is required for risk 
mitigation, reviews should be scheduled on a routine, recurrent basis and as acute responses 
to incidents and accidents. Surveillance of safety literature and manufactures’ information 
should be ongoing in order to assimilate new information that may require immediate 
changes to safety procedures and policy. These actions ensure risk assessment criteria and 
operations remain applicable and effective and that evidential changes to processes are 
implemented. This is necessary if a hitherto unknown risk has been identified as hazardous; 
risk management is therefore an evolutionary process and it requires consensus across 
communities of practice. The first risk assessment exercise will not usually be optimal, 
requiring refinement and testing for compliance and accuracy to meet local and group needs. 
Training in risk management is thus essential for both new and experienced personnel as it 
avoids the risk of poor practices being retained and infiltrating processes.  
  
This section overviews the development in slow growth and cryopreservation technologies 
based on and following the research agendas and recommendations of Normah et al. (1996), 
Ashmore (1997), Engelmann and Takagi (2000) and Reed et al. (2004a). A recommendation 
arising from the workshop on ‘Cryopreservation of Tropical Plant Germplasm’ proposed 
increased contact with institutes already using cryopreservation on a routine, large-scale, 
including those conserving microorganisms, and animal germplasm (Engelmann and Takagi 
2000). Accordingly, this section explores developments in the wider, global biological 
resources communities (Caboux et al. 2007; Coecke et al. 2005; Hartung et al. 2002; ISBER 
2005, 2008; NCI 2007; Parker and Hunt 2000). Many of these sectors are cooperating to 
pioneer quality management systems across different geographical regions and communities 
of practice (Kostiak 2000; Martínez-Pardo and Mariano-Magaña 2007; Smith 1998, 2001, 2003; 
Smith and Ryan 2001; WHO 2007). Their emphasis is on collaboration and networking for 
the transfer of safe storage technologies and their validation. The Organization for Economic 
Co-operation and Development’s programme (OECD 2001, 2007) and the coordinated Global 
Biological Resources Centres Network (GBRCN) exemplify these activities. The 
microbiological sector, in particular is developing at pace, quality assured and validated 
management systems for securing their genetic resources in culture collections (Smith and 
Ryan 2008).  
6.1 Utilizing quality systems for clonal crop in vitro genebanks 
Whilst the use of biological resources is domain specific, the quest for quality systems and 
best practices is generic across all sectors pursuing validation (Smith and Ryan 2008), third 
party accreditation (von Versen et al. 2000) and risk management (Tomlinson 2008). 
Appraising their experiences is timely for CGIAR’s crop plant genebank community, 
particularly as best practices are at the core of the OECD’s modern ‘Biological Resource 
Centre’ concept (OECD 2001, 2007). The International Society for Biological and 
Environmental Repositories (ISBER) is similarly developing best practice guidelines for the 
collection, storage, retrieval, and distribution of biological materials (ISBER 2005, 2008). In 
the Biological Resource Centre (BRC) framework, conservers of genetic resources also 
become providers of high quality information related to their holdings. This approach 
concurs with De Vicente (2004) regarding the evolving role of CGIAR’s genebanks, which is 
motivated by advances in genomics and molecular technologies. These promise to enhance 
genetic resources utility as an increased understanding of how a gene functions will provide 
powerful insights into the relationship between phenotype and genotype and can help 
inform how best to utilize germplasm conserved in genebanks. Consequently, genebank 
managers will need to offer services across different disciplines to satisfy the demands of 
modern molecular science. Meeting high standard in vitro storage and stewardship is a 
necessary part of this process, as stakeholders, researchers and beneficiaries require quality, 
authenticated and stable genetic resources (De Vicente 2004, Stacey and Doyle 1998; Stacey et 
al. 1999; Stacey 1999, 2004; Day and Stacey 2007; Stacey and Day 2007). 
 6.2 Progress in in vitro plant conservation strategies 
The in vitro conservation status report commissioned by IPGRI and compiled by Ashmore 
(1997) involved a broad consultation process, including two international workshops.  
1. International Workshop on ‚In Vitro Conservation of Plant Genetic Resources‛ held in 
Kuala Lumpur, Malaysia, 1995 (Normah et al. 1996) resulting in a consensus of 
Workshop recommendations (International Workshop on ‚In Vitro Conservation of Plant 
Genetic Resources 1996). 
2. International Workshop on the Management of Field and IVGBs held at CIAT, Colombia 
in 1996 that informed the IPGRI Handbook for Genebanks No. 7, technical guidelines for 
the management of field and in vitro germplasm collections (Reed et al. 2004a).  
Normah et al. (1996) made recommendations pertaining to training and information 
exchange, technique development and basic research. Reed et al. (2004a) formulated 
technical guidelines for initiating a collection, and operating germplasm health procedures. 
Because tissue culture and storage methods had been developed, but were not fully available 
or operational the need to standardize operational procedures for clonal plants was 
highlighted. Research requirements identified by Reed et al. (2004a) were: 
 Germplasm health: virus surveys, indexing techniques, development of effective virus 
testing in vitro and whether viruses can be transmitted in vitro, development of indexing 
techniques for latent endogenous bacteria. 
 Slow growth: research into the effects of plant growth regulators and growth retardants, 
light and light-temperature interactions, propagule type, size, growth stage (microtubers, 
bulbs, rooted plantlets, unrooted shoots), statistical rigour in experimental design, 
minimising the use of growth retardants. 
 Cryopreservation: widening its applicability to more crops and genotypes, methods 
developed for several localities, use of cryotherapy. 
 Genetic stability: selection pressure of in vitro maintenance, genetic variation in field 
compared to in vitro, field evaluations on material with known instabilities, development 
of markers to monitor genetic stability. 
Ashmore (1997) similarly listed key issues and actions for future consideration:  
Genetic stability: greater understanding of the causes and nature of SCV particularly 
after prolonged storage in culture and cryopreservation and establishing safe storage 
procedures.  
Actioned by: developing improved markers and methods of characterizing SCV and 
monitoring genetic instability. Encouragement of research aimed at understanding causal 
factors of SCV and comparative assessments of genetic stability in germplasm conserved in 
field and IVGBs recommended.  
Reproducible and wider use of slow growth and cryopreservation methods: improved, 
reproducible and robust protocols required for slow growth and cryopreservation optimized 
across genotypes held in genebanks, greater provision for species that have received limited 
attention, application of in vitro methods for safe movement of germplasm and prioritising 
problem species.  
Actioned by: developing methods using simple facilities, with general application, 
optimized, and tested in IVGBs; more information on in vitro distribution and transportation 
of in vitro material.  
  
Management issues: database of in vitro collections and their activities and operations 
required including routine methods and guidelines, particularly addressing what are 
acceptable ranges for survival and amount of material to be stored per accession for in vitro 
storage techniques. Strategies required to rationalize collections to: (1) account for issues of 
safety duplication and narrowing the genetic base but avoiding excessive use of resources in 
holding collections and (2) undertake cost analyses between IVGBs and field genebanks. 
Actioned by: creating an IVBG database, encouraging use of in vitro techniques and 
development of proper guidelines for the IVGB operation including rationalization of genetic 
strategies and carrying out of comprehensive cost analyses to compare IVGB with field 
genebank operations.  
Infrastructure: establishment of basic infrastructures in IVGBs for LN, supply and 
upgrading facilities, in many locations including back up, repairs, maintenance and servicing 
of equipment with a view to using simple facilities.  
Actioned by: provision of adequate infrastructures, locally serviced equipment and simple 
methods.  
Training: more information exchanges needed for knowledge sharing, collaboration and 
coordination with emphasis on local training for developing countries. More research carried 
out in developing countries and transfer of technologies between international centres and 
regional and national programmes.  
Actioned by: better coordination of in vitro conservation programmes to allow greater 
exchange of ideas and initiating of training in developing countries.  
Policy Issues: government commitment to mandate plant genetic resources conservation; 
sustainable funding needed as many in vitro projects are project-based and there is a need to 
emphasize the importance of in vitro techniques to encourage their adoption.  
Actioned by: exploring sustainable funding measures, a commitment to in vitro conservation 
and promotion of positive outcomes of using in vitro technologies to secure and control 
phytosanitary status and protect plant germplasm from environmental hazards.  
With an emphasis on tropical crops, Engelmann and Takagi (2000) recommended: 
 More basic research needed to improve understanding of biological and physical 
mechanisms involved in cryopreservation, broadening its application to problem species 
and achieving higher survival using simplified freezing protocols. 
 Systematic assessment of stability in plants regenerated from cryopreservation needed 
using all available detection techniques. 
 More research on tropical plants especially those with recalcitrant seeds.  
 Development of research emphasizing scale-up of cryopreservation. 
6.2.1 Contemporary developments in in vitro plant conservation 
Advances in cryopreservation and molecular biology have been considerable since the report 
by Ashmore (1997). One of the most significant advances has been in omics research, this 
comprises: (1) genomics, the quantitative study of genes, regulatory and non-coding 
sequences to yield information on DNA sequences and structure; (2) functional genomics, 
the dynamic, interpretive study of genes focusing on gene transcription, translation and 
protein interactions; (3) transcriptomics, the study of RNA, gene expression and regulation; 
(4) proteomics, the study of protein function and (5) metabolomics, the study of metabolites 
 and metabolic pathways and how they interconnect. Omics and molecular genetics 
technologies both support and utilize in vitro conservation (Carpentier et al. 2005, 2006, 2007; 
Ryynänen et al. 2002). Functional genomics and the use of candidate genes as tools to screen 
for useful traits in germplasm collections is expanding and collectively these approaches will 
enhance the greater utilization of banked material (de Vicente 2004).  
Technical progress in cryopreservation continues mainly by empirical study involving 
testing cryoprotectant strategies (Sakai 2004; Sakai and Engelmann 2007; Sakai et al. 2008). 
This approach (Figure 5) has the advantage of simplicity as direct observations are used to 
develop protocols.  
 
 
Figure 5. Road map examining the contributions of various types of research in the development of quality 
systems for in vitro conservation technologies. RTD = research, training and development. 
  
 
Reed (2008) describes cryopreservation protocols for a large range of species and explants, 
progress has been largely vitrification-based, enabling the large-scale cryobanking of 
germplasm (Engelmann 2004; Gonzalez-Arnao et al. 2008, Gonzalez-Arnao and Engelmann 
2006; Keller et al. 2005, 2006, 2008; Keller and Senula 2003; Kim et al. 2006, 2007; Panis et al. 
2005; Sakai and Engelmann 2007). Similar approaches have facilitated the MTS of plant genetic 
resources (Volk and Walters 2003; Cha-um and Kirdmanee 2007). These reports have satisfied 
many of the recommendations made by Ashmore (1997) and Engelmann and Takagi (2000), 
especially for tropical species, although storage remains a problem for species recalcitrant to 
tissue culture and/or those that produce desiccation sensitive seeds (Ashmore et al. 2007a; 
Benson 2008a; Berjak 2006, Berjak et al. 1990, Berjak and Pammenter 1994, 2008; Engelmann 
1999; Pritchard 2004; Withers and Williams 1980).  
Advances in fundamental research (Figure 5) have enhanced the knowledge base of plant 
in vitro storage technologies. The EU CRYMCEPT project (http://www.biw.kuleuven.be/ 
dtp/tro/crymcept/CRYMCEPT.htm) is the acronym for a European Commission Research 
Project (Reference: QLK5-CT-2002-01279) entitled: ‚Establishing CRYopreservation Methods 
for Conserving European PlanT Germplasm Collections‛, which has added substantially to 
fundamental plant cryopreservation research. The EU COST ACTION project 
‚CRYOPLANET‛ (http://www.biw.kuleuven.be/dtp/tro/cost871/Home.htm) similarly links 
fundamental research to cryopreservation implementation. In vitro conservation technology 
research has been appraised by the Australian International Association of Plant Tissue 
Culture and Biotechnology (Bennett et al. 2005). More specific research examples include the 
use of omics technologies to help understand storage recalcitrance (Carpentier et al. 2005, 2006, 
2007; Criel et al. 2005); thermal analyses to elucidate the mechanisms involved in creating and 
stabilizing the glassy state (Volk and Walters 2006; Volk et al. 2006) and oxidative stress and 
epigenetic markers applied to monitor cryoinjury in storage sensitive genotypes (Benson et al. 
2007; Fang et al. 2008; Johnston et al. 2005, 2007). Technological developments in molecular and 
analytical diagnostics have facilitated more stringent phytosanitary monitoring (Mumford et 
al. 2006) and storage stability assessments (Ahuja et al. 2002; Dixit et al. 2003; Harding 2004; 
Hirai and Sakai 2000; Kaity et al. 2008; Perazzo et al. 2000; Schäfer-Menuhr et al. 1997). The 
needs of in vitro conservationists are also being met by specialist cryo-engineering and 
products manufacturers (Benson et al. 2005). Knowledge management (KM) and information 
technology (IT) sectors are designing electronic barcode inventory systems products to support 
in vitro storage technologies. Collectively, these contemporary advances support the 
movement towards quality systems and accreditation in crop genebanks (Figure 5).  
6.3 Medium-term storage: slow growth  
Tissue culture provides two possibilities for storage, growth in the active state and slow 
growth which is designated as medium-term storage (Benson 1999). Reducing the growth 
rate of cultured plants enhances efficiency and reduces the costs of resources and labour 
intensive subculturing cycles. Disease-free, growth-arrested cultures are the primary source 
material for the IVAG (Figure 3) and the in vitro plants and propagules held in MTS 
constitute a complementary conservation strategy for cryobanked germplasm maintained in 
the IVBG (Keller and Senula 2003; Reed et al. 1998a, b). The development and 
implementation of slow growth is allied to other in vitro plant manipulations, especially 
micropropagation. Types of explants used in slow growth (usually) range from rooted 
 plants, microtubers, and storage organs to shoot cultures. Some treatments that incur slow 
growth for conservation purposes are similarly applied for the selection and production of 
stress tolerant genotypes (Ochatt et al. 1999), mutants (Luan et al. 2007) and somaclonal 
variants (Jain 2001). Thus, it is useful to reciprocate knowledge from these other fields of 
study as it has risk management relevance for clonal genebanks that are optimising MTS 
treatments, such that stresses imposed, do not incur permanent debilitating symptoms, or 
lead to phenotypic, genetic or epigenetic instability in recovered plants (Benson et al. 1989; 
Harding 1991, 1994, 1999; Harding et al. 1991, 2005; Joyce and Cassels 2002; Joyce et al. 2003).  
6.3.1 Principles of medium-term storage 
The objective of slow growth (or minimal growth) is to reduce subculture intervals to a 
critical level that does not impose a long-term deleterious effect on germplasm, or put at risk 
the stability of regenerated/regrown plants. However, slow growth treatments incur some 
level of stress and it is essential to optimize MTS with respect to the timing of subculture 
regimes and regeneration. When this is achieved, slow growth is a successful method of 
securing plant germplasm in MTS (Cha-um and Kirdmanne 2007). Minimal growth storage 
is useful for genotypes that cannot be cryopreserved and it is a key part of in vitro genebanks 
that clonally propagate crops for distribution services. Several MTS treatments are applied, 
either singularly or in combination to retard growth:  
 Physical growth limitation 
- low temperature  
- low light/restricted photoperiod 
- minimal containment 
- minimal O2  
- osmotic (water) stress.  
 Chemical growth limitation 
- growth regulator retardation  
- growth inhibitors. 
 Nutrient limitation 
- low macro nutrient levels 
- low micro nutrients levels. 
 
Choice of treatment is largely species-dependent and it is dictated by the ability to 
withstand the stresses incurred; the simplest and most successful slow growth strategies 
involve temperature and light limitation. Restrictions to MTS are deleterious effects, variable 
genotype responses, callus formation, hyperhydricity, and the proliferation of covert and 
systemic infections, including adventitious contamination entering in vitro vessels during 
extended culture (Golmirzaie and Toledo 1998). Containment is critical and Reed (1991) 
recommends using gas-permeable bags which have the advantage of small size, and 
resistance to breakages; a separate chamber for each plant reduces the risk of cross-infection 
and for an active collection individual bags can be easily removed for distribution. A bottle-
neck in the application of slow growth is adapting a generic, growth limiting protocol to 
every accession of a large multi-crop genebank. This has been explored by Reed et al. (2003) 
who adapted a basic cold storage protocol for unrelated genera by making minor technical 
  
modifications. Using shoot cultures of Humulus spp. (hops) as the test case, diverse 
genotypes were evaluated for MTS treatments comprising low light with cold storage (4°C) 
as first developed for strawberry and mint. Average storage time, without transfer for 70 
Humulus genotypes was 14 ± 3.5 months, ranging from 6-26 months. This study confirms that 
a standard MTS protocol can be applied across diverse genotypes, although improvements 
may be required for outlying, low response performers. 
Temperature is the main limiting abiotic factor, as it is applicable across both tropical and 
temperate plants. Low temperature (20°C) storage of cassava reduced shoot growth by a fifth 
compared to those propagated under standard growth at 25-30°C (Angel et al. 1996). 
Minimal growth conditions comprising low light (1000 lux) and temperature (15°C) have 
been used to maintain several Musa genotypes for 13-17 months (Banarjee and de Langhe 
1985). A low temperature treatment of 2°C and 10°C is used for the MTS of in vitro Allium 
cultures at IPK, extending the culture cycle to 12 months (Keller et al. 2006). Mint is generally 
amenable to in vitro culture and MTS, for which most in vitro-maintained clones at IPK can 
be stored at 2°C for up to 15-18 months (Keller et al. 2005); combinations of different growth 
limiting treatments are also effective for mint (Reed 1999). Reed (1992, 1993, 1999, 2002; Reed 
et al. 1998b; Reed and Aynalm 2005) extended and improved MTS for genotypes of several 
clonal crops by moderating photoperiod, light, nitrogen and temperature, thus 
complementing conservation in LTS. Complete light limitation in combination with 5°C 
storage has been applied to shoot cultures of Trifolium repens, extending the culture interval 
to 10 months (Bhojwani 1981). Son et al. (1991) report one of the most extended cold storage 
cycles as 5 years at 4°C for in vitro hybrid cultures of poplar shoots. Cha-um and Kirdmanee 
(2007) showed that small culture vessels minimized growth and development of plants by 
limiting gaseous exchange, space and nutrient supply; they comment this has cost-benefits in 
terms of space, media and personnel time. Adding osmotica to culture media to simulate 
water stress has been used for various crops (Cha-um and Kirdmanne 2007) including, 
mannitol for potato (Harding 1991, 1994), sorbitol for sweet potato and potato (Golmirzaie 
and Toledo 1998; Golmirzaie et al. 1999) and sucrose in combination with mannitol for yam 
(Ng et al. 1999). However, mannitol may cause epigenetic changes exacerbated by stress 
(Harding 1991, 1994).  
Reducing growth regulators as a minimal growth strategy has been applied to in vitro coffee 
(Bertrand-Desbrunais et al. 1991, 1992), low concentrations of 6-benzyladenine (BA) were 
effective, dependent upon genotype and morphogenetic proliferation. The substituted 
pyrimidine, Ancymidol is a potent plant growth regulator and growth retardant and it 
inhibits gibberellic acid biosynthesis. Sarkar et al. (2001) have used Ancymidol in the slow 
growth of potato; when used in combination with sucrose and temperature limitation it 
extended the culture cycle to 16 months. Storage of potato microplants using acetylsalicylic 
acid has been used as an alternative to applying mannitol at 18°C; demonstrating that 
subcultures could be maintained for up to 6 months (Lopez-Delgado et al. 1998). 
Cold-sensitive genotypes can be stored under slow growth conditions by limiting sucrose 
and/or nitrogen, this strategy was applied to chill-sensitive Rubus genotypes by culturing in 
vitro plants at 25°C under conditions of reduced nitrogen (Reed 1993); for papaya, sucrose 
 was replaced with fructose to limit growth (Drew 1992). Nutritional factors are important for 
maintaining health status, as demonstrated for the in vitro culture of hops. Iron formulations 
applied during cold storage affect growth, leading to the recommendation of Reed and 
Aynalem (2005) to use standard, EDTA-chelated iron rather than sequestrene iron. Calcium 
nutrition is a factor in the minimal growth storage of Solanum tuberosum microplants (Sarkar 
et al. 2005). 
Production of microtubers in vitro is an alternative storage method for potato (Golmirzaie 
and Toledo 1998) for which tuber dormancy can be controlled by environmental parameters 
(Golmirzaie et al. 1999). Slow growth maintenance of tubers generally requires a cyclic or 
sequential in vitro culture regime. In the case of the S. tuberosum collection held by IPK, 
Germany this involves: (1) the establishment of virus-free material, (2) long-day slow growth 
storage at 20°C for 2-3 months, (3) microtuber-induction using a short-day at 9°C for 2-4 
months and (4) cold storage of microtubers at 4°C for 16-18 months (Keller et al. 2006). Cha-
um and Kirdmanne (2007) highlight the preservation of storage organs and propagules of 
vegetatively propagated plants, including bulblets of Allium spp., microtubers of yam and 
potato and rhizomes of ginger, bamboo, orchids and turmeric.  
6.3.2 Performance indicators for slow growth  
Performance indicators include: (1) plant health, (2) extension of subculture interval, 
(3) contamination frequency and (4) capacity [viability, vigour, health status] to recover from 
stress treatments. Reed et al. (1998b, 2003) use descriptive scales of 0 and 1-5 to rate the 
performance of in vitro Pyrus and Humulus cultures maintained under minimal, low 
temperature growth:  
0 = all of the plantlet is brown and no visible indication of growth 
1 =  very poor, questionable viability, brown, necrotic shoots, only extreme shoot visibly green, plantlet 
mostly brown 
2 =  poor, much browning, most shoot tips necrotic, shoot tip green, leaves and stems mostly brown, base 
may be brown   
3 =  fair, some browning, some shoot tips necrotic, shoot tips and upper leaves green, etiolation present, 
base green 
4 =  good, elongated shoots, shoot tips generally healthy, green leaves, stem and limited etiolation 
5 =  excellent condition, dark green leaves and shoots, no etiolation. 
 
Surveillance of cultures held in MTS is required and regular reviews are recommended 
on a 1-4 monthly basis dependent upon the crop system. It is precautionary to consider that  
variable genotype responses to MTS treatments can occur when using performance 
indicators (Van den houwe et al. 1995). This is particularly relevant when managing IVGB 
cultures and regeneration cycles, for which barcoded tracking and electronic documentation 
systems assist operations and inventory administration (Van den houwe et al. 2006). 
6.3.3 Progress in medium-term storage 
In a comprehensive review Cha-um and Kirdmanne (2007) report (in combination with other 
growth limiting factors) 12 crop and forestry species being stored at <10°C; 7 stored at 10-
20°C and 10 stored at temperatures >20°C. In addition, alginate encapsulation of various 
explants and propagules has been combined with osmotica, low temperatures, light 
  
limitation and chemical growth retardants for various species. Examples have been collated 
by Cha-um and Kirdmanne (2007) they include: Cedrella fissilis, Chamaecyparis pisifera, 
Dalbergia sissoo, Fragaria x ananassa, Pinus patula, S. tuberosum, Rubus idaeus, and Vanilla spp. 
The IPK, Germany holds >630 accessions of crop plant germplasm in slow growth storage 
and, as from 2006 (Keller et al. 2006) this includes 99 clones of garlic and 35 of shallot. 
A review of the preservation of in vitro active collections in the USDA’s National Plant 
Germplasm Clonal Collections is provided by Volk and Walters (2003). Part II of the GPG2 
series on clonal crop conservation summarizes surveys of the CGIAR’s mandate species 
currently held in slow growth storage (Benson et al. 2011a); Part III (Benson et al. 2011b) 
provides technical guidelines pertaining to generic MTS methods and protocols.  
6.3.4 Stability and slow growth storage 
Conservation in tissue culture risks SCV (Rani and Raina 2000; Scowcroft 1984) during slow 
growth and the active growth phases preceding and following storage (Cassels and Curry, 
2001). In vitro maintenance of cultures for long periods can potentially lead to in vitro ageing 
and neoplastic progression exacerbated by nutrient limitation and stress (Benson 2000a, b, 
2008a; Gaspar et al. 2002; Häsler et al. 2003; Luan et al. 2007). Superimposed on these factors, is 
the possibility that minimal conditions confer an advantage on physiologically more tolerant 
genotypes or individuals in a clonal population, leading to the selection of resistant individuals 
(Ochatt et al. 1999) and/or mutations (Luan et al. 2007). Whilst clonal populations may be 
expected to be identical, this does not necessarily confer invulnerability to epigenetic and 
genetic changes occurring via the process of SCV (Harding 2004; Rani and Raini 2000; 
Scowcroft 1985). Moreover, individuals, in a clonal population may be expected to have 
different physiological attributes that confer variable propensities for tolerance which might 
potentially lead to selection. Thus, agents and procedures that impair growth, may cause 
abnormal morphogenetic responses and exacerbate epigenetic processes (e.g. DNA 
methylation) that have ramifications for stability and selection processes. Careful selection of 
donor germplasm and storage optimization was advised by Scowcroft (1984) as follows:  
 Prolonged periods of tissue culture are known to increase the frequency of gross 
chromosomal aberrations,  
 the frequency of SCV occurring is enhanced in prolonged tissue culture.  
 In vitro selection pressure is an effective means of generating mutants.  
 Exposure to minimal (suboptimal) growth conditions over long periods can be expected 
to lead to genetic change. 
 
Importantly, the problem of variation arising from clonally propagated plants is evident 
in both field and in vitro collections. Treatments can be incorporated to improve plant health 
and vigour during storage, whilst retaining the benefits of the minimal growth treatment. 
Plants maintained in vitro for long periods accumulate ethylene, which is detrimental to 
growth and exacerbates the stresses incurred during slow growth. Ethylene inhibitors such 
as alginate silver thiosulfate help circumvent this problem as demonstrated for potato 
(Sarkar et al. 1999, 2002). Reed (1992) tested the efficacy of containment on the contamination 
and health of in vitro strawberry plantlets cold-stored at 4°C, finding that a bag system was 
superior to boxes and tubes; as the bags are porous to gaseous exchange ethylene build-up is 
most likely reduced. Optimizing combinations of low temperatures, light and photoperiod 
improves the health of in vitro plants in cold stores. Studies by Reed (1993) on Rubus cultures 
 demonstrated poorer condition at warmer temperatures and that recovery from MTS can be 
variable and genotype dependent (Reed 1991).  
Risks of SCV occurring in slow growth cultures may be minimized by reducing or 
omitting plant growth regulators, particularly those that have a tendency to induce callus 
and produce adventitious shoots (Scowcroft 1984). For some species, the addition of 
phytohormones is required to support minimal storage, such is the case for banana shoot 
cultures (Van den houwe et al. 1995) stored at 16±1°C in medium supplemented with BA and 
indole acetic acid (IAA). Strosse et al. (2004) found no evidence that growth regulators used 
in routine tissue culture directly affected the rate of SCV, but instability was increased with 
time in culture and number of regeneration cycles. This supports the need to develop 
optimal MTS methods for genotypes susceptible to genetic instability as they produce 
increased numbers of off-types with time in culture. 
Cha-um and Kirdmanne (2007) summarize the genetic stability studies of several plant 
species exposed to MTS treatments, including: apple (Hao and Deng 2003); cassava (Angel et 
al. 1996); cedar (Renau-Morata et al. 2006); citrus and strawberry (Hao et al. 2002a, b, 2004); 
kangaroo paw (Turner et al. 2001); potato (Harding 1991) and silver birch (Ryynänen and 
Aronen 2005). Methods used to assess stability included DNA methylation, RAPD, RFLP and 
AFLP analyses and different outcomes concerning genetic and epigenetic stability were 
revealed, which in general were crop and species specific. Stability assessments of various in 
vitro shoot cultures e.g. apple (stored at 4°C) and citrus (stored at 10°C) revealed methylation 
sensitive amplified polymorphisms (MSAP) in some cases (Hao et al. 2002a, b, 2004; Hao and 
Deng 2002, 2003). This concurs with Harding (1994) who found changes in the DNA 
methylation status of potato plants recovered after six months of slow growth in medium 
supplemented by 6% (w/v) mannitol. This study showed that the majority of changes were 
due to preferential methylation in nuclear domains that contained EcoRII/Bst NI recognition 
sites, in contrast to those that contained HpaII/MSp I sites. Harding (1994) concluded that 
DNA methylation in slow-grown potato might be an adaptive response to osmotic stress. In 
contrast, Sarkar et al. (2001) did not detect any genetic variation in microplants conserved on 
limiting medium containing Ancymidol using RAPD analysis of genomic DNA. Angel et al. 
(1996) stored cassava under slow growth conditions for 10 years without evidence of genetic 
instability at the DNA level. 
Maintaining genetic stability is a pivotal requirement for MTS and it is an aspect of 
quality assurance, whilst studies remain limited, findings to date suggest the changes that do 
occur are mainly epigenetic. Nevertheless it may be insightful to explore if they are an 
adaptive genomic responses to the stresses incurred in vitro. This approach concurs with the 
studies of Joyce and Cassels (2002) in which DNA methylation was used to assess variation 
in potato microplant morphology produced by different in vitro protocols. As the molecular 
diagnostics currently used examine a very small part of the genome (Harding 1996, 2004) an 
alternate or complementary approach to assess stability may be to use trueness-to-type, 
particularly if the use of morphological and agronomic traits as stability criteria are applied 
in concert with germplasm and plant authentication procedures (Perazzo et al. 2000).  
  
6.4 Long-term storage: cryopreservation 
Cryopreservation is the storage of viable cells, tissues, organs and organisms at ultra low 
temperatures (ca. -130 to -196°C) in the vapour or liquid phase of LN. The primary role of 
cryogenic storage is to secure germplasm in perpetuity in the base genebank (Figure 3). 
Contemporary developments benefit from data emerging on cryobank longevity, including 
two investigations performed on: (1) cryopreserved seed germplasm stored for >10 years, by 
Walters et al. (2004) and (2) microalgae stored for 20-30 years (Day et al. 1997; Müller et al. 
2005). Whilst it is generally assumed that metabolic activity ceases at the temperatures of LN 
vapour and liquid, Walters (2004) reported molecular mobility can potentially occur at 
cryogenic temperatures, the extent of which being affected by water status. This is confirmed 
by Buitink et al. (2000) who used electron paramagnetic resonance spectroscopy to study 
rotational motion of a spin probe in various plant tissues as a function of moisture content 
and temperature, finding detrimental ageing rates to be associated with the extent of 
molecular mobility in the cytoplasm. The work of Walters et al. (2004) constitutes one of the 
most interesting longevity studies performed to date on cryopreserved plant germplasm. 
Measurable changes in the germination rates of dry seeds cryopreserved were observed for 
samples held under LN for >10 years, despite this, cryogenic seed storage was predicted to 
prolong shelf life of lettuce seeds for significant periods (>500 years). The benefit of low 
temperature storage was also found to be influenced by donor plant and germplasm 
physiology and pre-storage treatment before cryopreservation. Day et al. (1997) report long-
term viability of eukaryotic algae cryopreserved for ca. 20 years. Müller et al. (2005) 
compared AFLP profiles of strains of Chlorella vulgaris maintained in a cryobank for almost 
30 years with a population of the same strains grown in serial subculture. No significant 
genomic differences were found between strains derived from cryostorage compared to their 
actively cultured counterparts. Published reports regarding the long-term viability of 
preserved organisms are few; this is largely because information on extended storage 
timelines is only now emerging. Stacey and Day (2007) collated cryostorage longevity from 
diverse biological resources across timescales of 5-35 years, reporting no obvious or 
significant loss of viability, stability and function was found.  
6.4.1 Principles of long-term storage, cryopreservation 
Since Ashmore (1997), advances in cryopreservation research and storage technologies have 
been considerable across all disciplines; this is due to three main lines of progression: 
1. The formulation of new and adapted cryopreservation protocols, particularly using 
vitrification (Day and Stacey 2007; Day et al. 2008; Fuller 2004; Reed 2008).  
2. An explosion in fundamental cryobiological knowledge related to cryoprotection and 
understanding the effects of freezing on biological systems in vitro and in vivo (Fuller 
2004; Fuller et al. 2004; Day et al. 2008).  
3. A greater emphasis on regulatory issues and cryobank risk management (Stacey 2004; 
Tomlinson 2008).  
Developments in cryoengineering and thermal analysis have also aided the technical and 
theoretical study of cryopreserved systems (Benson et al. 2005). Examples of some basic 
equipment required for plant cryopreservation are shown in Figure 6. 
Advances have also helped to elucidate the principles of ultra low temperature storage, 
these initially involved the biophysical interpretation of cryoprotectant behaviour 
 (Mazur 2004). However, a paradigm shift is occurring (Baust and Baust 2007). This is due to 
the development of molecular, and omics research, which offers new and different 
perspectives as to what, contributes to cryopreservation success and failure. For plants, 
increasing advances in omics technologies are unravelling the complexities of cold and 
freezing stress (Xin and Browse 2000; Fowler and Thomashow 2002; Xiong et al. 2002; Kaplan 
et al. 2004; Gray and Heath 2005; Hannah et al. 2005; Yang et al. 2005; Chinnusamy et al. 
2006; Fujita et al. 2006; Nakashima and Yamaguchi-Shinozaki 2006; Beck et al. 2007; Zhu et 
al. 2007; Basu 2008). Proteomics technologies in particular are now being used to study 
cryostorage recalcitrance (Carpentier et al. 2005, 2006, 2007). 
 
Figure 6. Basic equipment used for the cryopreservation of plant genetic resources: Programmable 
freezer comprising freezing chamber, computer and pressurized liquid nitrogen coolant; solvent-cooled, 
passive small-scale freezing unit „Mr Frosty™‟, cryovial loading into cooling chamber and small (ca 50 L) 
storage Dewar, LN level alarm attached to large-capacity (ca 200 L) cryotank.  
 
Omics research promises a greater understanding of the fundamental processes that limit 
freeze, osmotic and dehydration tolerance. Technological innovations are also supporting the 
development of quality systems in modern biorepositories (Smith 1998, 2001, 2003; Benson et 
al. 2005; Day and Stacey 2007; Benson 2008a; Day et al. 2008) this is leading to an expansion of 
published literature pertaining to regulatory issues and cryobank security (Stacey 1999, 2004; 
Stacey and Day 2007). Developments have stimulated considerable activity in biobank risk 
management, especially related to microbiological containment and minimising adventitious 
and cross contamination in long-term cryobanks (Tedder et al. 1995; Fountain et al. 1997; Pegg 
1999; Stacey 1999; SLTB 1999, 2008; Bielanski et al. 2000, 2003; Tomlinson and Sakkas 2000; 
Khuu et al. 2002; Kipp et al. 2004; Bielanski 2005a, b; Morris 2005; Tomlinson 2005, 2008; Mazilli 
  
et al. 2006). Benson (2008a) reviews the possible implications of studies from other bioresources 
sectors for plant germplasm containment and highlights the importance of regulatory 
phytosanitary control before materials are cryobanked.  
The following sections describe the development of the main cryoprotection and cooling 
techniques that constitute: (1) colligative cryoprotection and slow (controlled rate) cooling, 
(2) vitrification-based cryoprotection and rapid cooling and (3) droplet freezing and 
vitrification.  
Mazur’s 2-factor hypothesis of cryoinjury comprises dehydration damage caused by excessive 
dehydration and ice (see Mazur 2004 for a review). Colligative properties are those attributed 
to the behaviour of solutions that are dependent upon the number of molecules or particles in 
a given volume of solvent. Colligative cryoprotectants must be non-toxic at the concentrations 
required for their efficacy, and they must penetrate the cell (Fuller 2004), this is because their 
mode of action depends on reducing injuries caused by excessive cell volume changes and 
toxic solution effects. Colligative cryoprotectants also depress the freezing point, such that 
when ice nucleation does occur it is not so injurious; the most common are glycerol, and 
dimethyl sulphoxide (DMSO) although cryoprotectant permeability and toxicity can be 
germplasm and plant dependent (Fuller 2004). The level at which colligative cryoprotectants 
are applied is variable, e.g. they can range from 5-10% (v/v) DMSO or 0.5 to 1 M glycerol. 
Colligative cryoprotectants are normally used in combination with controlled rate cooling 
using a programmable, computerized cooling unit, that regulates stepwise rates of cooling 
and hold times at subzero temperatures. The process takes advantage of the supercooling 
properties of water; the lowest point in nature is the temperature of homogeneous ice 
nucleation at, or around, -40°C. During cryopreservation the point at which ice is formed is 
induced by ‘seeding’ which is the initiation of ice crystals in the extracellular matrix. When 
liquid water is removed from an aqueous system by ice formation, solutes become 
concentrated, a process that has two important effects on the cryopreserved cell. First, the 
temperature at which further ice is formed is lowered (super cooling); secondly, a water 
vapour deficit is created across the cell membrane causing movement of intracellular water 
to the outside. In controlled rate cooling the operator optimizes cryoprotection, seeding, 
cooling rates and hold times to allow just enough intra-cellular water to exit without causing 
colligative injury. When the germplasm is finally plunged into LN ice damage should be 
sufficiently limited to be non-lethal, any ice crystals formed are so small they are non-
injurious. In practice, it is likely that germplasm cryopreserved in this way becomes partially 
vitrified (Fuller 2004; Benson 2008a, b). Non-penetrating cryoprotectants are often used in 
conjunction with colligative additives to remove potentially freezable water from the cell by 
osmosis; this approach is useful for preserving differentiated cells containing large vacuoles.  
Once optimized, an advantage of controlled rate cooling is that large batches of 
germplasm can be cryopreserved simultaneously in a programmable freezer chamber, 
providing efficient, high throughput methods for large-scale cryopreservation; this is of 
particular benefit for genebanks holding many accessions. If the cryoprotectant strategy is 
robust and reliable then controlled cooling is cost effective in the longer-term as 
cryoprotectant addition is undertaken in the cryovial. In contrast, some vitrification 
protocols can be laborious (e.g. aluminium foil preparation, dispensing micro-drops, hand 
manipulation of each sample for cryoprotectant additions) and take up more technical 
preparation and handling time. Computerized processing facilitates multiple manipulations 
 and offers cooling programme permutations, providing the operator with more variables to 
aid optimization. Electronic data handling and inventories store process information and 
support digital sample tracking which is an added advantage for quality auditing. The main 
economic disadvantages of programmable freezers are the initial cost outlays for equipment 
which requires regular servicing and the possibility that pressurized LN appliances need to 
conform to regular safety audits. Programmable freezers can use large amounts of LN to cool 
the chamber and together all these factors add regulatory, safety and cost burdens. An 
alternative low budget system is the passive freezer, Mr Frosty™ (Nalgene®) however, the 
major limitation of controlled rate cooling remains that certain types of plant germplasm are 
not amenable to the approach. Cases include complex tissues comprising different types of 
cells and many tropical plants that produce large, recalcitrant seeds and multipart vegetative 
tissues for which it is difficult to optimize cooling rates to protect cells with variable water 
contents. For these reasons, vitrification has been used to great advantage for plant 
germplasm that is not generally amenable to controlled rate cooling.  
Vitrification is the solidification of a liquid without crystallization, it is termed an amorphous 
‚glassy state‛ as it lacks organized structure, whilst possessing the mechanical and physical 
properties of a solid (Fuller 2004; Taylor et al. 2004). Cryopreservation in the absence of ice 
has the major advantage of reducing cryoinjury through ice formation and its associated 
colligative effects. Vitrification is consequently the method of choice for plant germplasm 
that is unresponsive to colligative and controlled cooling protocols or, where suitable 
equipment is not available. The glassy state is created via several mechanisms, for plants 
these include: osmotic, evaporative, and chemical dehydration, as well as the loading and 
unloading of penetrating cryoprotectants. Increasing cell solute concentration to a critical 
viscosity and temperature, termed the glass transition temperature (Tg) is the point at which 
the vitrified state is formed. The glassy state is metastable and it can revert to a liquid by 
devitrification, this process can involve ice formation on rewarming and it is one of the main 
disadvantages of vitrification; this process is sometimes called cold crystallization (Bart Panis 
pers comm). In addition, the material properties of unstable glasses make them susceptible to 
fractures or cracking on rewarming, particularly if it is undertaken rapidly. Rewarming of 
vitrified germplasm is often undertaken in two steps, the first is slow to allow for glass 
relaxation, usually at ambient room temperatures followed by more rapid rewarming at 
ca. 45°C to avoid ice nucleation. When utilized with care the metastable vitrified state has 
proved to be an effective means of cryopreserving germplasm that is not amenable to 
controlled rate cooling and colligative cryoprotection (Fuller 2004; Reed 2008a). Assessment 
of the advantages and disadvantages of the various rapid cooling and vitrification-based 
protocols is presented in Section 6.4.2.  
Two other cryoprotection strategies that are applied to plant germplasm on a large scale are 
droplet freezing and droplet-vitrification, (Schäfer-Menhur et al. 1996, 1997; Panis et al. 2005; 
Ashmore et al. 2007a; Sakai and Engelmann 2007; Gallard et al. 2008; Sakai et al. 2008; Sant et 
al. 2008). Both methods use a rapid cooling protocol, but their modus operandi is different due to 
the behaviour of water molecules contained in micro-droplets of single cryoprotectants 
(DMSO) or vitrification solutions (PVS2). Micro volumes (μL) of cryoprotective additives are 
deposited on highly efficient, heat conducting surfaces, usually aluminium foils or hypodermic 
  
needles (Grout and Henshaw 1978; Kartha et al. 1982). If the biophysical conditions are 
optimal, the droplets vitrify on direct exposure to LN or, in the case where ice crystals actually 
do form; they are so small that they do not cause lethal damage. This process is ultra rapid or 
flash-freezing although for certain cryoprotectants it is perhaps more accurate to use the term 
flash-vitrification; the protective principle of droplet-based techniques is yet to be elucidated. It 
is most likely crystallization caused by the alignment of H2O molecules forming H-bonds is 
impeded in micro-droplets due to insufficient numbers of H2O molecules, surface tension-
cohesion effects, cryoprotectants and cooling rates of thousands of degrees per minute (Benson 
2008b, Benson et al. 2005; Orief and Schultze-Mosgau 2005). A comparative assessment of the 
advantages and disadvantages of droplet protocols is presented in Section 6.4.2. 
6.4.2 Overview of progress in long-term storage  
Controlled rate cooling was the first method developed for routine plant germplasm 
cryopreservation, based on the original method of Withers and King (1980) and derivative 
protocols (Benson 2004, 2008a, b; Reed 2008). Controlled rate cooling is effective for 
cryopreserving a wide range of germplasm including: shoot tip meristems from temperate 
woody perennials and clonal crops (Reed 2001, Reed et al. 2003); dedifferentiated plant cell 
cultures (Heine-Dobbernack et al. 2008) and totipotent cell lines and embryogenic cultures 
used by the clonal forestry industry (Park et al. 1998; Cyr 1999; Cyr and Klimaszewsak 2002; 
Park 2002; Gale et al. 2007, 2008). Nevertheless, it has a major limitation in the 
cryopreservation of recalcitrant species and physiologically complex types of germplasm. 
The purchase of expensive programmable freezers is also a restriction (although the 
Mr Frosty™ system provides a cheaper option for poorly resourced genebanks). 
Consequently, progress in plant cryopreservation has preferentially lead to the development 
of vitrification-based and droplet freezing protocols that utilize permutations of the 
following treatments:  
1. Evaporative desiccation (air, silica gel) and osmotic dehydration (sucrose, sorbitol, 
mannitol).  
2. Osmotic dehydration, in combination with alginate bead encapsulation and evaporative 
desiccation (encapsulation-dehydration) based on the original method of Fabre and 
Dereuddre (1990) as reviewed by Engelmann et al. (2008). 
3. Vitrification using cryoprotectant cocktails of DMSO, ethylene glycol, polyethylene, 
glycol, sucrose and glycerol. The most common is the Plant Vitrification Solution (PVS) 
series, PVS2 is the most widely applied; PVS3 is an alternative method (Sakai et al. 2008).  
4. Encapsulation-vitrification, chemical additives combined with alginate bead encapsu-
lation (Sakai et al. 2008). 
5. Droplet freezing and droplet-vitrification, in which micro-droplets of respectively DMSO 
or vitrification solutions are cooled at ultra rapid rates by direct exposure to LN; based 
on the methods of Kartha et al. (1982) Schäfer-Menuhr et al. (1996, 1997) and Panis et al. 
(2005). 
This is a simple, cost-effective method involving dehydration and desiccation treatments using 
osmotica, heat-activated silica gel or air, followed by direct plunging into LN and, on retrieval 
from the cryobank, rewarming at ambient temperatures. Cryoprotective dehydration has been 
applied with success for the cryopreservation of recalcitrant and orthodox seed (Hamilton et 
 al. 2008; Normah and Makeen 2008; Pritchard and Nadarajan 2008; Walters et al 2008). The 
main disadvantage of this approach is its restriction to desiccation tolerant germplasm.  
Chemical cryoprotectants used for vitrification are applied at higher levels than is the case 
for colligative cryoprotection. Solutions formulated by Sakai and colleagues (reviewed by 
Sakai 2004; Sakai and Engelmann 2007; Sakai et al. 2008) are the main protocols applied to 
plant germplasm, of which the PVS series (PVS2 and 3) are the most popular. Because 
vitrification solutions are highly concentrated, protocol permutations often incorporate 
pregrowth and dehydration treatments to enhance recovery in osmotically sensitive 
genotypes. This involves pre-loading germplasm with 2 M glycerol and 0.4 M sucrose, 
followed by sequentially increasing the PVS to a final cryoprotective concentration. For PVS2 
this is 30% (w/v) glycerol, 15% (w/v) ethylene glycol, 15% (w/v) DMSO and 0.4 M sucrose. 
For PVS3 the composition is 50% (w/v) each of sucrose and glycerol, prepared in standard 
liquid culture medium (Sakai et al. 1990; Nishizawa et al. 1993; Sakai et al. 2008). Vitrification 
solutions are dispensed at ambient temperature or on ice to reduce the effects of osmotic 
shock and PVS-cryoprotected germplasm is directly plunged into LN. Vitrified germplasm is 
rewarmed rapidly in a water bath at 45C; alternatively the process involves two stages to 
prevent glass fracturing due to glass relaxation which risks devitrification and ice formation 
occurring as the system progresses through temperatures at and close to the Tg. This 
warming procedure can entail holding for 1 min in LN vapour or, at ambient temperatures 
(to allow for glass relaxation) followed by rapid warming for 2-3 min in a water bath at 45C. 
PVS mixtures are usually removed by rinsing in an unloading solution of 1.2 M sucrose.  
A technical and practical disadvantage of vitrification is the need to stabilize glasses 
around the critical Tg, during LTS, vapour phase transit storage and on sample input and 
retrieval from a cryobank. Volk and Walters, (2006) recommend germplasm cryopreserved 
using PVS2 should be maintained in the liquid phase of LN and it is prudent to check the 
stability of glasses and germplasm viability after transit and transfers between different 
cryotanks. Dry shippers have to operate in the vapour phase of LN for safety reasons, and the 
materials contained within them may reach temperatures outside the critical Tg zone. It is also 
essential to adopt stringent removal and addition strategies for vitrified germplasm held in 
cryobanks, particularly for samples at the top of inventory systems. Devitrification becomes 
more problematic if the cryoprotectant treatment duration and loading has not been fully 
optimized (Benson et al. 1996b). It is advisable to be aware of the thermal behaviour of glasses 
during the optimization of PVS cryoprotectant loading, cooling and rewarming. Sakai et al. 
(2008) and Sakai and Engelmann (2007) report the following thermal characteristics of PVS2: 
(1) solidification of a metastable glass at ca. -115°C; (2) a slow rewarming Tg at ca.-115°C; (3) an 
exothermic Td devitrification (ice crystallization) event at ca. -75°C and (4) an endothermic 
melt Tm, at ca -36°C.  
The technical advantage of chemical-additive vitrification is that the need for controlled 
freezing equipment is circumvented; the main methodological disadvantage is that 
processing many samples is labour intensive as compared to programmable controlled rate 
cooling. The PVS ‘cocktails’ can be toxic to some types of plants and germplasm although 
pretreatment and careful addition of the cryoprotectant reduces their toxicity (Sakai et al. 
2008). The main advantage of PVS-based cryoprotection is its efficacy and successful 
application for the cryopreservation of germplasm from many different tropical and 
temperate species (Sakai et al. 2008). It has been used as the method of choice for tropical 
  
plants and germplasm that are not amenable to cryopreservation using desiccation and 
controlled rate cooling methods (Sakai and Engelmann 2007).  
From the reports of Sakai et al. (2008) and others, PVS-based cryoprotection strategies 
(i.e. PVS2 and PVS3) have been applied to germplasm from: Allium porrum, Allium sativum, 
Allium wakegi, Ananas comosus, Arachis sp. Armoracia rusticana, Artocarpus heterophyllus, 
Asparagus, Atropa beladona, Beta vulgaris, Bletilla striata, Brassica campestris, Camellia sinensis, 
Carica papaya, Castanea sativa, Chrysanthemum, Citrus spp., Colocasia esculenta, Cymbidium spp., 
Cymbopogon, Daucus carota, Dendranthema, Dianthus caryophyllus, Dioscorea spp. Diospyros kaki, 
Doriteanopsis, Dortis pulcherrima, Fragaria x ananssa, Gentiana spp., Grevillaria scapigeram, 
Hyosciamus niger, Ipomea batatas, Lilium japonicum, Limonium spp. Macropidia fuliginosa, Malus 
spp., Manihot esculenta, Mentha spp., Musa spp., Nicotiana tabacum, Oryza sativa, Picorhiza 
kurroa, Populus alba, Prunus spp., Pyrus spp., Quercus robur, Quercus suber, Ribes spp. Secale, 
cereale, Solanum spp., Solemostemon rotundifolius, Trifolium repens, Vitis vinifera, Wasabia 
japonica, and Xanthosoma sp.  
This vitrification-based strategy was first developed for potato by Fabre and Dereuddre 
(1990), the procedure involves encapsulating germplasm in a calcium-alginate matrix, 
osmotic dehydration in sucrose, and evaporative desiccation in an air flow, or over silica gel, 
followed by direct plunging into LN. The glasses formed in the alginate beads are usually 
stable once desiccation conditions are optimized (Benson et al. 1996b, Gonzalez-Arnao and 
Engelmann 2006). Therefore, rewarming can be undertaken at ambient temperatures, usually 
for 20-30 min in a laminar airflow cabinet, followed by rehydration of the beads in liquid 
medium for 20 min to remove sucrose, before transfer to recovery medium. This method has 
the advantage of being a low technology protocol and like other vitrification protocols it is 
available to laboratories without access to controlled rate cooling equipment. An advantage 
of encapsulation-dehydration is its proven efficacy for germplasm unresponsive to 
controlled rate cooling (Gonzalez-Arnao and Engelmann 2006; Engelmann et al. 2008). One 
practical benefit is its application in artificial seed production, which is an advantage in 
clonal forestry (Gale et al. 2007, 2008). The main disadvantage of encapsulation-dehydration 
is that desiccation-sensitive germplasm remains problematic and care must be taken to 
achieve non-lethal desiccation (Benson et al. 1996b). Reproducibility of air desiccation may 
be a problem in laboratories operating in an unregulated ambient environment and in these 
situations, silica gel evaporation is advised (Sherlock et al. 2005). Encapsulation-dehydration 
is a labour intensive protocol and requires several steps, sometimes undertaken over  
1-2 days; therefore it may not be cost effective for processing large numbers of samples.  
Encapsulation-dehydration appears to be preferentially used for the cryopreservation of 
shoot tips (Engelmann et al. 2008; Reed 2008) and has been applied to germplasm from over 
70 plant species. Including, as reported by González-Arnao and Engelmann (2006) the 
following: Actinidia spp., Anthirrnium macrophyllum, Armoracia rusticana, Auricularia, Beta 
vulgaris, Brassica napus, Cychorium intybus, Chrysanthemum morifolium, Citrus spp., Cocos 
nucifera, Coffea racemosa, Cosmos atrosanguineus, Daucus carota, Dioscorea spp., Fragaria x 
ananassa, Holostemma annulare, Ipomea batatas, Iris nigricans, Lilium spp., Malus spp., Mentha 
spp., Musa spp., Morus bombysis, Olea europea, Polygonium aviculare, Prunus spp., Pyrus spp., 
Ribes spp., Solanum spp., Vitis vinifera, Wasabia japonica and Xanthosoma sp.  
 Sakai and colleagues (Sakai 2004; Sakai and Engelmann 2007; Sakai et al. 2008) developed the 
encapsulation-vitrification protocol which combines alginate encapsulation with PVS2 
vitrification. As applied to shoot meristems, shoots are first pregrown with sucrose, 
optimized at levels of ca. 0.3 M, followed by alginate encapsulation, loading with 0.4 M 
sucrose, or a mixture of 2 M glycerol and 0.4 M sucrose for 30-60 mins, followed by treatment 
with PVS2 for 1 h at 25°C; beads are removed and placed in cryovials to which 1 ml of PVS2 
solution is added. For storage, samples are directly immersed into LN; on retrieval the beads 
are rapidly rewarmed in a water bath at 35-45°C for ca. 1 min, the PVS2 is drained away and 
replaced with 1.2 M sucrose unloading solution for 10 min. The encapsulation-vitrification 
protocol was designed by Sakai (see Sakai et al. 2008) to process large numbers of meristems 
by eliminating the lengthy desiccation treatments required for encapsulation-dehydration. 
An advantage is the substitution of evaporative desiccation with osmotic dehydration 
making cryopreservation more accessible to desiccation-intolerant tropical plant germplasm. 
Encapsulation-vitrification has been successfully applied to different species as reviewed by 
Sakai and Engelmann (2007) and Sakai et al. (2008); they include: Ananas comosus, Citrus 
aurantium, Daucus carota, Dianthus caryophyllus, Dioscorea spp., Diospyros kaki, Fragaria x 
ananassa Duch., Gentiana spp., Ipomea batatas, Lilium spp., Malus domestica, Manihot esculenta, 
Mentha spicata, Olea europea, Poncirus trifoliate x Citrus sinensis, Prunus domestica, Pyrus spp., 
Rubus idaeus, Saintpaulia ioantha, Solanum tuberosum, and Wasabia japonica.  
These methods are permutations of ultra rapid freezing and vitrification protocols; Kartha et 
al. (1982) originally developed the droplet freezing protocol for cassava and this was adapted 
for potato shoot tip cryopreservation by Schäfer-Menuhr et al. (1996, 1997). DMSO is the 
cryoprotectant used in droplet freezing which, when applied with PVS2 (Benson et al. 2007, 
Panis et al. 2005; Sakai and Engelmann 2007) is referred to as droplet-vitrification. Both 
protocols involve the ultra rapid cooling of the sample by direct exposure of the germplasm 
to LN. Pretreatments are often applied before the cryoprotectant stage, which in the case of 
droplet freezing involves dispensing 2.5-20 μL droplets of 10% (v/v) DMSO onto sterile 
aluminium foil strips of 2-3 x 0.5-1.0 X 0.003 to 0.005 cm3 dimensions. After loading of  
5-10 droplets/strip with shoot meristems the foils are directly exposed to liquid phase LN 
and transferred to cryovials containing LN (2 foils per vial) after which they are stored in the 
liquid phase of LN. On rewarming, the foils are removed and placed directly into liquid 
medium at ambient room temperatures (ca. 25°C); the shoots dislodge and are plated onto 
recovery medium. In the case of droplet-vitrification, one method described by Panis et al. 
(2005) for Musa is as follows: shoot tip meristems are pretreated with an osmotic additive, 
followed by a preparative loading treatment with pre-chilled PVS2. Meristems are then 
transferred to 15 μl droplets of chilled PVS2 solution, dispensed onto strips of aluminium 
foil, plunged directly into liquid phase LN and transferred for permanent cryostorage to 2 ml 
cryovials pre-filled with LN. On rewarming, foils are placed in rinsing solution at ambient 
temperatures and after blotting on filter papers they are transferred to culture medium.  
The major advantage of droplet-vitrification is its broad-ranging success in cryo-
preserving shoot tip meristems of different types of crop plant germplasm (Panis et al. 2005; 
Halmagyi and Pinker 2006; Ashmore et al. 2007a; Kim et al. 2007; Sant et al. 2007; Gallard et 
al. 2008). In this capacity, it is helping to alleviate the bottleneck of differential genotype 
response which is a major limiting factor in the large-scale cryobanking of crop plant genetic 
  
resources. Droplet-vitrification (PVS2) and droplet freezing (DMSO) protocols are critically 
dependent upon using ultra rapid cooling and rewarming requiring direct exposure to LN, 
making non-containment the main disadvantage of both methods. Direct exposure to LN is 
essential to achieve the rapid rates of cooling required for survival, both droplet-vitrification 
(PVS2) and droplet freezing (DMSO) often involve purposeful filling of cryovials with LN 
which may have consequences for cross-contamination by microbial agents and pathogens. 
Stringent adherence to phytosanitary and indexing procedures and double-testing for 
endophytic contaminants before germplasm is cryopreserved using these protocols is 
therefore recommended. In some countries and institutions non-adherence to manufacturers’ 
safety recommendations, including the purposeful infiltration of cryovials with LN may not 
comply with health and safety regulations. Droplet freezing has the advantage of proven 
applicability across a wide crop-genotype range, as first applied to potato shoot meristems 
and afterwards for the cryobanking of plant germplasm in genebanks (Kryszczuk et al. 2006; 
Schäfer-Menuhr et al. 1997). Droplet-PVS2 vitrification is being increasingly applied to major 
crop plant species and has proved very successful in its application to diverse crops and 
different genotypes (Leunufna and Keller 2003, 2005; Kim et al. 2006, 2007; Ashmore et al. 
2007a; Sakai and Engelmann 2007; Sant et al. 2007; Sakai et al. 2008). Examples of which 
include: Allium sativum, Carica papaya, Colocasia esculenta, Cychorium intybus, Dendrathema 
grandiflora, Dioscorea spp., Fragaria x ananassa., Ipomea batatas, Lilium spp., Musa spp., 
Pelagonium spp., Phoenix dactylifera, Saccharum officinarum, Solanum tuberosum, Solanum 
stenotomum, Solanum spp. and Thymus. 
Part II of the GPG2 series on clonal crop conservation collates and summarizes surveys of 
the mandate species currently held in CGIAR’s cryobanks (Benson et al. 2011a). Part III 
(Benson et al. 2011b) of the series provides technical guidelines pertaining to generic LTS 
methods and protocols.  
6.4.3 Large scale deployment of cryopreservation  
The development of a wide range of protocols (Reed 2008) has resulted in the large-scale 
deployment of cryopreservation in international genebanks and biorepositories. Keller et al. 
(2008) report the status for major cryobanking initiatives at a number of international 
repositories, including, at the IPK, Gatersleben regarding 1,017 accessions of potato, 38 of 
garlic, 19 of mint, 1 for yam and 4 for other medicinal and aromatic plants; at the Northwest 
German Forest Research Institute, 450 elm accessions; in the Czech Republic’s crop plant 
genebank, 15 accessions of hop and potato; in the USDA’s germplasm repository, 27 accessions 
of garlic, 17 of Fragaria, 3 of Humulus, 20 of Ipomea, 2,201 of cold-hardened Malus buds, 44 of 
Mentha, 57 of Prunus, 100 of cold-hardened Pyrus buds, 27 of Ribes and 30 of Rubus, as well as 
37,654 cryopreserved seed accessions held in the Fort Collins cryobank and in the South 
Korean Genebank, 300 accessions of garlic. Gonzales-Arnao et al. (2008) review the large-scale 
application of cryopreservation for shoot and embryo cultures represented by citrus, various 
tropical crops, cassava and potato. Volk and Walters (2003) report on the use of 
cryopreservation and the status of in vitro active collections held in the USDA’s National Plant 
Germplasm Clonal Collections.  
6.4.4 Cryotherapy  
Virus elimination by cryogenic treatment is now used to eradicate pathogenic organisms from 
some cultures. The procedure is useful in that it circumvents the laborious dissection of small 
meristems and is applicable across different meristems sizes. First tested by Brison et al. (1997) 
 for plum, cryotherapy has been demonstrated by Wang et al. (2003) to eradicate grapevine 
virus A and by Kim et al. (2007) to eradicate Allium viruses. Wang and Valkonen (2008) also 
found cryotherapy effective for eliminating sweet potato little leaf phytoplasma. Helliot et al. 
(2002b) describe cryotherapy as a micro-scalpel, although cautioning not all viruses and plants 
responded effectively regarding complete pathogen eradication.  
6.4.5 Stability and cryopreservation  
Cryogenic stability pertains to the biophysical and molecular mobility of the vitrified state 
and the genetic stability of plants regenerated from cryobanked germplasm.  
Thermal analysis elucidates critical factors in cryopreservation protocols (Angell 2002; Block 
2003; Benson et al. 2005; Hor et al. 2005; Šest{k and Z{mečnik 2007) and provides 
information concerning the stabilization of the glassy state (Volk and Walters 2006). The 
International Society for Biological and Environmental Repositories (ISBER 2008) define Tg 
as: ‛the temperature at which a cell is dehydrated to the degree that the remaining liquid 
within it is so viscous that molecules have insufficient energy to order into a crystalline state. 
Below this temperature (generally regarded as -132°C), no diffusion can take place within the 
cells and its surroundings. Without this diffusion the ‘biological clock’ stops.‛  
Thermal analyses are useful, not only in optimising cryoprotective dehydration and 
desiccation, but also in risk management as they can confirm the principal storage 
temperatures required to stabilize vitrified germplasm (Benson et al. 1996b, 2005; Martínez et 
al. 1998; Dumet et al. 2000; Angell 2002; Block 2003; Šest{k and Zámečnik 2007). 
Manufacturers of cryogenic storage equipment recommend cell storage to be performed 
below the water recrystallization temperature of -130°C (Nunc™ 2005). Consequently, 
knowledge of cryoprotectant Tgs, as well as their ice nucleation and re-crystallization 
temperatures is a quality assurance parameter for storage stability. Walters (2004) cautions 
timescales for changes in viability of cryopreserved germplasm have yet to be calculated, 
noting that molecular mobility studies can provide approximations of deteriorative reactions 
that might affect longevity. For long-term cryobanks, knowledge of water status and Tgs 
provides evidence for creating standard operating procedures (e.g. for cryovial input and 
withdrawal) that do not compromise stability. Volk and Walters (2006) comment that the 
mechanism by which PVS2 exerts its protective properties has ramifications for the longevity 
of vitrified germplasm and recommend storing cryopreserved materials well below their Tgs 
as reduced cellular viscosity increases long-term survival. Knowledge of thermal behaviour 
in different glasses informs optimal choice of LN phase storage and the use of vapour phase-
only transit shippers. Taking into account the stability of Tgs for germplasm held at different 
storage temperatures concurs with the best practice recommendations of ISBER (2008).  
In vitro stability is a cross-cutting issue concerning MTS and LTS and cryopreservation is 
dependent upon culture manipulation before and after LN treatment. Harding (2004) 
summarizes the methods used to assess stability in cryopreserved germplasm as: 
 Phenotype variation: morphological assessment (in vitro and field-tested, preferably using 
crop plant descriptors) at sequential stages of short and long-term recovery. 
  
 Morphological assessments: in vitro characteristics (differentiation, dedifferentiation, 
adventitious shoot development) meristematic chimeras, vegetative and reproductive 
development in regenerated plants. 
 Biometric studies: comparative studies of development using principle component 
analyses, for different stages of plant development. 
 Histological and cytological analysis: tissue integrity, chromosome stability, ploidy status. 
 Biochemical and metabolite analysis: production of secondary metabolites. 
 Protein, enzyme analysis: isoenzyme profiles, proteomics technologies, 2D 
electrophoresis. 
 Molecular genetic analysis: genome structure, DNA-DNA hybridization, PCR-based 
techniques: RAPD, SSR, AFLP analysis, and the stability of transgenes. 
 Epigenetic: (non-Mendelian inheritance) chromatin analysis, DNA-methylation, 
methylation-specific PCR. 
Scowcroft (1984) suggested cryostorage could reduce the constraints of slow growth as the 
biological processes causing instability are arrested at ultra low temperatures. Some factors 
(osmotica, cold) are however, similar to those used for slow growth, albeit for significantly 
shorted durations. Using cryogenic storage to confer stability on cultures is a common 
principle that has been widely applied to microorganisms, human and animal cells. In these 
cases, both base and active collections are maintained in cryobanks (Stacey and Day 2007).  
To date, the consensus for stability assessments of cryopreserved germplasm and plants 
regenerated from cryobanks is positive and there exist various reports which confirm stability 
using different approaches applied to diverse species. Examples include: stable RAPD profiles 
of Melia azedarach, cryopreserved using encapsulation-dehydration (Scocchi et al. 2004) and 
genetic fidelity demonstrated by RAPD analysis of Populus tremula x Populus tremuloides, which 
was cryopreserved using controlled, slow cooling and PVS2 (Jokipii et al. 2004). Phenotype 
and karyotype analysis also indicated stability in Cyrtopodium hatschbachii, cryopreserved using 
encapsulation-dehydration (Surenciski et al. 2007). Ploidy status was retained in Solanum spp. 
cryopreserved using ultra rapid freezing or encapsulation-dehydration (Ward et al. 1993; 
Benson et al. 1996a). Various molecular studies have been performed on potato germplasm, 
including microsatellite analysis and DNA-DNA hybridization of nuclear and chloroplast 
DNA which demonstrated stability in S. tuberosum cryopreserved using encapsulation-
dehydration (Harding and Benson 2000; Harding and Benson 2001). Schäffer-Menuhr et al. 
(1997) confirmed stability using RFLP, cytological and phenotypic analyses for a large-
collection of potato germplasm cryopreserved using droplet freezing. Stable RFLP profiles 
were also observed in DNA extracted from mahogany trees recovered from germplasm 
cryopreserved by controlled rate cooling (Harding et al. 2000). For Arachis germplasm 
cryopreserved using PVS2, RAPD marker analysis confirmed stability (Gagliardi et al. 2003). 
Stable Inter Simple Sequence Repeats (ISSR) and RAPD profiles were respectively observed in 
apple (Liu et al. 2008) and citrus (Hao et al. 2002b) following recovery after vitrification.  
For some studies, multiple approaches have been applied to monitor stability, this is 
exemplified by the use of phenotypic, cytological, RAPD and AFLP analyses to confirm and 
corroborate stability in plants derived from of Prunus germplasm that had been 
cryopreserved using PVS2, encapsulation-dehydration or controlled rate cooling (Helliot 
 et al. 2002a). Similarly, stable morphologies, biosynthetic capabilities and RAPD profiles 
were found in Dioscorea bulbifera plants recovered after encapsulation-dehydration (Dixit et 
al. 2003). No detectable differences were found in protein, isozyme, RAPD and AFLP profiles 
of apple, plants recovered from cryopreserved germplasm using vitrification (Liu et al. 2004). 
Taking a different approach, the stability of integrated transgenes was confirmed in 
transformed embryogenic lines of European chestnut that had been cryopreserved using a 
PVS2 vitrification protocol (Corredoira et al. 2007).  
There are also reports of instability and/or changes in development competency found in 
plants regenerated from cryopreserved germplasm, it is precautionary to use this information 
to guide best practices and risk management in quality assurance strategies for LTS. Risk 
assessment for cryopreservation may be advised to include associated tissue culture 
manipulations as different components of a cryopreservation protocol may incur various risks 
to stability and in practice protocol success depends upon both cryogenic and tissue culture 
procedures. Examples of cryopreservation treatments incurring instability and/or changed 
phenotypic and genotypic characters include: ribosomal RNA gene DNA methylation in S. 
tuberosum cryopreserved using ultra rapid freezing (Harding 1997). Variation in RAPD profiles 
in DMSO-treated (non-cryopreserved) embryogenic cultures of Abies cephalonica were observed 
by Aronen et al. (1999). DNA-methylation changes have been found in citrus cryopreserved 
using PVS2 (Hao et al. 2002b); in strawberry, cryopreserved using encapsulation-dehydration 
(Hao et al. 2002a) and other epigenetic chromatin changes in mahogany, cryopreserved using 
controlled rate cooling (Harding et al. 2000). This suggests the propensity for epigenetic 
processes occurring during cryopreservation is genotype/species and protocol independent. A 
changed RAPD profile was observed in one regenerant of Dendranthema grandiflora 
cryopreserved using encapsulation-dehydration (Martín and González-Benito 2005). Possible 
SCV was observed in white spruce, cryopreserved using controlled rate cooling (DeVerno et al. 
1999). Genotype-dependent genetic variability based on RAF (Randomly amplified DNA 
fingerprinting) and AMP (Amplified DNA methylation polymorphism) markers were noted in 
papaya plants recovered from droplet-vitrification (Kaity et al. 2008). 
The issues of how to: (1) assess stability in cryopreserved germplasm and (2) minimize and 
manage the risk of instability are critically important in developing best practices, high 
standards of stewardship and quality assurance criteria for all types of biorepository (Stacey 
2004). For plant germplasm, these challenges are confounded by the tendency of plants to 
manifest SCV in tissue culture; this is also exacerbated by epigenetic and genetic changes in 
response to conditions of stress. Consequentially, Harding (2004) highlighted the need to 
develop more robust, practical approaches to assess stability in regenerated cryopreserved 
germplasm, giving rise to the concept of cryobionomics. This focuses on understanding the 
linkages between genetic stability and its possible causes (e.g. cryoinjury and somaclonal 
variation), and elucidating how they affect stability and quality (trueness-to-type). Harding 
(2004) reviewed the applicability of the different molecular analyses currently used to assess 
genetic stability, concluding that most analyse a very small fraction of the genome, which 
may not provide a sufficiently robust measure to detect variability in cryopreserved clonal 
crop germplasm. Using different levels of evaluation is prudent; assessments of trueness-to-
type and field performance are more rigorous than only using molecular analyses. 
  
Smith and Ryan (2008) recommend using multiple physiological, metabolic and genetic 
tests to assess stability of conserved strains of microorganisms held in cryobanks and advise 
tests should be validated and implemented on a periodic, rather than a regular basis. Routine 
checks will ensure standard procedures are being adhered to and well documented. AFLP 
analysis is the method of choice suggested by Smith and Ryan (2008) as it is both stringent 
and relatively reproducible, however AFLP analysis requires expensive, specialist equipment 
and alternative suggestions are the use of RAPDs, minisatellites or Variable Number 
Tandem Repeats (VNTR), Simple Sequence Repeats (SSR) and Inter Simple Sequence 
Repeats (ISSR). Smith and Ryan (2008) cautioned that PCR-based techniques are prone to 
interference and this can result in different banding patterns, this problem may be 
complicated by contaminated, non-axenic cultures (Stacey 1999, 2004). Long-term biometric, 
phenotype, and field assessments of plants recovered from cryopreserved germplasm 
remain valuable performance indicators for assessing stability (Harding and Benson 1994; 
DeVerno et al. 1999; Côte et al. 2000; Harding and Staines 2001; Mártinez-Montero et al. 2002; 
Konan et al. 2007; Medina et al. 2007). Ideally, these are best used to complement molecular-
based tests; for the sake of efficiency their application may be rationalized by first assessing 
the propensity of genotypes to produce off-types. 
Managing the risks of instability in IVBGs is critical, though it is wise to take a pragmatic 
approach as overall; the risks of not securing germplasm in in vitro genebanks might be 
greater than the risk of loss (or instability) being generated by other types of storage. 
Moreover, a number of strategies and practices can be applied to reduce and offset the 
potential problem of instability. These have been explored in the detailed study of Prunus, by 
Helliot et al. (2002a) which reiterates the potential problems of SCV first highlighted by 
Scowcroft (1984, 1985). It is advisable not to use, as source material in vitro plants that have 
been maintained in long-term culture, if this is not practicable it is precautionary to compare 
genetic stability at each stage of a protocol. Where it is necessary to cryopreserve germplasm 
that has been maintained in culture for longer periods, it is cautious to be aware of the 
increased risks of generating SCV over extended culture times; these risks highlight the 
practical importance of rejuvenation, regeneration and verification (see Figure 7). This is 
exemplified by the study of DeVerno et al. (1999) in which somaclones from cryopreserved 
cells of white spruce were attributed to tissue culture factors rather than cryopreservation per 
se. Medina et al. (2007) also observed undesirable agronomic characters in strawberry plants 
regenerated from cryopreserved shoot meristems. These variants were assigned to in vitro 
manipulations rather than to cryogenic factors. Nonetheless, as tissue culture is a necessary 
component of most cryopreservation protocols measures are required to reduce the effects of 
both cryogenic and non-cryogenic factors on long-term stability. 
 Integrated processes in the medium and long-term storage of clonal crops 
 
 
Figure 7. Schematic showing the integration of regeneration and rejuvenation cycles in the in vitro 
conservation of Musa germplasm, highlighting the role of field regeneration and verification as quality 
measures in slow growth (MTS) and cryopreservation (LTS).  
The image is kindly supplied by Ines Van den houwe, Bioversity International.  
 
  
Fundamental knowledge and practical outcomes of empirical research (Figure 5) are the 
building blocks of storage protocol development; however, progress towards quality 
management systems and best practices requires a more formal approach. Whilst 
contemporary advances in slow growth and cryopreservation have been achieved through 
several modes of research (Figure 5), it is critical that best practice development and 
validations in IVGBs are considered more holistically as shown in Figure 7.  
Validation is the mechanism by which a process is assessed against a specific criterion as 
fit-for-purpose; this could pertain to expected levels of survival and regrowth after 
cryopreservation and slow growth treatments. In a quality management system, validation 
provides confirmation that the needs of a client or end user are met, it necessitates 
documented evidence that a process or a system used within specific parameters can 
perform: (1) effectively and (2) reproducibly, with respect to predetermined specifications. A 
validated storage protocol also confers a level of confidence that is critically dependent upon 
carefully selecting and corroborating validation criteria which are linked to fitness-for-
purpose. In the case of validating a cryopreservation protocol for shoot meristems, the 
criterion should not be survival (viability) but shoot and preferably plant regeneration, this is 
because survival is not a sufficiently robust indicator that recovered germplasm is fit-for 
purpose. Albeit, in working up a protocol, viability is useful as an early indicator, it is not an 
appropriate measure of competency when implementing the protocol as a best practice and 
routine method. Different performance criteria (e.g. phenotype, genotype assessments) are 
also used to evaluate plants recovered from IVGBs and their methodologies can also be 
validated (Day et al. 2007). Various criteria may be required for different protocols and types 
of germplasm, noting that validation will remain an aspiration for methods under 
development. In progressing towards a quality assured management system, it is cautionary 
to build in a formal validation process for a method before it is disseminated for routine use 
as a best practice or standard operating procedure across collaborating consortia.  
7.1 Fundamental research in protocol development  
Fundamental research supports evidence-based decisions for storage protocol development, 
validation and risk assessment and it helps to calibrate performance indicators for best 
practices formalized in RTD programmes (Figure 5). One of the most insightful recent 
applications of fundamental knowledge is the biophysical study of cryopreserved germplasm 
longevity as this has implications for long-term risk management. Walters et al. (2004) found 
that cryogenic storage temperatures progressively increased seed longevity, but were not 
sufficient to stop deterioration as the benefits of low temperatures (at -18 or -135°C) on 
longevity were progressively lost if seeds were first stored at 5°C. This suggests that 
physiological status and pre-storage treatments applied before cryopreservation may have 
consequences for longevity. Walters et al. (2004) also found variability in seed ageing kinetics 
could not be accounted for by water content and temperature alone, demonstrating differences 
in germination across accessions, provenances and between collecting years. This implies that 
variability is not solely due to genetic factors, but can be affected by other parameters and 
cryobank operators should not always assume a particular accession will exhibit average 
 deterioration kinetics. Thus, basic knowledge assists storage protocol risk assessments, for 
example, where germplasm is exposed to phase-fluctuations in LN temperatures, during 
excursions in, and out of cryobanks and in dry shipper transport. Knowledge of Tgs in 
germplasm held at different storage temperatures concurs with the best practice 
recommendations of ISBER (2008) and thermal profiling helps optimize cryoprotection 
(Benson et al. 1996b, Dumet et al. 2000; Šest{k and Z{mečník 2007; Nadarajan et al. 2008) 
particularly in desiccation sensitive germplasm. Knowledge of stress physiology can be used to 
help develop risk management strategies and to ensure germplasm is in an appropriate state 
before it is cryobanked. For example, stress markers can help to refine cryoprotection strategies 
(Johnston et al. 2007) and proteomics research can be potentially used to elucidate the basis of 
storage recalcitrance (Carpentier et al. 2006, 2007) and inform corrective actions.  
7.2 Storage protocol validation and critical point assessment  
Empirical approaches to technology transfer usually involve non-validated skills training 
and protocol transfers (Figure 5), but achieving a validated in vitro storage protocol, 
sufficiently robust to become a collective best practice across dispersed genebanks requires 
formal procedures. This is important for validating storage protocols across communities of 
practice undertaking shared research, training and technology development activities. 
Validation provides added confidence that all parties are performing their tasks effectively to 
specific criteria and performance indicators. Similarly, validation of in vitro conservation 
practices is desirable for genebank personnel involved in the reciprocated safe duplication of 
their holdings in black boxes. For example, in the event black boxes succumb to catastrophic 
events (e.g. earthquakes) validated rescue protocols may be required as recovery procedures. 
Initially steps towards validation might involve internal (in house) verification of a 
protocol to meet specific performance criteria. This would be followed by technology 
transfers to ensure, through critical point analysis, all requirements are met for successful 
technology implementation in a recipient institute (Reed et al. 2001, 2004b). The final 
deployment of the protocol often needs adaptation to local circumstances to accommodate 
different facilities and operational conditions (Reed et al. 2001; Elster et al. 2008; Harding et 
al. 2008; Lukešov{ et al. 2008). Optimally, external validation (Reed et al. 2004b; Day et al. 
2007; Dyer et al. 2007) is calibrated and corroborated by validators with different levels of 
expertise and across different institutions. This more robust approach tests quality of 
supporting information and experimental designs, ensuring a best practice is the successful 
outcome (Figure 8). Currently there is no formal validation system in place for 
cryopreservation in BRCs (Smith and Ryan 2008) this is mainly due to variation in and 
between storage protocols applied to different germplasm types. Methods often require 
technical adaptations for local institutes and different bioresources, although this need not be 
a constraint as long as the validation is undertaken systematically. Few detailed 
cryopreservation validation exercises have been reported in the literature, although three 
from very different sectors have been successful: (1) shoot meristems of clonally propagated 
culture of Ribes nigrum cv ‘Ojebyn’ (Reed et al. 2001, 2004b); (2) Chlorella vulgaris, SAG 211-
11b, (Day et al. 2007) and (3) peripheral blood mononuclear cells (Dyer et al. 2007). Despite 
different biomaterials being cryopreserved these exercises had similar outcomes, comparable 
management criteria and modes of intervention. This provides confidence that validations 
based on basic principles can be undertaken across dispersed and diverse biobanks that 
service different communities of practice. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Experimental design for validating three cryopreservation protocols using encapsulation-
dehydration and controlled rate cooling with a programmable freezer and a Mr Frosty™ unit. From the 
algal cryopreservation validation exercise of Day et al. (2007) which comprised seven validating 
laboratories.  
Based on the experience of European Union‟s 5th Framework Programme, Quality of Life and 
Management of Living Resources, Research Infrastructures Biological Collections, COBRA Project 
QLRT-2000-01645.  
Reproduced with permission of CryoLetters (Day et al. 2007).  
 
7.3 Designing and evaluating a storage protocol validation exercise 
Ideally storage protocol validation involves a common experimental design applied in 
exactly the same way, concomitantly across several institutes, using an identical test culture, 
organism or cell line provided from the same source (Figures 8 and 9). A risk assessment 
should be undertaken prior to the validation exercise to ensure that the potential hazards of 
transmitting pathogens are offset. Validation requires detailed planning; arriving at 
consensus as to how the process is undertaken and engendering collective ownership of 
validation data that may be used for quality assurance. Some lead in time is necessary to 
dispatch test cultures to different validators, which on their receipt should be processed for 
health and competency. It is essential test cultures are cultivated similarly using the same 
growth media across participating laboratories, this requires crosschecks to ensure cultures 
are performing within expected criteria before they are used to test storage protocols. It is 
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 preferable the test culture has a known and well-proven amenability to storage (Reed et al. 
2004b; Day et al. 2007) as this can be used as a performance indicator (viability, shoot 
regrowth or colony forming units). The protocol should have been developed, tested and 
verified by at least one participating partner who usually takes the lead in the wider 
validation exercise. Once a protocol has been validated for test material, it can be extended to 
other organisms and cultures. It is critical that identical handbooks and technical instructions 
are provided so that technical operators are guided by the same information, which has been 
checked for understanding, eligibility, and accuracy, particularly if it is translated into 
different languages. Validation by personnel unfamiliar with in vitro storage procedures 
requires adjunct training, workshops and phone-conferences (Figure 9) instigated at each 
stage of the process (Reed et al. 2004b; Dyer et al. 2007). Training and knowledge transfers 
may not be necessary to achieve a successful outcome for validators with prior experience. 
Good communications throughout validation programmes are required and this is best 
achieved using face-to-face visits, conference calls and a virtual hub such as a project–
dedicated website. In the case of the European Union’s 5th Framework Programme for 
Research Infrastructures in Biological Collections, the ‘COBRA Project’ used both virtual and 
physical infrastructures enabling the team to validate cryopreservation protocols using a test 
strain of the single-celled green algae Chlorella vulgaris SAG 211-11b (Day et al. 2007). This 
reduced the risks of non-compliancy (Table 2) by the seven validators and problems could be 
largely rectified early in the process; changes to a validation exercise should be meticulously 
recorded using a commonly agreed template. This precautionary measure can be used as a 
diagnostic to explain why an expected performance indicator has not been satisfied and it 
assists in a successful outcome becoming a sustainable best practice, thereby supporting 
external accreditation at a later stage (Figures 5 and 9). 
7.3.1 Performance indicators  
Robust performance indicators are essential for storage validation, for the study concerning 
C. vulgaris SAG 211-11b (Figure 8) the exercise used prior experience of taxa with good levels 
of post-thaw survival (>50%) and a ~15% variation in batch-to-batch viability which was 
known to have no discernable effect on recovery or customer acceptability regarding sample 
quality. These parameters were already adopted as the CCAPs’ ‘in-house’ quality standard 
and, as such they set the performance target for validation within an acceptable level of 
variability of 15% of the mean or median. 
Day et al. (2007) also validated the assays used to assess survival (viability) and recovery as 
colony forming units (CFUs). Vital staining indicated significantly (p<0.0001) higher levels of 
viability following controlled rate cooling compared to measuring recovery as regrowth. Vital 
staining over-estimated survival compared to methods that use CFU and cell growth as the 
performance indicator, statistical analysis showed a significant (p<0.01) interaction between 
cooling technique and viability assessment method. In contrast, meristem survival is not a 
reliable assessment of recovery in the validation of Ribes cryopreservation protocols and Reed et 
al. (2001, 2004b) chose regrowth at six weeks as the performance indicator. It is therefore 
necessary that recovery times extending to several weeks are included in validation experiments. 
7.3.2 Critical point assessment: creating compliancy across consortia 
Validation exercises should identify the critical points that may affect successful outcomes, 
including non-compliancy and factors outside the validators’ control. These are usually 
constraints in local facilities and operational practices but they still need to be part of the 
  
analysis. As an exemplar (Figure 8), C. vulgaris SAG 211-11B was successfully cryopreserved 
using two controlled rate cooling methods and an encapsulation-dehydration protocol 
(Harding et al. 2008). Seven validating laboratories and two parameters were tested: (1) the 
cryopreservation protocol and (2) the performance criteria for viability. Validators comprised 
two groups, those internal to the project consortium were the UK’s Natural Environment 
Research Council’s Culture Collection of Algae and Protozoa (NERC-CCAP), the Universität 
Göttingen, Sammlung von Algenkulturen (SAG), Germany; Institute of Botany, Culture 
Collection of Algal Laboratory (CCALA), Czech Republic; Institute of Soil Biology, ISB 
Collection (ISB), Czech Republic; Universidade de Coimbra, Culture Collection of Algae, 
University of Coimbra (ACOI), Portugal; two validators external to the consortium: University 
of Caen, Algobank, France; CABI Europe-UK. These were selected on the basis of technical 
skills and knowledge, but had no direct experience of certain aspects of the procedure. 
Algobank had no previous practical experience of cryopreservation and CABI had limited 
phycological experience.  
 
Figure 9. A programme for critical point analysis of cryopreservation protocol technology transfer and 
validation for shoot meristems of Ribes cryopreserved by: (A) PVS2 vitrification and (B) encapsulation-
dehydration. The process was undertaken in three independent laboratories in Kazakhstan, Poland and 
Germany supported by the USDA Foreign Agricultural Service, Scientific Cooperation Programme. 
Schematic based on Reed et al. (2004b), reproduced with the permission of CryoLetters.  
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 In validating a controlled rate cooling protocol for Ribes shoot meristems, Reed et al. 
(2001) found that the type of programmable freezer was a critical point factor due to different 
seeding (ice nucleation) mechanisms. These influenced germplasm survival and shoot 
growth, although local adaptations of the protocol resulted in acceptable levels of survival 
and shoot recovery. In the case of C. vulgaris, all participating laboratories successfully 
validated three different cryopreservation protocols (Day et al. 2007). A significant difference 
(p<0.010) was observed between data generated by individual partners, personnel experience 
was identified a critical factor when staffing changes at one institution affected control and 
post-cryo CFU counts. This was the most likely cause of inter-individual variability, whereas 
overall variability between validating labs demonstrated a well controlled/regulated 
validation experiment even though significant differences (p<0.010) were sometimes 
observed (Day et al. 2007). The outcome of this study was that all partners achieved viability 
levels within 15% of the median value and they were considered to have achieved the 
predetermined specification. The cryopreservation validation exercise using C. vulgaris 
demonstrates the technical rigour of the validators and measures protocol reliability. Both 
controlled cooling devices tested positive with high levels of viability, even with minor 
deviations from the code of compliance (Table 3).  
Table 2 demonstrates a robust validation exercise employing both internal and external 
validators with different competencies from different institutions. Adherence to protocol 
instructions was tracked using an interactive website, enabling real-time monitoring of 
cooperative activities. High levels of compliance were achieved with the exception of factors 
outside the control of the project team (changes in personnel, variable suppliers, 
refrigerators). It was possible to ascertain critical point factors in the validation exercise 
(Tables 2 and 3) and critical point assessments of technology transfers and validation 
procedures provide a means of pinpointing those factors that affect deployment of protocols 
across different institutions. In the study conducted by Reed et al. (2004b) shoot tips derived 
from cultures of Ribes nigrum cv ‘Ojebyn’ were used to test the success of technology 
transfers across clonal fruit crop institutes in Poland, Germany and Kazakhstan. Several 
critical point factors were identified in the process: 
 General facilities: growth room, laminar airflow benches, water bath, growth room for 
cold acclimation, general laboratory facilities, air-conditioning and ambient temperature 
control. 
 Personnel: basic laboratory skills, competency and aptitude for meristem dissection, 
stringency of adherence to protocol procedures. 
 Instructions: clarification of written and oral communication of methods and technical 
points related to cryoprotectant preparation, meristems excision, controls and handling 
of LN, rewarming and rehydration. 
 Source plant status: origin, time in culture, subculture transfer interval, genotype 
(identical genotype/source required for validation). 
 Culture conditions: optimized standard culture regimes, growth room parameters (light, 
temperature, and diurnal regime), culture medium preparation (autoclave procedure), 
growth regulators (quality, sterilization procedure), and subculture interval. 
 Pregrowth and recovery: acclimation conditions, pregrowth treatment, medium for 
growth and recovery growth room parameters and subculture intervals. 
 Cryogenic facilities: Dewar type, vials, inventories, labelling, LN availability. 
  
Table 2. Compliance1 of external/internal validators to an experimental design and protocols to 
validate controlled cooling and encapsulation-dehydration protocols for Chlorella vulgaris strain 
SAG 211-11B. 1Compliance - dark grey; minor deviation – hatched; significant deviation – white; 
nd – not determined, 2Colligative cryoprotection and controlled cooling using a programmable 
controlled rate cooler; 3Colligative cryoprotection and controlled passive cooling using  
Mr Frosty®; 4Cryoprotection by encapsulation-dehydration. Based on experience of the 
European Union’s 5th Framework Programme, Quality of Life and Management of Living 
Resources, Research Infrastructures Biological Collections, COBRA Project QLRT-2000-01645.  
Reproduced with permission of CryoLetters (Day et al. 2007).  
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 Table 3. Viability analysis as a function of validating laboratory, for controlled rate cooling using 
two different cooling devices, CRF = controlled rate and Mr Frosty™ freezing unit.1Number of 
replicates; 2Inter-Quartile Range (IQR). Using Chlorella vulgaris strain SAG 211-11B as the test 
organism. CFU = colony forming unit; FDA = fluroscein diacetate. Based on the experience of 
European Union’s 5th Framework Programme, Quality of Life and Management of Living 
Resources, Research Infrastructures Biological Collections, COBRA Project QLRT-2000-01645.  
Reproduced with permission of CryoLetters (Day et al. 2007). 
 
Final experiments achieved successful levels of post-storage recovery and training in the 
use of performance indicators improved experimental outcomes (Figure 8). Critical factors 
across all laboratories were: plant health, operator skills, prior experience and clarification of 
technical details. It is recommended instructions and information is tested for clarity before 
embarking on a validation process. 
Lab 
Cooling 
device Viability assay N1 IQR (%)2 Median (%) 
CCAP CRF CFU 27 9.0 94.0 
  FDA 27 6.0 100.0 
 Frosty CFU 27 20.0 57.0 
  FDA 27 0.0 100.0 
SAG CRF CFU 24 24.0 61.5 
  FDA 24 14.5 87.5 
 Frosty CFU 26 20.0 62.5 
  FDA 26 21.0 91.0 
ACOI CRF CFU 27 6.0 103.0 
  FDA 27 6.0 97.0 
 Frosty CFU 27 51.0 91.0 
  FDA 27 2.0 95.0 
ISB CRF CFU 27 6.0 89.0 
  FDA 27 5.0 92.0 
 Frosty CFU 27 5.0 94.0 
  FDA 27 3.0 98.0 
ALGO CRF CFU 27 11.0 91.0 
  FDA 27 3.0 100.0 
 Frosty CFU 27 15.0 89.0 
  FDA 27 5.0 93.0 
CABI CRF FDA 20 37.0 83.5 
Total   544   
  
7.3.3 Learning from validation experiences  
It is important not to underestimate the costs, time and resources required to plan, document 
and execute validation exercises undertaken across international consortia, this is especially 
relevant for quality assurance programmes (Dyer et al. 2007; Smith and Ryan 2008). For 
practitioners new to in vitro storage meticulous identification of: (1) critical point factors that 
determine successful outcomes and (2) assessment criteria are required. Mode of 
cryoprotection and cooling are key parameters and regrowth must use definitive assessment 
criteria, preferably followed by quantifiable phenotypic and genotypic assessments that 
confirm plants recovered from stored germplasm are fit-for-purpose (Day et al. 2007; Harding 
2004; Reed et al. 2004b). Commonly identified general principals are practical ‚hands on‛ 
training, reciprocal visits, workshops, and pilot studies of the protocol before embarking on its 
validation; in the case of inexperienced personnel these activities are an essential preliminary.  
Validations must be appropriately costed, resourced, and scheduled, preferably by 
involving the participation of internal and external validating laboratories with different 
levels of expertise. It is vital that simple, clear, and detailed instructions are provided and 
where necessary these should be translated into a first language with stringent accuracy. 
Participants should check and refine draft documentation and progress a mutually agreed 
final version of the validation documents. Engaging as many participants as possible during 
the development of the process increases ‚ownership‛ of the exercise. A virtual collaborating 
environment and project-dedicated website is invaluable in validation management, 
technical communications, data compilation, transfer and interpretation. Standard reporting 
templates, online questionnaires (to assess conformity) and equipment calibration avoids the 
unnecessary bureaucracy that can be associated with validation exercises. 
Recommendations arising from the European Union’s 5th Framework Programme, 
Quality of Life and Management of Living Resources, Research Infrastructures Biological 
Collections, COBRA Project QLRT-2000-01645 are shown in Table 4. Smith and Ryan (2008) 
provide a summary of parameters that may be used to standardize and validate fungal 
cryopreservation protocols. It includes criteria of generic importance to all types of 
cryopreserved materials:  
 Performance of blind tests: a central laboratory sends a test culture with limited 
information to be tested by a validating laboratory. 
 Reproducibility check: comparing results of a validation performed at different times, 
comparisons of results obtained by different storage methods, comparisons of results 
obtained by different personnel and operators. 
 Equipment calibration: all equipment and facilities used in the validation are critical 
point parameters and should be regularly maintained and checked for performance.  
 Recording: daily recoding of temperatures and critical performance attributes of growth 
rooms, cryogenic and refrigerated freezers.  
 Table 4. Recommendations for planning international validation exercises for cryopreservation 
protocols, based on the experience of European Union’s 5th Framework Programme, Quality of 
Life and Management of Living Resources, Research Infrastructures Biological Collections, 
COBRA Project QLRT-2000-01645.  
Revised from Day et al. (2007) with permission of CryoLetters.  
 
Compliance area Action 
Training  Ensure those performing “hands on” work participate in pre-validation workshops and 
training courses. 
Experimental design  Ensure all participants have the equipment, logistics and staff available to undertake 
the validation exercise. Where appropriate translate handbooks and manuals into the 
first language of the validating laboratories and check for accuracy and clarity of all 
instructions. 
Methodology Undertake a pilot study in all participating labs and not just a sub-set of the validating 
laboratories. Make sure there is adequate technical support to deal with all requests 
immediately. 
Wherever possible ensure all equipment and consumables are identical, where this is 
not possible make detailed and accurate records as to where deviations from protocols 
and materials occur.  
Reporting  Where possible use a central, web-based hub to manage the validation exercise and 
train staff in completing any on-line reporting and data input. 
Data management Engage in dialogue at the planning stage with experts in validation and an appropriately 
experienced bio-statistician. 
Data exploitation Ensure the design of the experimentation is compliant with publishable results allowing 
widespread dissemination of the key findings of the study.  
 
7.4 Working towards accreditation: a multidisciplinary experience 
Quality Assurance (QA) is evidence of action needed to provide confirmation work is done 
effectively and involves a systematic accounting of activities, giving sufficient confidence a 
process or product meets given requirements for quality. Galsworthy (2007) explains a 
quality management system: (1) directs and controls an organization with respect to quality 
and (2) establishes policies and procedures required to achieve quality objectives. These 
should normally include all activities in the process including, documentation, calibration 
and maintenance. Implicit in QA is failure testing as this anticipates a weakness or critical 
point in a process, in the manufacturing industries Taguchi statistics are used to assess 
compliance and the approach is now applied to plant cryopreservation to determine critical 
parameters (Nadarajan 2005; Muthusamy et al 2005; Nadarajan et al. 2006; 2007). Statistical 
analysis also helps to quantify compliancy for variance around critical levels of tolerance 
(Day et al. 2007) and when routinely used it ensures a process is correct within defined levels 
and limits. Quality control involves QA across the whole process ensuring that it is reliable 
(robust) and safe with an overarching awareness a process is fit-for-purpose.  
Medical practitioners are pioneers in developing quality assured and accredited culture 
collections in both active culture and cryopreserved states (Day and Stacey 2007; Day et 
al. 2008). Von Versen et al. (2000) comment that reaching consensus within a community of 
  
practice, for best standards helps to confirm to authorities compliance with regulatory 
requirements. Quality systems have also driven the manufacture of high specification 
storage products, security systems and risk management logistics supporting the modern 
service biorepository and biobank and quality management has been a benchmark for 
service culture collections since their instigation. Smith and Ryan (2008) and Galsworthy 
(2007) similarly justify the importance of quality systems as follows: 
 managing risk effectively, 
 improving performance,  
 assuring the quality of the service or research provided, 
 formalizing systems for staff competency and training, 
 gaining recognition via accreditation and certification. 
 
Accreditation is the process by which a certificate of competency is awarded to an 
organization by an external, third party, auditor, which is itself accredited by formal 
standards and procedures. The auditor is thus assured competent to test the quality 
assurance. Certification is a third party attestation related to products, processes, systems or 
personnel and accreditation is undertaken in compliance with a body recognized to assess 
against internationally recognized standards. The international standards body for quality 
management systems is the International Organization for Standardization, represented by 
the logo and designation of ISO. The ISO body is a global organization comprising 
representatives from a wide range of national standard organizations that set standards of 
practice. There are three main international quality systems standards (Galsworthy 2007) 
relevant to accreditation in BRCs and IVGBs: 
1. ISO 9001: a quality system with limited or no technical input. 
2. ISO 17025: a quality system for the competency of a laboratory or organization with a 
high level of technical input. 
3. Good laboratory practice (GLP): covers the production of registration data for chemical 
submissions to registration bodies. 
 
The ISO 9000-9001 series is now being applied to tissue and cell banking in many 
disciplines, it is therefore advisable to explore how different biological resources sectors have 
developed their best practices and accredited quality systems. Smith and Ryan (2008) report 
the impacts of the OECD’s best practices (OECD 2007) on validating cryopreservation 
techniques for microorganisms held in BRCs. These involve the activities of the Global 
Biological Resource Centre Network (GBRNC) a worldwide federation of culture collections. 
Their experiences provide useful insights into how a large-scale collective proceeds towards 
validating best practices and developing quality criteria for active and cryopreserved 
cultures. The OECD best practices (OECD 2007) consolidate the earlier efforts of the UK’s 
National Culture Collections (UKNCC, http://www.ukncc.co.uk), the European Common 
Access to Biological Resources and Information (CABRI) and the European BRC Network. 
Guidance offered by the OECD (2007) is designed to ensure biological materials held in all its 
institutions supply them in compliance to a common set of four quality standards related to:  
 laboratory design and procedural requirements, 
 handling, authenticity, preservation, and distribution procedures, 
  compliance with national and international rules and regulations, 
 auditing and accreditations procedures.  
The OECD and UKNCC best practice guidelines are reiterated at two levels, the first is 
applicable to all biological resources, whilst the second is domain specific, the most rigorous 
specifications are in place for the microbial faculty, followed by human-derived materials. 
The principles on which the best practices are based are generic and as such are applicable to 
plant germplasm, they are listed as: 
 Competent persons carry out procedures. 
 Performance of stored germplasm authentication tests. 
 Number of subcultures, transfers, or generations of original material before storage are 
kept to a minimum. 
 Master stock is created from the original material. 
 Master stocks are cryopreserved from which further stocks for distribution are sourced. 
 Sufficient distribution stocks are made to minimize need to go back to master stocks for 
replenishment. 
 Materials are stored under environmental parameters that assure stability of properties. 
 Detail of inventory control, lead times and re-stocking practices are documented. 
 Validation of methods and recording of details of the validation process. 
 Details of protocols are laid down using domain-specific criteria. 
 Biological materials are preserved using at least two distinct methods. 
 Cryopreserved stocks are maintained in separate locations. 
 Disaster measures are in place in the event collections are placed at risk. 
 Establishment of baseline information on storage maintenance checks. 
 Maintenance plan for periodic control of each organism preserved. 
 Validation of materials after preservation. 
 Any deviation from standard operations requires accounting for discrepancies and 
recording. 
 Quality audits and review procedures are in place. 
The goals of quality management systems are to ensure the availability of known, 
validated and precisely identified biological resources that are conserved using validated and 
reproducible preservation protocols (Smith and Ryan 2008). To this end the OECD continues to 
examine mechanisms for adopting best practices, based in part, on the UKNCC quality 
management system (UKNCC 1998). Adopted by many collections is the ISO 9000 (9001):2000 
series certification, of which sixteen ‘collection’ organizations have been third party accredited 
(Smith and Ryan 2008). The German Collection of Microorganisms and Cell Cultures (DSMZ) 
holds ca. 750 plant lines certified by DIN EN ISO 9001-2000. The Leibniz Institute of Plant 
Genetics and Crop Plant Research (IPK), Gatersleben, Germany has realized ISO certification 
(DIN EN ISO 9001-2000). The International Potato Center (CIP), Peru, was awarded ‘ISO/IEC 
17025:2005 General Requirements’ for the competence of testing and calibration laboratories in 
February 2008, by the United Kingdom Accreditation Service. This accreditation is a 
considerable achievement for addressing quality systems in CGIAR’s clonal crop genebanks 
and a major milestone for the in vitro plant conservation community. 
  
7.5 Future perspectives: translational in vitro conservation technology 
The characteristics of translational research (TR) are complexity, trans-disciplinarity, and 
undertaking collective actions across multiple sectors and institutional types (Clackson 2006). 
First developed for medical disciplines, TR is described as the ‘Bench-to-Bedside’ approach 
to drug development (Littman et al. 2007) although it is now engaged by other sectors 
because of its broader definition of translating academic research into practical benefits. 
Realising best practices, managing risks, and validating protocols in the IVGB involves 
translational principles: 
1. Consolidating practices for connecting pure and applied research. 
2. Creating frameworks for delivering to practitioners and beneficiaries. 
3. Charting paths from scientific discovery to application. 
4. Utilizing roadmaps and technology implementation plans. 
5. Developing strategies to:  
a. capture and accelerate research benefits,  
b. close gaps between discovery and knowledge use by practitioners, 
c. yield high specification ‚fit-for-purpose‛ knowledge transfers, 
d. meet professional standards and safety criteria, 
e. make more cost effective use of research and development funds. 
Translational research is not a substitute for conventional research, rather it is a catalyst 
to achieving a desired outcome that satisfies the needs of end users. Operations within 
IVGBs are under regulatory control and are increasingly influenced by the changing 
expectations of stakeholders and beneficiaries, particularly in molecular and omics research 
which demand stringency in the quality and containment of genetic resources. The 
expectation is that IVGBs meet these demands through best practices and quality assured 
operations; a translational approach may help to ensure that research outcomes are 
acceptable within these contexts (Benson 2008a; Littman et al. 2007). 
 Ahuja S, Mandal BB, Dixit S, Srivastava PS. 2002. Molecular, phenotypic and biosynthetic stability in 
Dioscorea floribunda plants derived from cryopreserved shoot tips. Plant Science 163:971-977.  
Angel F, Barney VE, Tohme J, Roca WM. 1996. Stability of cassava plants at the DNA level after retrieval 
from 10 years of in vitro storage. Euphytica 90:307-313. 
Angell CA. 2002. Liquid fragility and the glass transition in water and aqueous solutions. Chemical Reviews 
102:2627-2650. 
Aronen TS, Krajnakovah J, Haggman HM, Ryynänen LA. 1999. Genetic fidelity of cryopreserved 
embryogenic cultures of open-pollinated Abies cephalonica. Plant Science 142:163-172. 
Ashmore SE. 1997. Status report on the development and application of in vitro techniques for the 
conservation and use of plant genetic resources. IPGRI, Rome, IT.  
Ashmore SE, Drew RA, Azimi M. 2007a. Vitrification-based shoot tip cryopreservation across 7 genotypes of 
Carica papaya and 1 wild relative (Vasconcellea pubescens). Australian Journal of Botany 55:1-7.  
Ashmore SE, Hamilton KN, Pritchard HW. 2007b. Development of conservation technologies in response to 
Target 8 of the GSPC. Proceedings of the 3rd Global Botanic Gardens Congress, 15-20 April 2007, 
Wuhan, CN. Available from URL: http://www.bgci.org/files/Wuhan/PapersConserving/Ashmore.pdf 
Banerjee N, De Langhe E. 1985. A tissue culture technique for rapid clonal propagation and storage under 
minimal growth conditions of Musa (Banana and plantain). Plant Cell Reports 4:351-354. 
Basu C. 2008. Gene amplification from cryopreserved Arabidopsis thaliana shoot tips. Current Issues in 
Molecular Biology 10:55-60. 
Baust JM, Baust JG. 2007. A paradigm shift in cryopreservation: molecular-based advances to improve 
outcomes. In: Timmerhaus KD, Reed RP, editors. Cryogenic Engineering. Part 4. International 
Cryogenics Monograph Series, Springer, New York, USA. pp. 340-366.  
Beck EH, Fettig S, Knake C, Hartig K, Bhattarai T. 2007. Specific and unspecific responses of plants to cold 
and drought stress. Journal of Biosciences 32:501-510.  
Benett IJ, Bunn E, Clarke H, McComb JA, editors. 2005. Contributing to a Sustainable Future. Proceedings 
of the Australian Branch of the IAPTC & B. Perth, Western Australia, AU.  
Benson EE, editor. 1999. Plant Conservation Biotechnology. Taylor and Francis, London, UK.  
Benson EE. 2000a. Special symposium: In vitro plant recalcitrance: an introduction. In Vitro Cellular and 
Developmental Biology Plant 36:141-148. 
Benson EE. 2000b. Special symposium: In vitro plant recalcitrance: do free radicals have a role in plant 
tissue culture recalcitrance? In Vitro Cellular and Developmental Biology Plant 36:163-170. 
Benson EE. 2004. Cryoconserving algal and plant diversity: historical perspective and future challenges. In: 
Fuller B, Lane N, Benson EE, editors. Life in the Frozen State. CRC Press, London, UK. pp. 299-328. 
Benson EE. 2008a. Cryopreservation of phytodiversity: a critical appraisal of theory and practice. Critical 
Reviews in Plant Sciences 27:141-219. 
Benson EE. 2008b. Cryopreservation theory. In: Reed B, editor. Plant Cryopreservation: a Practical Guide. 
Springer, New York, USA. pp. 15-32. 
Benson EE, Harding K, Smith H. 1989. Variation in recovery of cryopreserved shoot tips of Solanum 
tuberosum exposed to different pre- and post-freeze light regimes. CryoLetters 10:323-344. 
Benson EE, Wilkinson M, Todd A, Ekuere U, Lyon J. 1996a. Developmental competence and ploidy stability 
in plants regenerated from cryopreserved potato shoot-tips. CryoLetters 17:119-128. 
Benson EE, Reed BM, Brennan R, Clacher KA, Ross DA. 1996b. Use of thermal analysis in the evaluation of 
cryopreservation protocols for Ribes nigrum L. germplasm. CryoLetters 17:347-362. 
Benson EE, Johnston J, Muthusamy J, Harding K. 2005. Physical and engineering perspectives of in vitro 
plant cryopreservation. In: Dutta Gupta S, Ibaraki Y, editors. Plant Tissue Culture Engineering. 
Springer, NL. pp. 441-473. 
Benson EE, Harding K, Johnston J. 2007. Cryopreservation of shoot-tips and meristems. In: Day JG, Stacey 
G, editors. Methods in Molecular Biology Vol. 368, Cryopreservation and Freeze Drying Protocols 
(2nd ed.). Totowa, New Jersey, USA. pp. 163-184. 
  
Benson EE, Harding K, Debouck D, Dumet D, Escobar R, Mafla G et al. 2011a. Refinement and 
standardization of storage procedures for clonal crops. Part II. Status of in vitro conservation 
technologies for: Andean root and tuber crops, cassava, Musa, potato, sweetpotato and yam. 
Bioversity International, Rome, IT. In press. 
Benson EE, Harding K, Debouck D, Dumet D, Escobar R, Mafla G et al. 2011b. Refinement and 
standardization of storage procedures for clonal crops. Part III. Multi-crop guidelines for developing in 
vitro conservation best practices for clonal crops. Bioversity International, Rome, IT. In press. 
Berjak P. 2006. Unifying perspectives of some mechanisms basic to desiccation tolerance across life forms. 
Seed Science Research 16:1-15. 
Berjak P, Pammenter NW. 1994. Recalcitrance is not an all-or-nothing situation. Seed Science Research 
4:263-264. 
Berjak P, Pammenter NW. 2008. From Avicennia to Zizania: seed recalcitrance in perspective. Annals of 
Botany 101:213-228.  
Berjak P, Farrant JM, Mycock DJ, Pammenter NW. 1990. Recalcitrant (homoiohydrous) seeds: the enigma of 
their desiccation sensitivity. Seed Science and Technology 18:297-310. 
Bertrand-Desbrunais A, Noirot M, Charrier A. 1991. Minimal growth in vitro conservation of coffee (Coffea 
spp.). Plant Cell Tissue and Organ Culture 27:333-339. 
Bertrand-Desbrunais A, Noirot M, Charrier A. 1992. Slow growth in vitro conservation of coffee (Coffea spp.). 
Plant Cell Tissue and Organ Culture 31:105-110. 
Bhojwani SS. 1981. A tissue culture method for propagation and low temperature storage of Trifolium repens 
genotypes. Physiologia Plantarum 52:187–190. 
Bielanski A. 2005a. Non-transmission of bacterial and viral microbes to embryos and semen stored in vapour 
phase of liquid nitrogen in dry shippers. Cryobiology 50:206-210.  
Bielanski A. 2005b. Experimental microbial contamination and disinfection of dry (vapour) shipper Dewars 
designed for short-term storage and transportation of cryopreserved germplasm and other biological 
specimens. Theriogenology. 63:1946-1957.  
Bielanski A, Nadin-Davis S, Sapp T, Lutze-Wallace C. 2000. Viral contamination of embryos cryopreserved 
in liquid nitrogen. Cryobiology 40:110-116.  
Bielanski A, Bergeron H, Lau PCK, Devenish J. 2003. Microbial contamination of embryos and semen during 
long term banking in liquid nitrogen. Cryobiology 46:146-152.  
Block W. 2003. Water status and thermal analysis of alginate beads used in cryopreservation of plant 
germplasm. Cryobiology 47:59-72. 
Buitink J, Leprince O, Hemminga MA, Hoekstra FA. 2000. Molecular mobility in cytoplasm: an approach to 
describe and predict lifespan in dry germplasm. Proceedings of the National Academy of Sciences 
USA 97:2385-2390. 
Bunn E, Tan B. 2004. Microbial contaminants in plant tissue culture propagation. In: Sivasithamparama K, 
Dixon KW, Barrett RL, editors. Microorganisms in Plant Conservation and Biodiversity. Springer, NL. 
pp. 307-335. doi: 10.1007/0-306-48099-9_12. 
Brison M, de Boucaud M-T, Pierronnet A, Dosba F. 1997. Effect of cryopreservation on the sanitary state of a 
cv. of Prunus rootstock experimentally contaminated with Plum Pox Potyvirus. Plant Science 123:189-
196.  
Caboux E, Plymoth A, Hainaut P. 2007. Common minimum technical standards and protocols for biological 
resources centres dedicated to cancer research. World Health Organization, International Agency for 
Research on Cancer, Lyon, FR.  
Carpentier SC, Witters E, Laukens K, Deckers K, Swennen R, Panis, B. 2005. Preparation of protein extracts 
from recalcitrant plant tissues: an evaluation of different methods for two-dimensional electrophoresis 
analysis. Proteomics 5:2497-2507. 
Carpentier SC, Witters E, Laukens K, Swennen R, Panis, B. 2006. Proteome research in banana meristems 
to study cryoprotection. Cryobiology 53:422. 
Carpentier SC, Witters E, Laukens K, Van Onckelen H, Swennen R, Panis, B. 2007. Banana Musa spp. as a 
model to study the meristem proteome: acclimation to osmotic stress. Proteomics 7:92-105.  
 Cassells AC. 1991. Problems in tissue culture: culture contamination. In: Debergh PC, Zimmermann RH, editors. 
Kluwer Academic Publishers, Dordrecht, NL. pp. 31-44. 
Cassells AC, Curry RF. 2001. Oxidative stress and physiological, epigenetic and genetic variability in plant tissue 
culture: implications for micropropagators and genetic engineers. Plant Cell Tissue and Organ Culture 
64:145-157. 
CGIAR Science Council. 2005. Summary report on system priorities for CGIAR research 2005-2015. Science 
Council Secretariat, Rome, IT. 
Cha-um S, Kirdmanee C. 2007. Minimal growth in vitro culture for preservation of plant species. Fruit, 
Vegetable and Cereal Science and Biotechnology 1:13-25. 
Chinnusamy V, Zhu J, Zhu J-K. 2006. Gene regulation during cold acclimation in plants. Physiologia Plantarum 
126:52-61. 
Clackson T. 2006. Translational research in academic and industry. Experimental Biology and Medicine 
231:1685-1689. 
Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T et al. 2005. ECVAM good cell culture practice 
task force report 2. Alternatives to Laboratory Animals ATLA 33:261-287. 
Corredoira E, San-José MC, Vieitez AM, Ballester A. 2007. Improving genetic transformation of European 
chestnut and cryopreservation of transgenic lines. Plant Cell Tissue and Organ Culture 91:281-288. 
Côte FX, Goue O, Domergue R, Panis B, Jenny C. 2000. In-field behaviour of banana plants (Musa AA sp.) 
obtained after regeneration of cryopreserved embryogenic cell suspensions. CryoLetters 21:19-24. 
Criel B, Panta A, Carpentier S, Renaut J, Swennen R, Panis B et al. 2005. Cryopreservation and abiotic 
stress tolerance in potato: a proteomic approach. Communications in Agricultural and Applied 
Biological Sciences Ghent University 70:83-86. 
Cyr DR. 1999. Cryopreservation of embryogenic cultures of conifers and its application to clonal forestry. In: 
Jain SM, Gupta PK, Newton RY, editors. Somatic Embryogenesis in Woody Plants. Vol. 4. Springer, 
Dordrecht, NL. pp. 239-261. 
Cyr DR, Klimaszewsak K. 2002. Conifer somatic embryogenesis: II Applications. Dendrobiology 48:41-49.  
Day JG, Stacey G, editors. 2007. Methods in Molecular Biology. Cryopreservation and Freeze Drying 
Protocols. Vol. 368, (2nd ed.). Humana Press, Totowa, New Jersey, USA. 
Day JG, Watanabe MM, Morris GJ, Fleck RA, McLellan MR. 1997. Long-term viability of preserved 
eukaryotic algae. Journal of Applied Phycology 9:121-127. 
Day JG, Lorenz M, Wilding TA, Friedl T, Harding K, Pröschold T et al. 2007. The use of physical and virtual 
infrastructures for the validation of algal cryopreservation methods in international culture collections. 
CryoLetters 28:359-376. 
Day JG, Harding K, Nadarajan J, Benson EE. 2008. Cryopreservation: conservation of bioresources at ultra 
low temperatures. In: Walker JM, Rapley R, editors. Molecular Biomethods Handbook, (2nd ed.). 
Humana Press, Totowa, New Jersey, USA. pp. 915-945. 
De Oliveira RP, de Oliveira e Silva S, da Silva KM, Silveira DG. 2000. In vitro conservation of diploid banana 
accessions. Scientia Agricola 57:1-7. 
De Vicente MC. 2004. The evolving role of genebanks in the fast-developing field of molecular genetics. No 
11. Issues in Genetic Resources, IPGRI, Rome, IT. 
DeVerno LL, Park YS, Bonga JM, Barrett JD. 1999. Somaclonal variation in cryopreserved embryogenic 
clones of white spruce [Picea glauca (Moench) Voss.]. Plant Cell Reports 18:948-953. 
Dixit S, Mandal BB, Ahuja S, Srivastava PS. 2003. Genetic stability assessment of plants regenerated from 
cryopreserved embryogenic tissues of Dioscorea bulbifera L. using RAPD, biochemical and 
morphological analysis. CryoLetters 24:77-84. 
Drew RA. 1992. Improved techniques for in vitro propagation and germplasm storage of papaya. 
HortScience 27:1122-1124. 
Dumet D, Block W, Worland R, Reed BM, Benson EE. 2000. Profiling cryopreservation protocols for Ribes 
ciliatum using differential scanning calorimetry. CryoLetters 21:367-378. 
  
Dyer WB, Pett SL, Sullivan JS, Emery S, Cooper DA, Kelleher AD et al. 2007. Substantial improvements in 
performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality 
assurance program using single donor samples. Clinical and Vaccine Immunology 14:52-59. 
Elster J, Lukavský J, Harding K, Benson EE, Day JG. 2008. Deployment of the encapsulation/dehydration 
protocol to cryopreserve polar microalgae held at the Czech Republic Academy of Sciences Institute 
of Botany. CryoLetters 29:27-28. 
Engelmann F. 1999. Alternative methods for the storage of recalcitrant seeds – an update. In: Marzalina M, 
Khoo KC, Jayanthi N, Tsan FS, Krishnapillay B, editors. IUFRO Seed Symposium 1998, Recalcitrant 
Seeds, Proceedings of the Conference; 12-15 October 1998, Forest Research Institute of Malaysia, 
Kuala Lumpur, MY. pp. 159-170.  
Engelmann F. 2004. Plant cryopreservation: progress and prospects. In Vitro Cellular and Developmental Biology 
Plant. 40:427-433.  
Engelmann F, Takagi H, editors. 2000. Cryopreservation of tropical plant germplasm current research 
progress and its applications. JIRCAS, Tsukuba, Japan and IPGRI, Rome, IT. 
Engelmann F, Gonzalez Arnao M-T, Wu Y, Escobar R. 2008. Development of encapsulation dehydration. In: 
Reed BM, editor. Plant Cryopreservation: a Practical Guide. Springer, New York, USA. pp. 59-76. 
Engels JMM, Visser L. 2003. A guide to effective management of germplasm collections. No 6. Handbooks 
for Genebanks, IPGRI, Rome, IT. 
Fabre J, Dereuddre J. 1990. Encapsulation/dehydration: a new approach to cryopreservation of Solanum 
shoot-tips. CryoLetters 11:413-426. 
Fang J-Y, Wetten A, Johnston J. 2008. Headspace volatile markers for sensitivity of cocoa (Theobroma 
cacao L.) somatic embryos to cryopreservation. Plant Cell Reports 27:453-461. 
FAO. 1996. Global plan of action, for the conservation and sustainable utilization of plant genetic resources 
for food and agriculture. FAO of the UN, Rome, IT. 
FAO. 2002. The international treaty of plant genetic resources for food and agriculture. FAO of the UN, 
Rome, IT. 
Fountain D, Ralston M, Higgins N, Gorlin JB, Uhl L, Wheeler C et al. 1997. Liquid nitrogen freezers: a 
potential source of microbial contamination of hematopoietic stem cell components. Transfusion 
37:585-591.  
Fowler S, Thomashow MF. 2002. Arabidopsis transcriptome profiling indicates that multiple regulatory 
pathways are activated during cold acclimation in addition to the CBF cold response pathway. Plant 
Cell 14:1675-1690. 
Fujita M, Fujita Y, Noutoshi Y, Takahashi F, Narusaka Y, Yamaguchi-Shinozaki K, Shinosaki K. 2006. 
Crosstalk between abiotic and biotic stress responses: a current view from the points of convergence 
in the stress signaling networks. Current Opinion in Plant Biology 9:436-442. 
Fuller BJ. 2004. Cryoprotectants: the essential antifreezes to protect life in the frozen state. 
CryoLetters 25:375-388. 
Fuller BJ, Dijk S. 2008. Low temperature organ preservation, blood vessels and the human tissue act in 
2007: impact and implications. CryoLetters 29:175-179. 
Fuller BJ, Lane N, Benson EE, editors. 2004. Life in the Frozen State. CRC Press, London, UK. 
Gachon CMM, Day JG, Campbell CN, Pröschold T, Saxon RJ, Küpper KC. 2007. The culture collection of 
algae and protozoa (CCAP): a biological resource for protistan genomics. Gene 406:51-57.  
Gagliardi RF, Pacheco GP, Carneiro LA, Valls JFM, Vieira MLC, Mansur E. 2003. Cryopreservation of 
Arachis species by vitrification of in vitro-grown shoot apices and genetic stability of recovered plants. 
CryoLetters 24:103-110. 
Gale S, John A, Benson EE. 2007. Cryopreservation of Picea sitchensis (Sitka Spruce) embryogenic 
suspensor masses. CryoLetters 28:225-239. 
Gale S, John A, Harding K, Benson, EE. 2008. Cryopreservation of Picea sitchensis (Sitka Spruce) somatic 
embryos using vitrification. CryoLetters 29:135-144.  
Gallard A, Panis B, Dorion N, Swennen R, Grapin, A. 2008. Cryopreservation of Pelargonium apices by 
droplet-vitrification. CryoLetters. 29:243-251. 
 Galsworthy D. 2007. Quality management systems and implementation at CIP. GPG2 Clonal Plants 
Workshop, Presentation, November 2007, CIP, Peru. 
Gaspar T, Franck T, Bisbis B, Kevers C, Jouve L, Hausman JF et al. 2002. Concepts in plant stress 
physiology. Application to plant tissue cultures. Plant Growth Regulation 37:263-285. 
Genebank Standards. 1994. Food and Agriculture Organization of the United Nations, International Plant 
Genetic Resources Institute, Rome, IT. Available from URL: ftp://ftp.fao.org/docrep/fao/meeting/ 
015/aj680e.pdf 
Golmirzaie A, Panta A, Toledo J. 1999. Biotechnological advances in the conservation of root and tuber crops. In: 
Benson EE, editor. Plant Conservation Biotechnology. Taylor and Francis London, UK. pp. 165-178. 
Golmirzaie A, Toledo, J. 1998. In vitro conservation of potato and sweetpotato germplasm. CIP programme 
report 1997-98. CIP, Lima, Peru. Available from URL: http://www.cipotato.org/publications/ 
programme_reports/97_98/41invitr.pdf. 
Gonzalez-Arnao MT, Engelmann F. 2006. Cryopreservation of plant germplasm using the encapsulation-
dehydration technique: review and case study on sugarcane. CryoLetters 27:155-168. 
Gonzalez-Arnao MT, Panta A, Roca WM, Escobar RH, Engelmann F. 2008. Development of large scale 
application of cryopreservation techniques for shoot and somatic embryo cultures of tropical crops. 
Plant Cell Tissue and Organ Culture 92:1-13.  
Gray GR, Heath D. 2005. A global reorganization of the metabolome in Arabidopsis during cold acclimation 
is revealed by metabolic fingerprinting. Physiologia Plantarum 124:236-248. 
Grout, BWW, Henshaw GG. 1978. Freeze preservation of potato shoot-tips. Annals of Botany 42:1227-1229. 
Halmagyi A, Pinker I. 2006. Plant regeneration from Rosa shoot tips cryopreserved by a combined droplet 
vitrification method. Plant Cell Tissue and Organ Culture 84:145-153. 
Hamill S, Wasmund K, Smith M, Eccleston K, McKay D. 2005. Endogenous bacterial isolated from banana 
meristems during tissue culture initiation: problems and potential. In: Benett IJ, Bunn E, Clarke H, 
McComb JA, editors. Contributing to a Sustainable Future. Proceedings of the Australian Branch 
IAPTC & B. Perth, Western Australia, AU. pp.101-111. 
Hamilton KN, Ashmore SE, Drew RA. 2008. Desiccation and cryopreservation tolerance of near mature 
seeds of Citrus garrawayi. Seed Science and Technology 36:157-161. 
Hannah MA, Heyer AG, Hincha DK. 2005. A global survey of gene regulation during cold acclimation in 
Arabidopsis thaliana. PloS Genetics 1:0179-0196. 
HaoY-J, Lui QL, Deng X-X. 2001. Effect of cryopreservation on apple genetic resources at morphological, 
chromosomal, and molecular levels. Cryobiology 43:46-53. 
Hao Y-J, Deng X-X. 2002. Occurrence of chromosomal variations and plant regeneration from long-term-
cultured Citrus callus. In Vitro Cellular and Developmental Biology Plant 38:472-476. 
Hao Y-J, Deng X-X. 2003. Genetically stable regeneration of apple plants from slow growth. Plant Cell 
Tissue and Organ Culture 72:253-260. 
Hao Y-J, You C-X, Deng X-X. 2002a. Analysis of ploidy and the patterns of amplified fragment length 
polymorphism in strawberry plants recovered from cryopreservation. CryoLetters 23:37-46. 
HaoY-J, You C-X, Deng X-X. 2002b. Effects of cryopreservation on developmental competency, cytological 
and molecular stability of Citrus callus. CryoLetters 23:27-35. 
Hao Y-J, You C-X, Deng X-X. 2004. Genetic and epigenetic evaluations of Citrus calluses recovered from 
slow-growth culture. Journal of Plant Physiology 161:479-484. 
Harding K. 1991. Molecular stability of the ribosomal RNA genes in Solanum tuberosum plants recovered 
from slow growth and cryopreservation. Euphytica 55:141-146. 
Harding K. 1994. The methylation status of DNA derived from potato plants recovery from slow growth. Plant 
Cell Tissue and Organ Culture 37:31-38. 
Harding K. 1996. Approaches to assess the genetic stability of plants recovered from in vitro culture. In: 
Normah MN, Narimah MK, Clyde MM, editors. In Vitro Conservation of Plant Genetic Resources. 
Plant Biotechnology Laboratory, Faculty of Life Science, Universiti Kebangsaan, MY. pp. 135-168. 
Harding K. 1997. Stability of the ribosomal RNA genes in Solanum tuberosum L. plants recovered from 
cryopreservation. CryoLetters 18:217-230. 
  
Harding K. 1999. Stability assessments of conserved plant germplasm. In: Benson EE, editor. Plant 
Conservation & Biotechnology. Taylor and Francis Ltd., London, UK. pp. 97-107. 
Harding K. 2004. Genetic integrity of cryopreserved plant cells: a review. CryoLetters 25:3-22. 
Harding K, Benson EE. 1994. A study of growth, flowering, and tuberization in plants derived from 
cryopreserved potato shoot tips: implications for in vitro germplasm collections. CryoLetters 15:59-66. 
Harding K, Benson EE. 2000. Analysis of nuclear and chloroplast DNA in plants regenerated from 
cryopreserved shoot-tips of potato. CryoLetters 21:279-288. 
Harding K, Benson EE. 2001. The use of microsatellite analysis in Solanum tuberosum L. in vitro plantlets 
derived from cryopreserved germplasm. CryoLetters 22:199-208. 
Harding K, Staines H. 2001. Biometric analysis of phenotypic characters of potato shoot-tips recovered from 
tissue culture, dimethyl sulphoxide treatment and cryopreservation. CryoLetters 22:255-262. 
Harding K, Benson EE, Smith H. 1991. The effects of pre-freeze in vitro culture period on the recovery of 
cryopreserved shoot tips of Solanum tuberosum. CryoLetters 12:17-22. 
Harding K, Marzalina M, Krishnapillay B, Nashatul Z, Normah MN, Benson EE. 2000. Molecular stability 
assessments of trees regenerated from cryopreserved Mahogany (Swietenia macrophyllum) seed 
germplasm using non-radioactive techniques to examine chromatin structure and DNA methylation 
status of the ribosomal RNA genes. Journal of Tropical Forest Sciences 12:149-163.  
Harding K, Johnston J, Benson EE. 2005. Plant and algal cell cryopreservation: issues in genetic integrity, 
concepts in „Cryobionomics‟ and current European applications. In: Benett IJ, Bunn E, Clarke H, 
McComb, JA, editors. Contributing to a Sustainable Future. Proceedings of the Australian Branch of 
the IAPTC & B. Perth, Western Australia, AU. pp.112-119.  
Harding K, Friedl T, Timmermann H, Lorenz M, Müller J, Day JG et al. 2008. Deployment of the 
encapsulation/dehydration protocol to cryopreserve microalgae held at Sammlung Von Algenkulturen, 
Universität Göttingen, Germany. CryoLetters 29:15-20. 
Hartung T, Balls M, Bardouille C, Blanck O, Coecke S, Gstraunthaler G et al. 2002. ECVAM good cell culture 
practice, Task Force Report 1. Alternatives to Laboratory Animals ATLA 30:407-414. 
Häsler J, Wüest J, Gaspar T, Crèvecoeur M. 2003. Long-term in vitro cultured plant cells show typical 
neoplastic features at the cytological level. Biology of the Cell 95:357-364. Available from URL: 
http://submit.biolcell.org/boc/095/0357/boc0950357.pdf. 
Heine-Dobbernack E, Kiesecker H, Schumacher HM. 2008. Cryopreservation of dedifferentiated cell 
cultures. In: Reed BM, editor. Plant Cryopreservation: a Practical Guide. Springer, New York, USA. 
pp. 141-176. 
Helliot B, Madur D, Dirlewanger E, de Boucaud MT. 2002a. Evaluation of genetic stability in cryopreserved 
Prunus. In Vitro Cellular and Developmental Biology Plant 38:493-500. 
Helliot B, Panis B, Poumay Y, Swennen R, Lepoivre P, Frison E. 2002. Cryopreservation for the elimination of 
cucumber mosaic and banana streak viruses from banana (Musa spp.). Plant Cell Reports 20:1117-1122.  
Hirai D, Sakai A. 2000. Cryopreservation of in vitro-grown meristems of potato (Solanum tuberosum L.) by 
encapsulation-dehydration. In: Engelmann F, Takagi H, editors. Cryopreservation of Tropical Plant 
Germplasm Current Research Progress and its Applications. JIRCAS, Tsukuba, Japan and IPGRI, 
Rome, IT. pp. 205-211. 
Hor YL, Kim YJ, Ugap A, Chabrillange N, Sinniah UR, Engelmann F et al. 2005. Optimal hydration status for 
cryopreservation of intermediate oily seeds: Citrus as a case study. Annals of Botany 95:1153-1161. 
Available from URL: http://aob.oxfordjournals.org/content/95/7/1153.full.pdf+html 
HSE-Health and Safety Executive. 2006. Five steps to risk assessment. UK Health and Safety Executive, 
Caerphilly, Wales, UK. 
HFEA-Human Fertilization and Embryology Authority. 1998. Consultation on the safe cryopreservation of 
gametes and embryos. HFEA London, UK.  
HFEA-Human Fertilization and Embryology Authority. 2007. HFEA Code of Practice 7th ed. HFEA, London, 
UK. 
IBPGR. 1986. Design, planning and operation of in vitro genebanks. Report of the Subcommittee of the 
IBPGR Advisory Committee on In Vitro Storage. IBPGR, Rome, IT. 
 IBPGR. 1988. Conservation and movement of vegetatively propagated germplasm: In Vitro Culture and 
Disease Aspects. IBPGR, Rome, IT. 
IPGRI-CIAT. 1994. Establishment and operation of a pilot in vitro active genebank. Report of a CIAT-IBPGR 
Collaborative Project Using Cassava Manihot Esculenta Crantz as a Model. A Joint Publication of 
IPGRI and CIAT, Cali, Colombia and IPGRI, Rome, IT. 
ISBER. 2005. Best practices for repositories I: collection, storage and retrieval of human biological materials 
for research. Cell Preservation Technology 3:5-48. doi:10.1089/cpt.2005.3.5. 
ISBER. 2008. 2008 Best practices for repositories: collection, storage, retrieval and distribution of biological 
materials for research. Cell Preservation Technology 6:3-58. doi:10.1089/cpt.2008.9997. 
Jain SM. 2001. Tissue culture-derived variation in crop improvement. Euphytica 118:153–166. 
Johnston JW, Harding K, Bremner DH, Souch G, Green J, Lynch PT, Grout B, Benson EE. 2005. HPLC 
analysis of plant DNA methylation: a study of critical methodological factors. Plant Physiology and 
Biochemistry 43:844-853.  
Johnston JW, Harding K, Benson EE. 2007. Antioxidant status and genotypic tolerance of Ribes in vitro 
cultures to cryopreservation. Plant Science 172:524-534.  
Jokipii S, Ryynänen L, Kallio PT, Aronen T, Häggman H. 2004. A cryopreservation method maintaining the 
genetic fidelity of a model forest tree, Populus tremula L. x Populus tremuloides Michx. Plant 
Science 166:799-806. doi:10.1016/j.plantsci.2003.11.017. 
Joyce SM, Cassells AC. 2002. Variation in potato microplant morphology in vitro and DNA methylation. Plant 
Cell Tissue and Organ Culture 70:125–137. 
Joyce SM, Cassells, AC, Jain SM. 2003. Stress and aberrant phenotypes in in vitro culture. Plant Cell Tissue 
and Organ Culture 74:103–121. 
Kaity A, Ashmore SE, Drew RA, Dullo ME. 2008. Assessment of genetic and epigenetic changes following 
cryopreservation of papaya. Plant Cell Reports 27:1529-1539. 
Kaplan F, Kopka J, Haskell DW, Zhao W, Schiller KC, Gatzke N, Yul Sung D, Guy CL. 2004. Exploring the 
temperature-stress metabolome of Arabidopsis. Plant Physiology 136:4159-4168. Available from URL: 
http://www.plantphysiol.org/content/136/4/4159.full.pdf+html 
Kartha KK, Leung NL, Moroginski LA. 1982. In vitro growth and plant regeneration from cryopreserved 
meristems of cassava (Manihot esculenta Crantz.). Zeitschrift für Pflanzenphysiologie Band 107:133-
140. 
Keller ERJ, Senula A. 2003. Germplasm preservation in Allium species: an integrated approach to store 
morphologically characterized virus-free plant material via cryopreservation. ISHS Acta Horticulturae 
623:201-208. 
Keller ERJ, Senula A, Dreiling M. 2005. Genebanking of vegetatively propagated medicinal plants - two 
cases: Allium and Mentha. ISHS Acta Horticulturae 676:103-109. 
Keller ERJ, Senula A, Leunufna S, Grube M. 2006. Slow growth storage and cryopreservation-tools to 
facilitate germplasm maintenance of vegetatively propagated crops and living plant collections. 
International Journal of Refrigeration 29:411-417. 
Keller ERJ, Kaczmarczyk A, Senula A. 2008. Cryopreservation for plant genebanks: a matter between high 
expectations and cautious reservation. CryoLetters 29:53-62. 
Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sportes C, Wayne AS, Solomon SR, Bishop MR, 
Childs RM, Read EJ. 2002. Catastrophic failures of freezing bags for cellular therapy products: 
description, cause and consequences. Cytotherapy 4:539-549. 
Kim H-H, Lee J-K, Hwang H-S, Engelmann F. 2007. Cryopreservation of garlic germplasm collections using 
the droplet-vitrification technique. CryoLetters 28:471-481.  
Kim H-H, Yoon J-W, Park Y-E, Cho E-G, Sohn J-K, Kim T-S, Engelmann F. 2006. Cryopreservation of potato 
cultivated varieties and wild species: critical factors in droplet vitrification. CryoLetters 27:223-234.  
Kipp F, Linnemann E, Fischer R-J, Sibrowski W, Cassens U. 2004. Cryopreservation reduces the 
concentration of detectable bacteria in contaminated peripheral blood progenitor cell products. 
Transfusion 44:1098–1103. 
  
Konan EK, Durand-Gasselin T, Kouadio YJ, Niamké AC, Dumet D, Duval Y et al. 2007. Field development of 
oil palms (Elæis quineensis Jacq.) originating from cryopreserved stabilized polyembryonic cultures. 
CryoLetters 28:377-386. 
Kostiak PE. 2000. The evolution of quality systems in human bone banking: the U.S. experience. Cell and 
Tissue Banking 1:155-160.  
Kryszczuk A, Keller J, Grübe M, Zimnoch-Guzowska E. 2006. Cryopreservation of potato (Solanum 
tuberosum L.) shoot tips using vitrification and droplet method. Journal of Food Agriculture and 
Environment 4:196-200. 
Lakshmanan V, Venkataramareddy SR, Neelwarne B. 2007. Molecular analysis of genetic stability in long-
term micropropagated shoots of banana using RAPD and ISSR markers. Electronic Journal of 
Biotechnology 10:106-113. 
Leifert C, Waites WM. 1990. Contaminants of plant tissue cultures. Newsletter of the International 
Association of Plant Tissue Culture 60:2-22. 
Leifert C, Cassells AC. 2001. Microbial hazards in plant tissue and cell cultures. In Vitro Cellular and 
Developmental Biology Plant 37:133-138. 
Leunufna S, Keller ERJ. 2003. Investigating a new cryopreservation protocol for yams (Dioscorea spp.). 
Plant Cell Reports 21:1159-1166. 
Leunufna S, Keller ERJ. 2005. Cryopreservation of yams using vitrification modified by including droplet 
method: effects of cold acclimation and sucrose. CryoLetters 26:93-102. 
Littman BH, Di Mario L, Plebani M, Marincola FM. 2007. What‟s next in translational medicine? Clinical 
Science 112:217-227. 
Liu Y, Wang X, Liu L. 2004. Analysis of genetic variation in surviving apple shoots following cryopreservation 
by vitrification. Plant Science 166:677-685. 
Liu Y-G, Liu L-X, Wang L, Gao A-Y. 2008. Determination of genetic stability in surviving apple shoots 
following cryopreservation by vitrification. CryoLetters 29:7-14. 
Lopez-Delgado H, Jimenez-Casas M, Scott IM. 1998. Storage of potato microplants in vitro in the presence 
of acetylsalicylic acid. Plant Cell Tissue and Organ Culture 54:145-152. 
Luan Y-S, Zhang J, Gao X-R, An L-J. 2007. Mutation induced by ethylmethanesulphonate (EMS), in vitro 
screening for salt tolerance and plant regeneration of sweet potato (Ipomoea batatas L.). Plant Cell 
Tissue and Organ Culture 88:77-81. 
Lukešová A, Hrouzek P, Harding K, Benson EE, Day JG. 2007. Deployment of encapsulation/dehydration 
cryo-conservation protocols to terrestrial microalgae held at the Czech Republic Academy of 
Sciences, Institute of Soil Biology, Czech Republic. CryoLetters 29:21-26. 
Maertens A, Bourlet T, Plotton N, Pozzetto B, Levy R. 2004. Validation of safety procedures for the 
cryopreservation of semen contaminated with hepatitis C virus in assisted reproductive technology. 
Human Reproduction 19:1554-1557. 
Martín CM, González-Benito E. 2005. Survival and genetic stability of Dendranthema grandiflora Tzvelev shoot 
apices after cryopreservation by vitrification and encapsulation-dehydration. Cryobiology 51:281-289.  
Martínez DM, Revilla A, Espina A, Jaimez E, García JR 1998. Survival after cryopreservation of hop shoot 
tips monitored by differential scanning calorimetry. Thermochimica Acta 317:91-94. 
Martínez-Montero ME, Ojeda E, Espinosa A, Sanchez M, Castillo R, Gonzalez-Arnoa MT et al. 2002. Field 
performance of sugarcane (Saccharum sp.) plants derived from cryopreserved calluses. CryoLetters 
23:21-26. 
Martínez-Pardo ME, Mariano-Magaña D. 2007. The tissue bank at the Instituto Nacional de Investigaciones 
Nucleares: ISO 9001:2000 certification of its quality management system. Cell Tissue Banking 8:221-
231. 
Mazur P. 2004. Principles of Cryobiology. In: Fuller B, Lane N, Benson EE, editors. Life in the Frozen State. 
CRC Press, Boca Raton, USA. pp. 3-65. 
Mazzilli F, Delfino M, Imbrogno N, Elia J, Dondero, F. 2006. Survival of microorganisms in cryostorage of 
human sperm. Cell Tissue Banking. 7:75-79.  
 Medina JJ, Clavero-Ramırez I, Gonzalez-Benito ME, Galvez-Farfan J, Lopez-Aranda JM, Soria C. 2007. 
Field performance characterization of strawberry (Fragaria ananassa Duch.) plants derived from 
cryopreserved apices. Scientia Horticulturae 113:28–32. 
Morris, G.J. 2005. The origin, ultrastructure and microbiology of the sediment accumulating in liquid nitrogen 
storage vessels. Cryobiology 50:231-238. 
Müller J, Friedl T, Hepperle D, Lorenz M, Day JG. 2005. Distinction between multiple isolates of Chlorella 
vulgaris (Chlorophyta, Trebouxiophyceae) and testing for conspecificity using amplified fragment 
length polymorphism and ITS RDNA sequences. Journal of Phycology 41:1236-1247.  
Müller J, Day JG, Harding K, Hepperle D, Lorenz M, Friedl T. 2007. Assessing genetic stability of a range of 
terrestrial microalgae after cryopreservation using amplified fragment length polymorphism (AFLP). 
American Journal of Botany 94:799-808. 
Mumford R, Boonham N, Tomlinson J, Barker I. 2006. Advances in molecular phytodiagnostics - new 
solutions for old problems. European Journal of Plant Pathology 116:1-19. 
Muthusamy J, Staines HJ, Benson EE, Mansor M, Krishnapillay B. 2005. Investigating the use of fractional 
replication and Taguchi techniques in cryopreservation: a case study using orthodox seeds of a 
tropical rainforest tree species. Biodiversity and Conservation 14:3169-3185. 
Nadarajan J. 2005. Development of efficient experimental strategies for the cryopreservation of problematic 
tropical forest tree germplasm. PhD Thesis. Forest Research Institute of Malaysia-University of 
Abertay Dundee, Scotland, UK. 
Nadarajan J, Staines HJ, Benson EE, Marzalina M, Krishnapillay B, Harding K. 2006. Optimization of 
cryopreservation protocol for Sterculia cordata zygotic embryos using Taguchi experiments. Journal of 
Tropical Forest Sciences 18:222-230. 
Nadarajan J, Staines HJ, Benson EE, Marzalina M, Krishnapillay B, Harding K. 2007. Optimization of 
cryopreservation for Sterculia cordata zygotic embryos using vitrification techniques. Journal of 
Tropical Forest Sciences 19:79-85. 
Nadarajan J, Mansor M, Krishnapillay B, Staines HJ, Benson EE, Harding K. 2008. Applications of differential 
scanning calorimetry in developing cryopreservation strategies for Parkia speciosa, a tropical tree 
producing recalcitrant seeds. CryoLetters 29:95-110. 
Nakashima K, Yamaguchi-Shinozaki K. 2006. Regulons involved in osmotic stress-responsive and cold 
stress-responsive gene expression in plants. Physiologia Plantarum 126:62-71. 
NCI-National Cancer Institute. 2007. Best practices for biospecimen resources. National Cancer Institute, 
National Institutes of Health, US Department of Health and Human Services. 
Nishizawa S, Sakai A, Amano Y, Matsuzawa T. 1993. Cryopreservation of asparagus (Asparagus officinalis L.) 
embryogenic suspension cells and subsequent plant regeneration by vitrification. Plant Science 91:67-73. 
Ng SYC, Mantell SH, Ng NQ. 1999. Biotechnology in germplasm management of cassava and yams. In: 
Benson EE, editor. Plant Conservation Biotechnology. Taylor and Francis London, UK. pp. 179-209.  
Normah MN, Narimah MK, Clyde MM, editors. 1996. In vitro conservation of plant genetic resources. Plant 
Biotechnology Laboratory, Faculty of Life Science, Universiti Kebangsaan, MY.  
Normah MN, Makeen AM. 2008. Cryopreservation of excised embryos and embryonic axes. In: Reed BM, 
editor. Plant Cryopreservation: a Practical Guide. Springer, New York, USA. pp. 211-240. 
Nunc™ 2005. Safe cryogenic storage. Advice Note No. 77071 ver.3.2/YN108/05.  
Ochatt SJ, Marconi PL, Radice S, Arnozis PA, Caso OH. 1999. In vitro recurrent selection of potato: 
production and characterization of salt tolerant cell lines and plants. Plant Cell Tissue and Organ 
Culture 55:1-8.  
OECD 2001. Biological resource centres: underpinning the future of life sciences and biotechnology. OECD, 
Paris, FR. 
OECD 2007. OECD Best practice guidelines for biological resource centres. OECD, Paris, FR. 
Orief Y, Schultze-Mosgau A. 2005. Vitrification: will it replace the conventional gametes cryopreservation 
techniques? Middle East Fertility Society Journal 10:171-184.  
Panis B, Thinh NT. 2001. Cryopreservation of Musa germplasm: INIBAP Technical Guidelines No. 5. 
(Escalant JV, Sharrock S, editors.). INIBAP, Montpellier, FR and IPGRI, Rome, IT.  
  
Panis B. 2009. Cryopreservation of Musa germplasm. Technical Guidelines No. 9. (Engelman F, Benson EE, 
editors.). (2nd ed.). Bioversity International, Montpellier, FR. 
Panis B, Piette B, Swennen R. 2005. Droplet vitrification of apical meristems: a cryopreservation protocol 
applicable to all Musaceae. Plant Science 168:45-55. 
Park Y-S. 2002. Implementation of conifer somatic embryogenesis in clonal forestry: technical requirements 
and deployment considerations. Annals of Forest Science 59:651-656. 
Park Y-S, Barrett JD, Bonga JM. 1998. Application of somatic embryogenesis in high-value clonal forestry: 
deployment, genetic control and stability of cryopreserved clones. In Vitro Cellular and Developmental 
Biology Plant 34:231-239.  
Parker R, Hunt C. 2000. European association of tissue banks standards for cryopreserved cardiovascular 
tissue banking. Cell and Tissue Banking 1:241-245. 
Pegg DE. 1999. Safe cryopreservation of tissues and cells: general principles and current practices. 
CryoLetters 20:137-140.  
Pence C, Sandoval JA, Villalobos VM, Engelmann F. editors. 2002. In vitro collecting techniques for 
germplasm conservation. Technical bulletin No. 7. IPGRI, Rome, IT. 
Perazzo G, Panta A, Rodriguez F, Gomez R, Toledo J, Huamán Z et al. 2000. Clonal true-to-type verification of 
potato accessions retrieved from in vitro conservation and cryopreservation. CIP programme report 
1999-2000. CIP, Lima, PE. Available from URL: http://www.cipotato.org/publications/programme_ 
reports/99_00/20clonverif.pdf. 
Pritchard HW. 2004. Classification of seed storage types for ex situ conservation in relation to temperature 
and moisture. In: Guerrant EO, Haven K, Maunder M, editors. Ex situ Plant Conservation. Supporting 
Species Survival in the Wild. Washington DC, Island Press. pp. 139-161.  
Pritchard HW, Nadarajan J. 2008. Cryopreservation of orthodox (desiccation tolerant) seeds. In: Reed BM, 
editor. Plant Cryopreservation: a Practical Guide. Springer, New York, USA. pp. 485-501. 
Ramage CM, Borda AM, Hamill SD, Smith MK. 2004. A simplified PCR test for early detection of dwarf off-
types in micropropagated Cavendish banana (Musa spp. AAA). Scientia Horticulturae 103:145-151.  
Rani V, Raina SN. 2000. Genetic fidelity of organized meristem-derived micropropagated plants: a critical 
reappraisal. In Vitro Cellular and Developmental Biology Plant 36:319-330. 
Rao NK, Hanson J, Dulloo ME, Ghosh K, Nowell D, Larinde M. 2006. Manual of seed handling in genebanks. 
Handbooks for Genebanks No. 8. Bioversity International, Rome, IT.  
Reed BM. 1991. Application of gas-permeable bags for in vitro cold storage of strawberry germplasm. Plant 
Cell Reports 10:431-434. 
Reed BM. 1992. Cold storage of strawberries in vitro: a comparison of three storage systems. Fruit Varieties 
Journal 46:98-102. 
Reed BM. 1993. Improved survival of in vitro-stored Rubus germplasm. Journal of the American Society for 
Horticultural Science 118:890-895. 
Reed BM. 1999. In vitro storage conditions for mint germplasm. Horticulture Science 34:350-352. 
Reed BM. 2001. Implementing cryogenic storage of clonally propagated plants. CryoLetters 22:97-104. 
Reed BM. 2002. Photoperiod improves long-term survival of in vitro-stored strawberry plantlets. Horticulture 
Science 37:811-814. 
Reed BM. 2008. Cryopreservation - practical considerations. In: Reed BM, editor. Plant Cryopreservation: a 
Practical Guide. Springer, New York, USA. pp. 3-13. 
Reed BM, Aynalem H. 2005. Iron formulation affects in vitro cold storage of hops. ISHS Acta Horticulturae 
668:257-262. 
Reed BM, Denoma J, Luo J, Chang Y, Towill L. 1998a. Cryopreservation and long-term storage of pear 
germplasm. In Vitro Cellular and Developmental Biology Plant 34:256-260. 
Reed BM, Paynter CL, Denoma J, Chang Y. 1998b. Techniques for medium- and long-term storage of 
Pyrus L. genetic resources. Plant Genetic Resources Newsletter 115:1-5. 
Reed BM, Dumet DJ, Denoma JM, Benson EE. 2001. Validation of cryopreservation protocols for plant 
germplasm conservation: a pilot study using Ribes L. Biodiversity and Conservation 10:939-949. 
 Reed BM, Okut N, D‟Achino J, Narver L, Denoma J. 2003. Cold storage and cryopreservation of hops 
(Humulus L.) shoot cultures through application of standard protocols. CryoLetters 24:389-396. 
Reed BM, Engelmann F, Dulloo ME, Engels JMM. 2004a. Technical guidelines for the management of field 
and in vitro germplasm collections. Handbooks for Genebanks No. 7. IPGRI, Rome, IT.  
Reed BM, Kovalchuk I, Kushnarenko S, Meier-Dinkel A, Schoenweiss K, Pluta S et al. 2004b. Evaluation of 
critical points in technology transfer of cryopreservation protocols to international plant conservation 
laboratories. CryoLetters 25:341-352. 
Renau-Morata B, Arrillaga I, Segura I. 2006. In vitro storage of cedar shoot cultures under minimal growth 
conditions. Plant Cell Reports 25:636-642. 
Ryynänen L, Aronen T. 2005. Genome fidelity during short- and long-term tissue culture and differentially 
cryostored meristems of silver birch (Betula pendula). Plant Cell Tissue and Organ Culture 83:21-32. 
Ryynänen L, Sillanpää M, Kontunen-Soppela S, Tiimonen H, Kangasjärvi J, Vapaavuori E et al. 2002. 
Preservation of transgenic silver birch (Betula pendula Roth) lines by means of cryopreservation. 
Molecular Breeding 10:143-152.  
Sahijram L, Soneji JR, Bollamma KT. 2003. Analyzing somaclonal variation in micropropagated banana 
(Musa spp.). In Vitro Cellular and Developmental Biology Plant 39:551-556. 
Sakai A. 2004. Plant Cryopreservation. In: Fuller B, Lane N, Benson EE, editors. Life in the Frozen State. 
CRC Press, London, UK. pp. 329-345. 
Sakai A, Engelmann F. 2007. Vitrification, encapsulation-vitrification and droplet-vitrification: a review. 
CryoLetters 28:151-172. 
Sakai A, Kobayashi S, Oiyama I. 1990. Cryopreservation of nucellar cells of navel orange (Citrus sinensis 
Osb. var. brasiliensis Tanaka) by vitrification. Plant Cell Reports 9:30-33. 
Sakai A, Hirai D, Niino T. 2008. Development of PVS-based vitrification and encapsulation-vitrification 
protocols. In: Reed BM, editor. Plant Cryopreservation: a Practical Guide. Springer, New York, USA. 
pp. 33-57. 
Sandoval JA, Côte FX, Escoute J. 1996. Chromosome number variations in micropropagated true-to-type 
and off-type banana plants (Musa AAA Grande Naine CV.). In Vitro Cellular and Developmental 
Biology Plant 32:14-17. 
Sant R, Panis B, Taylor M, Tyagi A. 2008. Cryopreservation of shoot-tips by droplet vitrification applicable to all 
taro (Colocasia esculenta var. esculenta) accessions. Plant Cell Tissue and Organ Culture 92:107-111. 
Santos MDM, Buso GCS, Torres AC. 2008. Evaluation of genetic variability in micropropagated propagules 
of ornamental pineapple [Ananas comosus var. bracteatus (Lindley) Coppen and Leal] using RAPD 
markers. Genetic and Molecular Research 7:1097-1105. 
Sarkar D, Kuashik SK, Naik PS. 1999. Minimal growth conservation of potato microplants: silver thiosulfate 
reduces ethylene-induced growth abnormalities during prolonged storage in vitro. Plant Cell 
Reports 18:133-122.  
Sarkar D, Chakrabarti SK, Naik PS. 2001. Slow growth conservation of potato microplants: efficacy of 
ancymidol for long-term storage in vitro. Euphytica 117:133-142.  
Sarkar D, Sud KC, Chakrabarti, Naik PS. 2002. Growing of potato microplants in the presence of alginate 
silver thiosulfate capsules reduces ethylene-induced growth abnormalities during minimal growth 
conservation in vitro. Plant Cell Tissue and Organ Culture 68:79-98.  
Sarkar D, Pandey SK, Chanemougasoundharam A, Sud KC. 2005. The role of calcium nutrition in potato 
(Solanum tuberosum) microplants in relation to minimal growth over prolonged storage in vitro. Plant 
Cell Tissue and Organ Culture 81:221-227. 
Schäfer-Menuhr A, Müller E, Mix-Wagner G. 1996. Cryopreservation: an alternative for the long-term storage 
of old potato varieties. Potato Research 39:507-513. 
Schäfer-Menuhr A, Schumacher HM, Mix-Wagner G. 1997. Long-term storage of old potato varieties by 
cryopreservation of shoot-tips in liquid nitrogen. Plant Genetic Resources Newsletter 111:19-24.  
Scocchi A, Faloci M, Medina R, Olmos S, Mroginski L. 2004. Plant recovery of cryopreserved apical 
meristem-tips of Melia azedarach L. using encapsulation/dehydration and assessment of their genetic 
stability. Euphytica 135:29-38.  
  
Scowcroft WR. 1984. Genetic variability in tissue culture: impact on germplasm conservation and utilization. 
International Board for Plant Genetic Resources. Report (AGPG:IBPGR/84/152), Rome, IT. 
Scowcroft WR. 1985. Somaclonal variation: the myth of clonal uniformity. In: Hohn B, Dennis ES, editors. 
Genetic Flux in Plants. Springer Verlag, NY, USA. pp. 217-245.  
Šesták J, Zámečník J. 2007. Can clustering of liquid water and thermal analysis be of assistance for better 
understanding of biological germplasm exposed to ultra-low temperatures? Journal of Thermal 
Analysis and Calorimetry 88:411-416. doi: 10.1007/s10973-006-8232-8. 
Sharma SK, Bryan GJ, Winfield MO, Millam S. 2007. Stability of potato (Solanum tuberosum L.) plants 
regenerated via somatic embryos, axillary bud proliferated shoots, microtubers and true potato seeds: 
a comparative phenotypic, cytogenetic and molecular assessment. Planta 226:1449-58. 
Sherlock G, Block W, Benson EE. 2005. Thermal analysis of the plant encapsulation/dehydration protocol 
using silica gel as the desiccant. CryoLetters 26:45-54. 
SLTB - Society for Low Temperature Biology. 1999. Ensuring the safe cryopreservation of tissues and cells. 
Symposium of the SLTB, September 1998, Bristol, UK. CryoLetters 20:133-162.  
SLTB - Society for Low Temperature Biology. 2008. Validation, safety and ethical issues impacting low 
temperature storage of biological resources. Symposium of the SLTB, 12-14 September 2007, Derby, 
UK. CryoLetters 29:43-72.  
Smith D. 1998. United Kingdom national culture collection, UKNCC quality manual, UK new strategy for 
microbial collections 1998. CABI Bioscience UK Centre, Egham, UK. 
Smith D. 2001. Provision and maintenance of micro-organisms for industry and international research 
networks. CryoLetters 22:91-96. 
Smith D. 2003. Culture collections over the world. International Microbiology 6:95-100.  
Smith D, Ryan MJ. 2001. Culture collections in the 21st century. The Biologist 48:125-128. 
Smith D, Ryan MJ. 2008. The impact of OECD best practice on the validation of cryopreservation techniques 
for microorganisms. CryoLetters 29:63-72. 
Son HS, Chun Y W, Hall RB. 1991. Cold storage of in vitro cultures of hybrid poplar shoots (Populus alba L. 
x P. grandidentata Michx.). Plant Cell Tissue and Organ Culture 27:161-168. 
Stacey GN. 1999. Control of contamination in cell and tissue banks. CryoLetters 20:141-146.  
Stacey GN. 2004. Fundamental issues for cell-line banks in biotechnology and regulatory affairs. In: Fuller B, 
Lane N, Benson EE, editors. Life in the Frozen State. CRC Press, London, UK. pp. 437-452. 
Stacey GN, Doyle A. 1998. The biodiversity convention the key role of culture collections. CryoLetters 
Supplement 1:31-38. 
Stacey GN, Day JG. 2007. Long-term ex situ conservation of biological resources and the role of biological 
resource centres. In: Day JG, Stacey G, editors. Methods in Molecular Biology. Cryopreservation and 
Freeze Drying Protocols, Vol. 368, (2nd ed.). Humana Press, Totowa, New Jersey, USA. pp. 1-14. 
Stacey GN, Lynch PT, Benson EE. 1999. Plant genebanking: agriculture, biotechnology and conservation. 
Agri-Food-Industry Hi-Tech 10:9-14. 
Strosse H, Van den houwe I, Panis B. 2004. Cell and tissue culture, and mutation research. In: Jain SM, 
Swennen R, editors. Banana Improvement, Cellular, Molecular Biology and Induced Mutations. A joint 
Publication of FAO/IAEA and INIBAP. Science Publishers Inc. Enfield, NIH, USA. pp. 1-12. 
Surenciski MR, Dematteis M, Flachsland EA. 2007. Chromosome stability in cryopreserved germplasm of 
Cyrtopodium hatschbachii (Orchidaceae). Annals of Botany Fennici 44:287-292. 
Tanprasert P, Reed BM. 1997a. Detection and identification of bacterial contaminants from strawberry runner 
explants. In Vitro Cellular and Developmental Biology Plant 33:221-226. 
Tanprasert P, Reed BM. 1997b. Determination of minimal bactericidal and effective antibiotic treatment 
concentrations for bacterial contaminants from micropropagated strawberries. In Vitro Cellular and 
Developmental Biology Plant 33:227-230. 
Taylor MJ, Song YC, Brockbank KGM. 2004. Vitrification in tissue preservation: new developments. In: Fuller 
B, Lane N, Benson EE, editors. Life in the Frozen State. CRC Press, London, UK. pp. 603-641. 
Tedder RS, Zuckerman MA, Brink NS, Goldstone AH, Fielding A, Blair S et al. 1995. Hepatitis B transmission 
from contaminated cryopreservation tank. Lancet 346:137-140.  
 Thomas P. 2007. Isolation and identification of five alcohol-defying Bacillus spp. covertly associated with in 
vitro culture of watermelon. Current Science 92:983-987. 
Thomas P, Prakash GS. 2004. Sanitizing long-term micropropagated grapes from covert and endophytic 
bacteria and preliminary field testing of plants after 8 years in vitro. In Vitro Cellular and 
Developmental Biology Plant 40:603-607. 
Tomlinson MJ. 2005. Managing risk associated with cryopreservation. Human Reproduction 20:1751-1756.  
Tomlinson MJ. 2008. Risk management in cryopreservation associated with assisted reproduction. 
CryoLetters 29:165-174.  
Tomlinson MJ, Sakkas D. 2000. Is a review of standard procedures for cryopreservation needed? Safe and 
effective cryopreservation - should sperm banks and fertility centres move toward storage in nitrogen 
vapour? Human Reproduction 15:2460-2463. doi: 10.1093/humrep/15.12.2460. Available from URL: 
http://humrep.oxfordjournals.org/content/15/12/2460.full.pdf+html 
Tomlinson MJ, Pacey AA. 2003. Practical aspects of sperm banking for cancer patients. Human Fertility 
6:100-105.  
Turner S, Krauss SL, Bunn E, Senaratna T, Dixon K, Tan B et al. 2001. Genetic fidelity and viability of 
Anigozanthos viridis following tissue culture, cold storage and cryopreservation. Plant Science 161:1099-
1106. 
Tyagi RK, Agrawal A, Mahalakshmi C, Hussain, Z, Tyagi H. 2007. Low-costs media for in vitro conservation 
of turmeric (Curcuma longa L.) and genetic stablity assessment using RAPD markers. In Vitro Cellular 
and Developmental Biology Plant 43:51-58. 
UKNCC 1998.  United Kingdom National Culture Collection Quality Manual. UKNCC Secretariat, CABI 
Bioscience UK Centre, Egham, UK. 
Van den houwe I, De Smet K, Tezenas du Montcel H, Swennen R. 1995. Variability in storage potential of 
banana shoot cultures under medium term storage conditions. Plant Cell Tissue and Organ Culture 
42:269-274.  
Van den houwe I, Panis B, Arnaud E, Markham R, Swennen R. 2006. The management of banana (Musa 
spp.) genetic resources at the IPGRI/INIBAP genebank: the conservation and documentation status, 
In: Segers H, Desmet P, Baus E, editors. Tropical Biodiversity: Science, Data, Conservation 
Proceedings of the 3rd GBIF Science Symposium, 18-19 April 2005, Brussels, BE. pp. 143-152. 
Volk GM, Walters C. 2003. The preservation of genetic resources in the national plant germplasm 
collections. Plant Breeding Reviews 23:291-344. 
Volk GM, Walters C. 2006. Plant vitrification solution 2 lowers water content and alters freezing behaviour in 
shoot tips during cryoprotection. Cryobiology 52: 48-61. Available from URL: 
http://ddr.nal.usda.gov/bitstream/10113/28717/1/IND44194488.pdf 
Volk GM, Harris JL, Rotindo KE. 2006. Survival of mint shoot tips after exposure to cryoprotectant solution 
components. Cryobiology 52:305-308. 
von Versen R, Mönig H-J, Salai M, Bettin D. 2000. Quality issues in tissue banking: quality management 
systems - a review. Cell Tissue Banking 1:181-192. 
Walters C. 2004. Temperature dependency of molecular mobility in preserved seeds. Biophysical Journal 
86:1253-1258. 
Walters C, Wheeler L, Stanwood PC. 2004. Longevity of cryogenically stored seeds. Cryobiology 48:229-244. 
Walters C, Wesley-Smith J, Crane J, Hill LM, Chmielarz P, Pammenter NW, Berjak P. 2008. 
Cryopreservation of recalcitrant (i.e. desiccation-sensitive seeds). In: Reed BM, editor. Plant 
Cryopreservation: a Practical Guide. Springer, New York, USA. pp. 465-484. 
Wang Q, Mawassi M, Li P, Gafny R, Sela I, Tanne E. 2003. Elimination of grapevine virus A (GVA) by 
cryopreservation of in vitro-grown shoot tips of Vitis vinifera L. Plant Science 165:321-327.  
Wang QC, Valkonen JPT. 2008. Efficient elimination of sweetpotato little leaf phytoplasma from sweetpotato 
by cryotherapy. Plant Pathology 57:338-347. 
Ward ACW, Benson EE, Blackhall NW, Cooper-Bland S, Powell W, Power JB, Davey MR. 1993. Flow 
cytometric assessments of ploidy stability in cryopreserved dihaploid Solanum tuberosum and wild 
Solanum species. CryoLetters 14:145-152. 
Williamson P, Day JG. 2007. The problem with protists: is barcoding the answer? The Biologist 54:86-90. 
  
Withers LA. 1985. Minimum requirements for receiving and maintaining tissue culture propagation material. 
FAO of the UN, Rome, IT. 
Withers LA. 1989. In vitro conservation and germplasm utilization. In: Brown AHD, Marshal DR, Frankel OH, 
Williams JT, editors. The Use of Plant Genetic Resources. Cambridge University Press, Cambridge, 
UK. pp. 309-334. 
Withers LA, King PJ. 1980. A simple freezing unit and routine cryopreservation methods for plant cell 
cultures. CryoLetters 1:213-220.  
Withers LA, Williams JT. 1980. Crop genetic resources. The Conservation of Difficult Material. Proceedings 
of an International Workshop held at the University of Reading, UK. 8-11 September 1980, IBPGR, 
Rome, IT. 
WHO - World Health Organization - international agency for research on cancer. 2007. Common minimum 
technical standards and protocols for biological resource centres dedicated to cancer research. IARC 
recommendations and protocols for biobanking, version 1. Caboux E, Plymoth A, Hainaut P, editors. 
IARC Working Group Reports 2. International Agency for Research on Cancer, Lyon, FR. 
Xin Z, Browse J. 2000. Cold comfort farm: the acclimation of plants to freezing temperatures. Plant, Cell and 
Environment 23:893-902. 
Xiong L, Schumaker KS, Zhu J-K. 2002. Cell signaling during cold, drought and salt stress. Plant Cell 
14:Supplement 1 S165-S183. 
Yang T, Zhang L, Zhang T, Zhang H, Xu S, An L. 2005. Transcriptional regulation network of cold-responsive 
genes in higher plants. Plant Science 169:987-995.  
Zhu J, Dong C-H, Zhu J-K. 2007. Interplay between cold-responsive gene regulation, metabolism and RNA 
processing during plant cold acclimation. Current Opinion in Plant Biology 10:290-295. 
 
 
 
